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Introduction 
 
Essential fatty acids (EFAs) and their longer-chain more-unsaturated derivatives 
(the long-chain polyunsaturated fatty acids, abbreviated as LCPUFAs) are 
collectively named the essential PUFAs (ePUFAs) 
(1)
. These fatty acids are 
integral components of all cell membranes, in which they play an important role 
in maintaining the structural and functional characteristics of those membranes. 
Furthermore, especially LCPUFAs may contribute to other life processes such 
as fetal brain development, fetal growth and the development of the immune 
system 
(2-4)
. Since EFAs cannot be synthesized de novo by humans and the 
fetal LCPUFA synthesis from these EFAs is rather low 
(5)
, the fetuses depend 
on their mother’s ePUFA consumption and metabolism as well as on the 
placental transfer of these fatty acids. This is indicated by the positive 
correlation between the maternal and neonatal LCPUFA status at birth 
(6-8)
. 
Given that pregnancy is associated with a decrease in the LCPUFA status, this 
may have consequences for fetal development. Therefore, in this thesis, we 
present studies which are conducted to elucidate whether fetal exposure to 
certain LCPUFAs, reflected by maternal fatty acid concentrations during 
pregnancy and/or neonatal fatty acid levels at birth, are associated with fetal 
brain function (measured by fetal habituation), fetal growth and later immune 
function.  
The lactation period is characterized by a decrease in the relative maternal 
docosahexaenoic acid (DHA, 22:6n-3) levels and supplementation with n-3 
LCPUFAs may prevent this decline. However, an increased consumption of n-3 
LCPUFAs may cause for a concomitant reduction of the required n-6 LCPUFAs 
and of arachidonic acid (AA, 20:4n-6) in particular 
(9)
. Since breast milk contains 
AA and DHA, this reduction in AA may be unfavorable for breast-fed infants, 
because they also require an optimum supply of n-6 LCPUFAs. Accordingly, 
this may influence neonatal development and, therefore, we investigated the 
effect of n-3 and n-6 fatty acid supplementation on their concentrations in 
human milk.  
The next paragraphs give relevant background information on fatty acids in 
general and the influence of pregnancy and lactation on ePUFA concentrations. 
Subsequently, some introductory information about fetal habituation, fetal 
growth, the humane immune system and their relation with fatty acids is given. 
Finally, an overview of the research questions will be presented.  
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Essential fatty acids and their long-chain polyunsaturated derivatives 
 
Fatty acids are the building blocks for lipids and comprise a chain of carbon 
atoms (C-atoms) with at one end a methyl (CH3) head group and at the other 
end a carboxyl (COOH) tail group, see figure 1.  
 
 
Omega / n- →                                      ← ∆ 
                                O  
CH3          CH2         CH2         CH2         (CH2)n         C 
                                     OH  
methyl head group                      carboxyl tail group 
 
Figure 1. General structure of a saturated fatty acid 
 
 
Fatty acids with no double bonds between the carbon atoms are named 
‘saturated’, those with one or more double bonds are called mono- or 
polyunsaturated, respectively. According to the position of the first double bond 
(designated as ‘omega’ or ‘n-’), unsaturated fatty acids can either belong to the 
n-3, n-6, n-7 or n-9 family. In these families the first double bond of the fatty acid 
is located between the 3
rd
 and 4
th
, 6
th
 and 7
th
, 7
th
 and 8
th
 or 9
th
 and 10
th
 carbon 
atom, as counted from the methyl head group, respectively. There are several 
notations to identify fatty acids. In this thesis, the first number of the notation 
refers to the number of C-atoms, the second number to the number of double 
bonds and the last number refers to the family assignment. For example: DHA, 
written as 22:6n-3, contains 22 C-atoms, 6 double bonds and belongs to the n-3 
family.  
Parent fatty acids containing 18 carbon atoms with the first double bond at 
the n-6 or n-3 position, cannot be synthesized endogenously from other 
components by humans. The reason is that humans lack the ∆12- and ∆15-
desaturase enzymes, which enable the insertion of double bonds between the 
6
th
 and 7
th
, and 3
rd
 and 4
th
 carbon atom, respectively, counted from the methyl 
head group. Since these fatty acids are needed for several important body 
functions, they have to be obtained from the diet and are therefore called EFAs 
(10)
. The parent EFAs of the n-6 and n-3 families are linoleic acid (LA, 18:2n-6) 
and α-linolenic acid (ALA, 18:3n-3), respectively. These EFAs are mainly 
present in seed oils (LA and ALA) and green leafs (mainly ALA). Both parent 
fatty acids can be further metabolized in the human body by the same series of 
desaturase and elongase enzymes to longer-chain more-unsaturated 
derivatives, the LCPUFAs (see figure 2).  
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        n-7 family                n-9 family                             n-6 family                     n-3 family 
 
Figure 2. The main synthetic pathways of fatty acid metabolism 
Diet and de novo synthesis 
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(LA) 
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22:4n-6 
adrenic acid 
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dihomo-Mead 
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(DHMA) 
22:5n-3 
docosapentaenoic 
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 (DPA) 
Elongation, ∆6-desaturation and peroxisomal β-oxidation 
 
22:5n-6 
Osbond acid 
 (ObA) 
22:6n-3 
docosahexaenoic acid 
(DHA) 
20:3n-6 
dihomo-γ-linolenic acid 
(DGLA) 
20:2n-9 20:4n-3 
eicosatetraenoic acid 
∆5-desaturation 
 
20:4n-6 
arachidonic acid 
(AA) 
20:3n-9 
Mead acid 
 (MA) 
20:5n-3 
eicosapentaenoic acid 
(EPA) 
elongation 
 
16:2n-7 18:2n-9 18:3n-6 
γ-linolenic acid 
18:4n-3 
stearidonic acid 
elongation 
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The desaturase enzymes only insert double bonds between the carboxyl tail 
group and the closest double bond and, consequently, do not affect the 
molecular structure at the methyl end of the fatty acid molecule. Therefore, all 
metabolized fatty acids remain in the same fatty acid family. The ∆6-desaturase 
enzyme, which inserts a double bond between the 6
th
 and 7
th
 carbon atom 
counted from the carboxyl tail of the chain, prefers ALA, followed by, in order, 
LA, oleic acid (18:1n-9) and palmitoleic acid (16:1n-7) 
(3)
. The ∆6-desaturation is 
very important, since this step is considered to be the controlling step of the 
pathway 
(11)
. Although the ∆6-desaturase has a preference for ALA, the 
abundant availability of LA compared to ALA in the present Western diet can be 
expected to promote LA conversion at the expense of ALA. As a result, only a 
little bit of ALA can be converted in eicosapentaenoic acid (EPA, 20:5n-3) (6.95 
%) and DHA (0.08 %) 
(12,13)
.  When the LA and ALA levels are inadequate to 
meet the requirements, oleic acid will be metabolized to Mead acid (MA, 20:3n-
9) and dihomo-Mead acid (DHMA, 22:3n-9). Because LCPUFAs inhibit MA and 
DHMA synthesis, the presence of MA and DHMA indicate a shortage of all 
ePUFAs and are, therefore, named ePUFA status markers 
(1)
. There can also 
be a functional shortage of DHA. In that case, the body starts to synthesize the 
most comparable LCPUFA of the n-6 family, Osbond acid (ObA, 22:5n-6) 
(14,15)
. 
However, evidence is becoming available that ObA may not always be a useful 
biochemical measure of a low DHA status 
(16)
.  
 
 
Trans fatty acids  
 
Trans fatty acids are unsaturated fatty acids with at least one double bond in the 
trans configuration. They occur naturally in dairy and other animal fats as a 
result of the biological hydrogenation of polyunsaturated fatty acids in the 
stomach of ruminants, but dietary trans fatty acids result mainly from industrial 
hydrogenation of edible oils. Foods with major contributions to trans fatty acid 
intake are baked goods such as doughnuts, margarines, imitation cheese and 
deep-fried foods like fried chicken and french-fried potatoes 
(17)
. There is 
increasing evidence that industrially produced trans fatty acids promote 
ischemic heart disease. In addition, positive associations between the intake of 
these fatty acids and allergy, diabetes and cancer are reported 
(18)
. As a result, 
the food industry responded by reducing the use of partially hydrogenated fats 
which resulted in a decrease in the consumption of trans fatty acids. 
Consequently, the intake of trans fatty acids in the Netherlands fell from 15 g 
per day in 1980 to 3 g per day in 2003 
(19)
.   
Positive correlations are observed between maternal and neonatal trans 
fatty acids 
(20,21)
. Since the human fetus does not possess the function to 
produce trans fatty acids 
(22)
, the neonatal trans fatty acids originate from the 
maternal diet. Dietary trans unsaturated fatty acids have been shown to inhibit 
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the conversion of parent EFAs into their LCPUFAs, especially when the EFA 
contents are low 
(22,23)
. They may also impair placental LCPUFA transfer 
(24)
. 
Thus, trans fatty acids may lower the fetal LCPUFA status and thereby could 
compromise fetal development such as growth. This will be investigated in the 
present thesis. 
 
 
The influence of pregnancy on maternal ePUFA concentrations 
 
During pregnancy, accretion of maternal, placental and fetal tissue occurs. As a 
result, the mother adapts her metabolism in order to support the continuous 
draining of substrates, like n-3 and n-6 fatty acids, necessary for these changes 
(25)
. A prospective longitudinal study of Al et al. showed that the total absolute 
amount (mg/L) of fatty acids in maternal plasma phospholipids (PLs), measured 
from early pregnancy towards the end of the pregnancy, increased by 51 % 
(26)
. 
Similar patterns were found for the individual fatty acids and their fatty acid 
families. For example, the absolute amounts of DHA and AA increased by 52 % 
and 23 %, respectively. However, the proportional rise in absolute amounts of 
the non-essential unsaturated fatty acids (65 %) is considerably larger than the 
fractional increase in the absolute ePUFA amounts, which results in a 
significant decline of the EFA index [(n-3 + n-6)/(n-7 + n-9)] as pregnancy pro-
gresses.  
Besides measuring fatty acids in absolute amounts, fatty acids can also be 
expressed as relative concentrations (% by wt of total amount of identified fatty 
acids). The relative fatty acid concentrations showed a different pattern as 
compared to the absolute amounts. Thus, as pregnancy progressed, the 
relative level of AA declined. The relative DHA levels increased between the 
10
th
 and the 18
th
 week of pregnancy. After this period a gradual reduction was 
found, but DHA levels remained higher than prepregnancy levels throughout 
gestation. Nonetheless, the ObA synthesis, reflected by the ObA/adrenic acid 
(22:4n-6) ratio, increased gradually throughout pregnancy, which could indicate 
a reduction of the functional DHA status. These results suggest that the 
maternal ePUFA status declines during pregnancy.  
After delivery, a slow normalization of the ePUFA status in maternal plasma 
PLs takes place in approximately 32 weeks 
(26,27)
.  
  
 
The influence of lactation on maternal ePUFA concentrations  
 
Human milk fat is the major source of energy for the infant, contributing 40-55 % 
of the total energy intake. The fat composition is influenced by factors such as 
maternal diet, duration of pregnancy and stage of lactation. The relative n-6 and 
n-3 LCPUFA concentrations of mature breast milk lipids from mothers 
Thesis_Dirix_v2.pdf   12 6-4-2009   16:40:13
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consuming a western diet is about 1.28 % and 0.48 % of the total amount of 
fatty acids, respectively. Furthermore, the relative AA and DHA concentrations 
in human milk are 0.45 % and 0.23 %, respectively 
(28)
. The newborn infant is 
capable of synthesizing AA and DHA from precursor fatty acids, but this 
capacity seems insufficient to meet the high demands of the developing tissues 
(29,30)
. Consequently, for these LCPUFAs, infants largely depend on an 
adequate dietary supply after birth, preferably from breast milk.  
During lactation, women continue the transfer of their own LCPUFAs to their 
infants. The relative DHA concentrations in plasma PLs of lactating mothers, 
become lower than those of non-lactating mothers and even lower than those 
before conception 
(27)
. Since DHA seems to be important for brain and retina 
development and function, this may have negative effects for the neonate. On 
the other hand, increasing the consumption of n-3 LCPUFAs may cause a 
concomitant reduction of circulating n-6 LCPUFA concentrations and of AA in 
particular 
(9)
. This may be unfavorable in pregnant women and lactating women, 
because AA is considered essential for fetal and neonatal development 
(31,32)
. 
Since data from supplementation studies are limited we studied the effect of n-3 
LCPUFA supplementation, with or without AA, on AA and DHA levels in breast 
milk of lactating women.   
 
 
Fetal habituation and the ePUFA status 
 
In the womb the human fetus is surrounded by several acoustic stimuli, like the 
maternal intestinal and vascular noises. A fetus, just like an animal in the 
wildlife, needs to be able to distinguish those stimuli that are biologically normal 
and safe, like wind noises, from those stimuli that are potentially dangerous, like 
a growling lion. The fetus must learn to ignore the meaningless and safe stimuli 
in order to prevent needless anxiety. The ability to ignore this constant 
stimulation is provided by the process which is called habituation. Habituation is 
defined as the decrease in, and ultimate cessation of, the response to repeated 
stimulation with the same stimulus 
(33,34)
. Furthermore, it is often considered to 
represent a form of learning and probably requires an intact and functioning 
central nervous system 
(35)
. Memory, a prerequisite for fetal learning, is 
essential for normal functioning and it is likely that memory starts to develop 
during the prenatal period. In the beginning it probably functions in some 
rudimentary form and develops as the individual matures. Fetal memory may be 
important for the development of attachment and maternal recognition, for the 
establishment of breastfeeding, and for language acquisition 
(36)
. Nowadays, it 
still is not known from what fetal age this memory can be established and for 
how long this memory lasts. Therefore, we investigated this in the present 
thesis.   
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Brain development is a complex process in which early disruptive events, 
like an inappropriate nutrients supply, can have long-lasting effects on later 
functional adaptations 
(37)
. During periods of rapid brain growth, especially 
during the third trimester of pregnancy and the first months after birth, high 
accretion of both AA and DHA take place in the brain 
(2)
. Therefore, these fatty 
acids are thought to be important for fetal brain development and brain function 
(37,38)
. Since pregnancy is associated with a temporary decrease in the 
biochemical LCPUFA status of the mother, fetal brain function may not be 
optimal. Therefore, we investigated if some aspects of fetal brain function 
measured by fetal habituation, viz. fetal learning and memory, were related to 
the ePUFA status.  
 
 
Potential consequences of the early LCPUFA status on fetal growth 
 
The LCPUFAs DHA and AA are thought of critical importance for fetal brain 
development and fetal growth, respectively 
(2,3)
. Because the maternal LCPUFA 
status declines during the course of pregnancy, the LCPUFA supply to the 
developing fetus may not always be optimal. Since more evidence is becoming 
available that low birth weight is associated with negative health outcomes later 
in life, it seems prudent to optimize fetal growth during pregnancy 
(39)
. Several 
studies investigated the relationship between fetal growth and LCPUFAs, but 
results remain inconclusive 
(40-42)
. Therefore, we investigated if there are 
associations between some specific birth dimensions and maternal and 
neonatal LCPUFAs measured during pregnancy and/or directly after delivery. 
 
 
Arachidonic acid and the human immune system  
 
The immune system consists of several organs and cell types that protect the 
host against pathogenic organisms. There are two types of immunity, the innate 
and the adaptive system. Innate immunity is present at all times in normal 
individuals and is thus fully functional before infectious agents enter the body. In 
this type of immunity phagocytes, including monocytes, macrophages and 
neutrophils, play an important functional role. In addition, the human body has 
the possibility to develop specific immunity against individual invading agents 
such as bacteria, viruses, toxins, etc. This is called the adaptive system, in 
which lymphocytes play an important role 
(43)
.  
20-carbon LCPUFAs can serve as precursors for the synthesis of bioactive 
lipid mediators named eicosanoids. Eicosanoids include prostaglandins, 
thromboxanes, leukotrienes and other oxidized derivatives. Since immune cells 
contain high contents of AA, and low contents of other 20-carbon PUFAs, AA is 
usually the major substrate for prostaglandin E2 (PGE2), which is thought to be 
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an important mediator of immune responses 
(44,45)
. As mentioned above, earlier 
studies revealed that the maternal AA status declines during pregnancy 
(26)
. As 
a result, the AA supply to the developing fetus and its immune system may not 
always be optimal. In the literature, the relationship between prenatal AA 
concentrations and later immune-related variables remains relatively 
unexplored. Therefore, we investigated if prenatal AA exposure is related to 
several immune-related clinical conditions and inflammation markers of the child 
at seven years of age.  
 
 
Research questions 
 
The above presented literature underlines the importance of getting insight in 
the associations between EFAs and LCPUFAs and fetal learning and memory, 
growth and immune function. Also the effect of n-6 and n-3 fatty acid 
supplementation on breast milk levels is of importance. Therefore, in this thesis 
we will concentrate on the following research questions: 
 
1) From which gestational age can fetal learning and memory be 
established, how long does fetal memory lasts and do fetal learning 
and memory depend on fetal age? (Chapter 2) 
 
2) Are fetal learning and memory associated with the early essential 
polyunsaturated fatty acid status? (Chapter 3) 
 
3) Are neonatal birth dimensions associated with maternal essential and 
trans fatty acid contents, sampled during pregnancy and at delivery? 
(Chapter 4) 
 
4) Are neonatal birth dimensions associated with prenatal exposure to 
essential and trans fatty acids? (Chapter 5) 
 
5) What is the effect of n-3 LCPUFA supplementation, with or without AA, 
on AA and DHA levels in breast milk of lactating women? (Chapter 6) 
 
6) Is prenatal AA exposure associated with immune-related clinical 
conditions and plasma markers in childhood? (Chapter 7) 
 
In chapter 8, the main results of these studies and their possible implications 
are discussed. 
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Aspects of fetal learning and memory 
 
Chantal E.H. Dirix, Jan G. Nijhuis, Henk W. Jongsma and Gerard Hornstra 
 
Based on: Child Development (in press) 
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Abstract 
 
Ninety-three pregnant women were recruited to assess fetal learning and 
memory, based on habituation to repeated vibroacoustic stimulation of fetuses 
of 30-38 weeks gestational age (GA). Each habituation test was repeated 10 
minutes later to estimate fetal short-term memory. For groups 30-36, both 
measurements were replicated in a second session at GA 38 for the 
assessment of fetal long-term memory. Within the time frame considered, fetal 
learning appeared GA-independent. Furthermore, we observed that fetuses 
have a short-term (10 minutes) memory from at least 30 weeks GA onwards, 
which also appeared independent of fetal age. In addition, results indicated that 
34 week old fetuses are able to store information and retrieve it 4 weeks later.  
 
 
 
Thesis_Dirix_v2.pdf   18 6-4-2009   16:40:14
Fetal learning and memory | 
19 
Introduction 
 
Habituation is the decrement in attention or response following repeated 
stimulation with the same stimulus 
(33)
. This phenomenon can be distinguished 
from phenomena such as effector fatigue or receptor adaptation since it 
requires an immediate recovery of the response on presentation of a different 
stimulus and it also requires that the response decrement occurs faster upon re-
presentation of the original stimulus 
(33,35)
. The first study of fetal habituation was 
reported in 1925, in which a decrease in fetal movements was observed after 
repeated stimulation with a car horn 
(46)
. Since then several studies have shown 
that repeated stimulation of a fetus with the same stimulus, such as an electric 
toothbrush 
(47)
, a vibroacoustic stimulator 
(48)
 or a door buzzer 
(49)
, resulted in a 
decrement of its response. The decrement of the fetal response was assessed 
by, for example, changes in fetal heart rate 
(50)
 or fetal movements 
(51)
.  
Habituation is considered to represent a form of learning and probably 
requires an intact and functioning central nervous system (CNS) 
(35)
. A better 
understanding of the normal development of the fetal CNS will lead to more 
insight into abnormalities, allowing, prevention and/or extra care in the first 
years of life and, as a consequence, to less problems in later life. Fetuses 
whose behavioral development lags behind need significantly more stimuli 
before habituation occurred than well-developed fetuses of the same 
gestational age (GA). This was demonstrated by Morokuma et al., who defined 
three behavioral indicators to classify the developmental stage of fetal CNS 
function: 1) alteration of the eye movement and no eye movement periods, 2) 
rapid and slow eye movement patterns and 3) concurrence of regular mouthing 
movement in the no eye movement period 
(51)
. Impaired habituation 
performance has also been identified in fetuses diagnosed with Down’s 
syndrome. In the study by Hepper and Shahidullah, one fetus failed to habituate 
completely and the other habituated more slowly than the normal fetuses tested 
(52)
.  
It is likely that memory starts to develop during the prenatal period. In the 
beginning it probably functions in some rudimentary form and develops as the 
individual matures. Fetal memory may be important for the development of 
attachment and maternal recognition, for the establishment of breastfeeding 
and for language acquisition 
(36)
. Memory can be divided in a short-term 
memory, which lasts seconds till a couple of hours, a long-term memory, which 
may lasts hours to months and a long-lasting memory which may last a life-time 
(53)
. Van Heteren et al. used fetal habituation to assess fetal memory 
(48,54)
. 
Repeated vibroacoustic stimuli of 1 second each were applied every 30 
seconds and a general movement of the fetal trunk within 1 second of 
application was defined as a positive response. Cessation of the fetal response 
movements for 4 consecutive stimuli was taken to indicate habituation. Using 
this methodology, these authors observed that a short-term memory of at least 
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10 minutes is present in normal healthy term fetuses, which may even last for 
24 hours. 
Several investigators studied fetal habituation in relation to post- 
conceptional age with inconsistent results. Morokuma et al., for example, 
defining habituation as the gradual and ultimately complete extinction of the 
fetal movement response for five consecutive vibroacoustic stimuli, observed 
that the number of stimuli to require habituation was significantly and inversely 
related to GA 
(51)
. Groome and coworkers scored the intensity of the fetal 
response to each stimulus and they classified the fetal response as: fast 
general (a rapid, intense full-body startle response), fast local (a fast head or 
limb movement), slow roll (slow turning of fetus, usually confined to slow 
movement of the head and/or trunk) and no response 
(55)
. Repeated 
vibroacoustic stimuli were given for 2 seconds each, separated by 5-second off 
periods. In total, a maximum of 14 stimuli were presented and they also found 
that older fetuses habituated significantly faster than younger ones. Madison 
and coworkers on the other hand could not find a significant correlation between 
fetal age and the rate of habituation 
(56)
. However, they used a vibrator to 
stimulate the fetuses and defined habituation as extinction of the fetal response 
for five consecutive stimulations. Consequently, it still is not known from what 
post-conceptional age a fetal memory can be ascertained and for how long a 
fetus can recognize a specific stimulus. Therefore, the purpose of the present 
study was to investigate from which gestational age fetal learning and memory 
can be established, how long fetal memory lasts and whether fetal learning and 
memory depend on fetal age.   
 
 
Method 
 
Study population 
 
The population of the habituation study included 100 healthy Dutch Caucasian 
pregnant women who were recruited through midwives in the Southern Limburg 
region of The Netherlands and the Department of Obstetrics and Gynaecology 
of the Maastricht University Medical Centre (MUMC) in Maastricht. The study 
was approved by the Ethics Committee of the MUMC and all mothers gave their 
informed consent in writing.  
Inclusion criteria at intake were: (a) gestational age between 28-38 
completed weeks (gestational age was determined using the last menstrual 
period or by ultrasound when dates were uncertain); (b) absence of maternal 
metabolic, cardiovascular, renal or neurological disorders; (c) no use of 
medication (iron and folate allowed), drugs or alcohol (more than 7 glasses per 
week); (d) smoking less than 6 cigarettes per day; (e) no change in nutritional 
habits during pregnancy; (f) no depression during the present pregnancy or not 
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more than one episode of depression before the present pregnancy; (g) a 
diastolic blood pressure below 90 mm Hg; (h) single fetus without apparent 
structural anomalies.  
Exclusion criteria during the study were: (i) parturition before week 37 or 
after week 43 of gestation; (j) fetus with a birth weight below the 10
th
 percentile 
according to population-based tables adjusted for pregnancy duration and fetal 
sex 
(57)
; (k) abnormal amniotic fluid volume as assessed by ultrasound.  
 
Maternal and neonatal characteristics 
 
At the start of the study, a basal (intake) questionnaire was filled out by all 
volunteers, which included the following items: maternal age, pre-pregnancy 
weight, height, weight and height of the father, medical history of the mother 
including former pregnancies, maternal consumption of fish and nutrient 
supplements, smoking and drinking habits of the mother and choice of infant 
feeding. Education was scored on an 8-point scale, ranging from primary 
education to higher vocational training and university 
(58)
. The outcome of each 
pregnancy was examined in terms of mode of delivery, birth weight, Apgar 
scores, infant sex, gestational age at delivery and the presence of neonatal 
abnormalities.  
 
Fetal habituation method 
 
Fetal habituation was assessed according to the protocol used by Van Heteren 
and coworkers 
(48,59)
. All habituation tests were performed by the same 
examiner (C.E.H. D.), between 5 and 8 pm in a darkened quiet room. The 
volunteers were placed in a semi-recumbent position and were not allowed to 
drink coffee or tea, smoke and eat for 3 hours before testing. 
Every 30 seconds, a vibroacoustic stimulus (VAS) of 1 second was applied 
to the maternal abdomen above the fetal legs, using a fetal vibroacoustic 
stimulator (Corometrics model 146, Wallingford, CT, USA; audible sound 20-
9000 Hz, vibrations 67-83 Hz, sound level 74 dB at 1 m in air). Movements of 
the fetus within 1 second after application of the stimulus and monitored by an 
ultrasound scanner (HDI-5000, Bothell, USA) displaying the fetal trunk, was 
considered a positive response. VAS-elicited fetal responses are typical 
immediate movements which can easily be distinguished from a coincidental 
movement by the mother. Therefore, fetal movements experienced by the 
mother within 1 second after application of the stimulus, but missed by the 
scanner, were accepted as a positive response also. However, in the vast 
majority of the tests, movements were readily picked up by the scanner. 
Disappearance of the response for four consecutive stimuli was taken to 
demonstrate habituation. To prevent interference by spontaneous fetal 
movements, habituation tests started after a three-minutes period in which the 
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fetus was not moving spontaneously 
(60)
. After fetal habituation was identified, 
stimulation was stopped. There was a maximum of 24 stimulus applications in 
each test. However, when a fetus was still responding to the 21
st
 stimulus, a 
minimum of 4 extra stimuli would be necessary to determine habituation. 
Therefore, no further stimuli were given if a fetus still responded to the 21
st
 
stimulus. The habituation rate was defined as the number of consecutive stimuli 
applied before habituation was established. This is considered a measure of the 
fetal learning capacity at the moment of the habituation measurement. 
Habituation tests, in which fetuses reacted inconsistently to the VAS so that 
habituation could not be established, were considered missing and as a 
consequence these data were ignored in calculating and analyzing the results. 
Fetuses were excluded if they did not respond to VAS at the initial habituation 
test. 
 
Measuring scheme and calculations of fetal learning and memory 
 
Habituation was measured several times in each fetus, as explained below and 
outlined in table 1. 
 
 
Table 1. Schedule of habituation measurements per group
a
 
First session  Second session 
GA 30 GA 32 GA 34 GA 36  GA 38 Group 
A B A B A B A B  A B C D 
30 HR HR          HR HR 
32   HR HR        HR HR 
34     HR HR      HR HR 
36       HR HR    HR HR 
38          HR HR 
Not 
applicable 
a 
HR measurement =  measurement of habituation rate; GA = gestational age in weeks; A = initial 
habituation rate measurement at first session; B = repetition, 10 minutes after A; C = initial 
measurement at second session; D = repetition, 10 minutes after C. 
 
 
Habituation rate (fetal learning) as function of gestational age  
 
Depending on their pregnancy durations, volunteers were divided over five 
groups. Fetal habituation rates (HR) were measured at two times during a first 
test session at GA of 30 (group 30), 32 (group 32), 34 (group 34), 36 (group 36) 
or 38 weeks (group 38). For groups 30-36, these two measurements were 
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repeated during a second test session at GA 38. The values of the first 
habituation rate measurement (HR-A) were considered a measure of fetal 
learning and were correlated to GA as described in data analysis. 
 
Fetal 10-minute memory 
 
The difference in habituation rates (HR) of a given fetus between the two tests 
in each session is taken as a reflection of its short-term (10 minutes) memory 
and is expressed as a percentage of the initial habituation rate. After the initial 
habituation test of the first session at 30, 32, 34, 36 or 38 weeks of gestation 
(HR-A, see table 1), all fetuses were tested again in exactly the same way 10 
minutes later (HR-B). The fetal 10-minute memory during these first test 
sessions (STM-1) was calculated as 100*[(HR-A) minus (HR-B)]/(HR-A). At GA 
38, habituation rates of the fetuses of groups 30-36 were again measured twice 
with a 10 minutes interval (HR-C and HR-D, respectively) and the 10-minute 
memory during this second session (STM-2) was calculated as 100*[(HR-C) 
minus (HR-D)]/(HR-C). However, if fetuses did not respond to the initial VAS 
stimulus at the second session (HR-C = 0), percentage calculation would 
require division by zero, which is not possible. Therefore, 0.5 was added to all 
HR values measured.  
 
Fetal long-term memory 
 
The habituation rates measured in fetuses of groups 30-36 at 38 weeks GA 
may, at least partly, result from ‘memorizing’ the earlier habituation 
measurements at GA 30-36. If this is the case, their HR values at GA 38 (HR-C) 
will be significantly lower than their HR values at 30-36 weeks GA (HR-A) and 
they will also be significantly lower than those of 38 weeks old fetuses who did 
not experience an earlier habituation test before (Group 38). Therefore, to 
assess the presence of a long-term memory in 38 week old fetuses, HR-C 
values of the fetuses of groups 30-36 were statistically compared to their own 
HR-A values. Finally, in the groups in which this comparison demonstrated 
significance (indicating the presence of a long-term memory indeed), these HR-
C values were statistically compared to the HR-A values of group 38. This 
comparison was not performed in groups with no significant differences 
between HR-C and HR-A values, since this outcome excludes the presence of 
a long-term memory. 
 
Data analysis 
 
All data were checked for normality by histograms and Shapiro’s test. Since 
most data were not normally distributed, non-parametric statistics were applied 
for data evaluation.  
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Differences in maternal and neonatal characteristics between the five 
groups were tested for significance with either the Chi-Square test (discrete 
variables) or the Kruskal-Wallis test (continuous variables). Differences between 
paired data were evaluated with the Wilcoxon signed-rank test and distinctions 
between unpaired data were analyzed with the Mann-Whitney U test.  
Relations between two variables were assessed with the Spearman’s rank 
correlation test. Application of the various tests will be mentioned when 
describing the results.  
For all statistical analyses, a p-value < 0.050 was considered statistically 
significant. All statistical analyses were performed using the statistical package 
SPSS 11.5 for Windows (release 11.5, SPSS Inc., Chicago, Illinois). 
 
 
Results 
 
Eleven women who were included in the study dropped out for various reasons: 
(a) one volunteer delivered (almost 24 hours after rupture of the membranes) 
her baby before the planned test date at 38 weeks GA and her baby died one 
day after birth due to a streptococcal infection; (b) two mothers had pregnancy-
induced hypertension; (c) one volunteer stopped because her fetus developed 
intra-uterine growth retardation; (d) one child was born before 37 weeks GA; (e) 
one child had a birth weight below the 10
th
 percentile and (f) five volunteers 
were excluded because their fetuses did not react to the VAS at the initial 
habituation test of the first session (HR-A). Women who were excluded during 
the study were replaced by new volunteers. However, due to time restrictions, 
seven volunteers could not be replaced, leaving 93 volunteers instead of 100. 
Therefore, group 30 included 17 volunteers and groups 32 and 38 consisted of 
18 volunteers instead of 20. 
The relevant maternal and neonatal characteristics are displayed in table 2. 
Groups did not differ significantly in maternal age, height, pre-pregnancy body 
mass index (BMI), educational level, parity and mode of delivery (p = 0.189 - 
0.991; Kruskal-Wallis test). Differences in neonatal weight, gestational age at 
delivery and Apgar score at 5 minutes (p = 0.301 - 0.909; Kruskal-Wallis test) 
were also not significant between the groups. The same holds for infant sex, 
although there was a trend for a higher number of female fetuses (p = 0.052; 
Chi-Square test). All included neonates were in good health after birth, with a 5-
minute Apgar score ≥ 8 and a birth weight > 10
th
 percentile and no congenital 
anomalies were detected. 
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 Subjects with incomplete data were nevertheless included. As a 
consequence, not all data analyses were based on the same number of 
subjects. In the vast majority of the habituation tests (95.2 %) the presence or 
absence of habituation could reliably be established. Only in 16 out of the 336 
tests this appeared impossible, due to irregular responses (4 tests) or birth 
before the planned test date (12 tests). These 16 habituation tests concerned 
nine fetuses which did not differ from the others for the above mentioned 
maternal and neonatal clinical characteristics (p = 0.092 - 0.784; Mann-Whitney 
U test). The discrete variable infant sex was also not significantly different (p = 
0.677; Chi-Square test). However, as expected, a significant difference existed 
in gestational age (p = 0.001; Mann-Whitney U test) due to the fetuses who 
were born before the planned test date. The maternal and neonatal 
characteristics of the fetuses (n = 5) who were excluded due to non-responses 
at HR-A were comparable with those included in the statistical analyses (p = 
0.209 - 0.891; Mann-Whitney U test); this also accounts for infant sex (p = 
0.992; Chi-Square test). The results of all habituation measurements are given 
in table 3.  
 
Habituation rate (fetal learning) as function of gestational age 
 
At 30 weeks GA, almost all fetuses demonstrated habituation already and no 
significant relation was observed between fetal learning, as reflected by the first 
measured HR values (HR-A) of all five groups, and gestational age at 
measurement (Spearman’s rho = 0.052; p = 0.622).  
  
Fetal 10-minute memory 
 
In each group, with the exception of group 32, a significant decline was 
observed between the initial (HR-A) and repeated (HR-B) habituation tests in 
the first session (Wilcoxon signed-rank test; p = 0.001, p = 0.305, p < 0.001, p < 
0.001, p = 0.001, for groups 30-38 respectively). Furthermore, there was a 
significant decrease in each group between HR-C and HR-D values of the 
second session at GA 38 (p = 0.012, p = 0.001, p = 0.002, p < 0.001, for groups 
30-36 respectively). The 10-minute memory values (short-term memory, STM) 
were quantified as described above and results are reported in table 4. No 
significant correlation was observed between fetal age at the time of 
measurement and STM of the first session (STM-1, Spearman’s rho = 0.042, p 
= 0.692). Between the STM of the first (STM-1, GA between 30 and 36 weeks) 
and second session (STM-2, GA 38 weeks) no significant differences were 
found for any of the groups (p = 0.069 - 0.983; Wilcoxon signed-rank test). Also, 
no significant difference was found between STM-2 of groups 30-36 taken 
together and STM-1 of group 38 (Mann-Whitney U test; p = 0.590). When the  
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STM-2 values of groups 30-36 were tested separately against the STM-1 values 
of group 38, also no significant differences were found (Mann-Whitney U test; p 
> 0.384). 
 
 
Table 4. Short-term (10-minutes)  memory during both sessions
d
 
Session 1 
(GA shown by group) 
Session 2 
(GA 38 week) Group 
n Median (IQR) n Median (IQR) 
30 16 78.3 (46.8 - 85.7) 16 54.4 (0.0 - 92.0) 
32 17 72.7 (-33.3 - 84.4) 16 73.8 (37.3 - 88.9) 
34 20 76.6 (62.2 - 91.4) 16 76.2 (12.7 - 94.2) 
36 20 75.2 (28.5 - 92.2) 19 70.6 (40.0 - 90.9) 
38 18 69.5 (37.1 - 94.5) Not applicable 
d
 Short-term (10-minutes) memory, given as median and interquartile ranges (IQR), is the decrease 
between two successive habituation rates measured with a 10 minutes interval and is expressed as 
a % of the initial habituation rate. GA = gestational age in weeks at measurement. 
 
 
Fetal long-term memory 
 
HR-C values of groups 30-36 were invariably lower than their HR-A values (see 
table 3), although these differences were significant for groups 34 and 36 only 
(p = 0.017 and p = 0.044, respectively; Wilcoxon signed-rank test). When HR-A 
results of group 38 were tested against HR-C values of the two groups 
separately (Mann-Whitney U test), p-values of 0.053 (group 34) and 0.331 
(group 36) were found. These non-significant results might be due to the rather 
limited power and, therefore, HR-C values of groups 34 and 36 were taken 
together and compared to the HR-A values of group 38 by means of the Mann-
Whitney U test. In this way it was evaluated whether there are significant 
differences between earlier tested fetuses and fetuses who had never been 
tested before. It then appeared that the habituation rates of earlier tested 
fetuses tended to be somewhat lower than those of fetuses of the same GA but 
tested for the first time. However, the differences were not significant (p = 0.095; 
Mann-Whitney U test).  
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Discussion 
 
The aim of this study was to determine from which gestational age fetal learning 
and memory could be established, how long this memory lasts in utero and 
whether fetal learning and memory depend on gestational age. Our results 
showed that fetal learning, as reflected by the first habituation rate outcomes 
between the age of 30 and 38 weeks, is independent of GA. Furthermore, it was 
found that fetuses have a short-term (10 minutes) memory from 30 weeks GA 
onwards, which also seems independent of gestational age when it is measured 
for the first time. A long-term memory of 4 weeks is possibly present in 38 week 
old fetuses. 
 
Habituation rate (fetal learning) as function of gestational age 
 
Groome et al. found that older fetuses (36-40 weeks GA) habituated 
significantly faster than younger ones (28-32 weeks GA) 
(55)
. A study of 
Morokuma et al. also showed that the number of stimuli to require habituation 
was significantly and inversely related to gestational age 
(51)
. On the other hand, 
Madison et al. studied 39 fetuses between 28 and 37 weeks of gestation and 
could not find a significant correlation between fetal age and the rate of 
habituation, which is in line with our results 
(56)
. Due to different methodologies 
used to assess habituation, it is difficult to point out reasons for these 
discrepancies. Although Groome et al. as well as Morokuma et al. used the 
same vibroacoustic stimulator as we did, these two studies differed from each 
other and ours in the maximum number of stimulations applied in each session. 
Groome et al. and we used maximally 14 and 24 stimuli, respectively, while 
Morokuma et al. did not define a maximum number of stimuli. Furthermore, 
Morokuma et al. included the data of only 26 volunteers in the study, whereas 
the study of Groome et al. and our own study enclosed 90 and 93 volunteers, 
respectively. Moreover, Groome et al. always gave 14 stimulations to each fetus 
while Morokuma et al. and we accepted a lack of response to five, respectively, 
four consecutive stimuli as habituation. Finally, the study of Madison et al. also 
differed in the aspects mentioned above and, moreover, their stimulator 
provided only vibrations and no acoustics.  
In our study, the fetuses tested at 32 weeks GA showed the lowest HR-A 
values of all groups, which might suggest that fetal brain maturation reached an 
optimum for the habituation reaction already or that other undefined factors 
could have impacted the HR-values. For these suggestions to be acceptable, 
however, the HR-A values of groups 34-38 would need to be of the same order 
of magnitude, whereas they were comparable to the value observed for group 
30. So it seems that the low HR-A values of group 32 happened by chance.  
For a proper interpretation of our results it is essential to know whether the 
response decrement we observed is really due to habituation and not to effector 
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fatigue or receptor adaptation. Habituation can be distinguished from adaptation 
or fatigue by the recovery of a habituated response on presentation of a new 
stimulus (dishabituation) and faster habituation upon re-presentation of the 
original stimulus 
(33,35)
. Although we did see faster habituation to the original 
stimulus in the 10-minutes test series (HR-B and HR-D), a limitation of the 
current study is that we did not present a novel (dishabituation) stimulus in the 
habituation series to exclude effector fatigue or receptor adaptation. However, 
since these phenomena have not been observed in comparable fetuses tested 
at a gestational age similar to that of the fetuses in our study and using stimuli 
largely comparable to the ones we applied 
(52,61,62)
, it seems unlikely that effector 
fatigue or receptor adaptation contributed to the response decrement we 
observed, but we cannot rule it out completely.  
 
Fetal 10-minute memory 
 
The presence of a short-term memory of ten minutes confirms the results of 
Van Heteren et al., who showed that, after an initial habituation test, fetuses 
between 37-40 completed weeks GA needed less stimuli for habituation 10 
minutes later 
(48,54)
. Hepper and Shahidullah also found a short-term memory in 
fetuses measured between 34-36 weeks GA 
(52)
. The present study showed that 
the 10-minute memory, measured at the first session, was not dependent on 
fetal age from 30 weeks GA on. This implies that a 10-minute memory could 
already be present before week 30 of pregnancy. Although the earliest 
habituation response of a fetus to an auditory stimulus was noted at a post-
conceptional age of  22-23 weeks 
(63)
, previous studies showed that only a 
minority of the fetuses is able to respond to VAS before the 29
th
 week of 
pregnancy 
(64,65)
. As a consequence, fetal memory might be present in an earlier 
stage of pregnancy, but this cannot be verified with this method.  
 
Fetal long-term memory 
 
In the present study, paired analyses in each group demonstrated a decline in 
habituation rate between the initial tests of the first and second session (HR-A 
versus HR-C), which suggests the presence of a long-term memory. Since 
these decreases were significant for groups 34 and 36 only, our observation 
suggests that a fetus of 34 weeks GA is able to store information and retrieve it 
4 weeks later and, consequently, may have a 4-week’s memory already at 38 
weeks GA. However, in the unpaired comparison between HR-C tests of groups 
34 and 36 taken together (measured at GA 38, fetuses were exposed to VAS 
before) and the HR-A test of group 38 (measured at GA 38 as well, but first 
VAS experience of the fetuses), the habituation rates were not significantly 
different. Since the p-value of this comparison (p = 0.095) indicates a trend, this 
outcome may point to the presence of a long-term memory indeed. It should be 
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recalled that unpaired statistics usually require more cases for a given 
difference to reach significance than paired analyses. Consequently, the power 
of the study may have been too low for this latter comparison. Under the 
presumption that adding more cases would not change the distribution of the 
habituation rate outcomes, post hoc power calculations showed that 40 % more 
cases per group would be required for significance of the present difference 
between the HR-C tests of group 34 and 36 and the HR-A test of group 38. In 
the literature, only one study used habituation to assess the presence of a long-
term memory and found that habituation rates of ten fetuses between 34-36 
weeks GA were not significantly different when they were measured again 7 
days later 
(52)
. Our results, nonetheless, indicate that a 4-week memory may 
exist in fetuses of 38 weeks GA, but further research is required for 
confirmation. 
In conclusion, we observed that fetal learning and short-term (10 minutes) 
memory, as assessed by repeated fetal habituation, is present at 30 weeks GA 
already. In addition, we present some evidence that 34 week old fetuses are 
able to store information and retrieve it 4 weeks later.  
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Abstract 
 
To study the potential associations between fetal brain functions and the early 
essential polyunsaturated fatty acid (ePUFA) status, fetal learning and memory 
were assessed by repeated habituation rate measurements (HR) in fetuses of 
30, 32, 34 or 36 weeks gestational age (GA). HR tests were repeated 10 
minutes later. Both measurements were replicated in a second session at GA 
38. Fetal short-term memory (STM) and long-term memory (LTM) were 
calculated from these habituation rates and related to concentrations of 
ePUFAs and their status markers, measured in umbilical artery wall 
phospholipids. The only relevant associations observed were positive trends 
(0.010 < p < 0.050) between STM measured before 38 weeks GA and levels of 
the ePUFA status markers Mead acid and Mead acid+dihomo-Mead acid, and 
between LTM and levels of Osbond acid, a marker of the n-3 LCPUFA status. 
Although these weak associations may imply some negative relationships 
between fetal brain functions and the early ePUFA status, we concluded that 
physiological differences in the availability of these fatty acids may probably not 
determine the differences in these primitive brain functions during the third 
trimester of fetal development. 
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Introduction 
 
The essential long-chain polyunsaturated fatty acids (LCPUFAs), arachidonic 
acid (20:4n-6, AA) and docosahexaenoic acid (22:6n-3, DHA), are considered 
of great importance for brain development and function 
(37,38)
. During pregnancy, 
the last trimester is noted for rapid development of the fetal brain and high 
accretion rates of AA and DHA 
(66)
. To obtain these LCPUFAs, the fetus 
depends primarily on the placental transfer, and thus on the maternal supply, of 
these fatty acids 
(26)
. However, since pregnancy is associated with a reversal 
decrease in the LCPUFA status of the mother, the fetal LCPUFA status may not 
be optimal 
(1)
, which may have consequences for the development of the fetal 
brain. We, therefore, assessed fetal brain functions and related these to the 
fetal exposure to essential fatty acids (EFAs) and their LCPUFAs, collectively 
called essential polyunsaturated fatty acids (ePUFAs) 
(1)
. These fatty acids and 
their status markers were measured in the phospholipids (PLs) of umbilical cord 
artery walls. To assess fetal brain function, we measured fetal habituation, 
which is a non-invasive method to test the integrity of the fetal central nervous 
system functions 
(47)
 and can also be used to assess fetal memory 
(48)
. Fetal 
habituation is the decrease in, and ultimate cessation of, a fetal response to 
repeated stimulation. It is considered to represent a form of learning and 
requires an intact and functioning central nervous system 
(35)
.  
 
 
Patients and methods 
 
Study design and population  
 
Learning capacity and memory performance of fetuses were derived from 
habituation data, available from a previous study 
(67)
. By means of unadjusted 
and multivariable-adjusted regression analyses, these early brain functions 
were related to the ePUFA status of the fetuses as reflected by selected fatty 
acid concentrations measured in the arterial wall PLs of their umbilical cords 
collected directly after delivery. The study was approved by the Ethics 
Committee of the Maastricht University Medical Centre and all included mothers 
gave their written informed consent. Initially, 5 groups of 20 women were 
included. Pregnancy duration at the start of the habituation measurements was 
30-38 weeks. Details of in- and exclusion for the habituation data have been 
published before 
(67)
. In addition, we excluded volunteers if the umbilical cord 
could not be collected at birth.  
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Fetal habituation method 
 
All habituation tests were performed by the same examiner (C.E.H. D.) as 
described before 
(67)
. Briefly, the fetal trunk was visualized by an ultrasound 
scanner and every 30 seconds a vibroacoustic stimulus (VAS) of 1 second 
duration was applied to the maternal abdomen above the fetal legs. A general 
movement of the fetus within 1 second of application of the stimulus was 
considered a positive response. A lack of response to 4 consecutive stimuli was 
taken to indicate habituation. We allowed a maximum of 24 stimuli in each 
habituation test and when fetal habituation was identified, stimulation was 
stopped. The habituation rate (HR) was defined as the number of consecutive 
stimuli applied before a fetus stopped responding. Habituation tests, in which 
fetuses reacted inconsistently to the VAS so that habituation could not be 
established, were considered missing and as a consequence these data were 
ignored in calculating and analyzing the results. Mothers were excluded if their 
fetuses did not respond to VAS at the initial habituation test and replaced by 
other volunteers of similar pregnancy durations. 
 
Habituation protocol and fetal learning and memory calculations  
 
Fetal habituation rates were measured for the first time (HR-A) during a session 
at gestational ages (GA) of 30 (group 30), 32 (group 32), 34 (group 34) or 36 
weeks (group 36) and tests were repeated 10 minutes later (HR-B). Gestational 
age was determined using the last menstrual period or by ultrasound when dates 
were uncertain. Both measurements were replicated under the same conditions 
during a second test session at GA 38 (HR-C and HR-D). 
The first habituation test outcome of each fetus (HR-A) was taken to reflect 
its learning capacity. The difference in habituation rates of a given fetus 
between the two tests in each session was regarded a reflection of its short-
term (10 minutes) memory and expressed as a percentage of the initial 
habituation rate. Thus, fetal short-term memory during the first test session 
(STM-1) was calculated as 100*[(HR-A minus HR-B)/HR-A]. The short-term (10 
minutes) memory during the second session (STM-2) was calculated as 
100*[(HR-C minus HR-D)/HR-C]. However, if fetuses did not respond to the 
initial VAS stimulus at the second session (HR-C = 0), percentage calculation 
would require division by zero, which is not possible. Therefore, 0.5 was added 
to all HR values measured to calculate STM-1 and STM-2.  
As mentioned before, habituation of the fetuses of groups 30-36 was 
measured at 38 weeks GA again. This allowed us to asses the long-term 
memory (LTM) of these fetuses, since this is reflected by the difference 
between HR-A and HR-C. However, this difference not only results from 
‘memorizing’ the earlier habituation measurements at GA 30-36, but also from 
the normal GA-associated brain development during the 2-8 weeks between 
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both test sessions. To correct for this, the difference between HR-A and HR-C 
values (in % of HR-A) was decreased by the difference (also in % of HR-A) 
between each individual HR-A value and the median HR-A value (11.0) of a 
control group of 20 fetuses measured at 38 weeks GA. Consequently, individual 
long-term memory values were calculated according to the equation LTM = 
{100*[(HR-A minus HR-C)/(HR-A)]} minus {100*[(HR-A minus 11.0]/(HR-A)]}. 
 
Cord sampling and fatty acid measurements 
 
From the fetuses of groups 30-36, a piece of the umbilical cord was collected 
immediately
 
after birth, rinsed with saline and stored at -80 °C until fatty acid 
analysis. It was decided to analyze only PLs of the artery walls, because this 
tissue represents the lowest essential fatty acid concentration available to more 
‘upstream’ tissues in the fetal body. These fatty acid compositions were 
determined by capillary gas-liquid chromatography as described elsewhere 
(26,68)
 and expressed as relative values (% by wt of total identified PL-associated 
fatty acids). Fatty acid values < 0.05 % were considered too low for reliable 
detection and treated as missing. The selected fetal ePUFAs of interest were 
the major LCPUFAs for brain development, AA and DHA, their respective 
dietary precursors, the EFAs linoleic acid (18:2n-6, LA) and α-linolenic acid 
(18:3n-3, ALA) and three ePUFA status markers 
(5)
 (Osbond acid, 22:5n-6, ObA; 
Mead acid, 20:3n-9, MA; dihomo-Mead acid, 22:3n-9, DHMA).  
 
Covariables 
 
Parity 
(69)
, maternal smoking 
(70)
 and drinking during pregnancy 
(71)
, socio-
economic status (SES) 
(72)
 and infant sex 
(73)
 were included in the multivariable-
adjusted regression analyses as potential confounding factors. These 
characteristics were obtained via study questionnaires and medical records, as 
detailed before 
(67)
. In the regression analyses two dummy variables for parity 
were used, one for parity = 1 and one for parity ≥ 2, with parity = 0 as reference 
category. Maternal smoking during pregnancy was categorized as 0 = non-
smoking and 1 = 1-5 cigarettes per day. Maternal drinking during pregnancy 
was classified as 1 = 1 glass per week and 2 = 2-7 glasses per week, with 0 = 
no alcohol use as reference category, and infant sex as boy = 0 and girl = 1. 
Exact information on SES was not available. Therefore, parental SES was 
measured by proxy, using the variable ‘highest educational level’ 
(58)
. For this 
variable, the education levels from both parents were compared and the highest 
education level (measured on an 8-point scale) was chosen as the value for the 
socio-economic status.  
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Statistical analyses 
 
All data are presented as median (25
th 
- 75
th
 percentile), unless otherwise 
mentioned. 
Associations between various fetal learning and memory outcome 
measures and the neonatal fatty acid concentrations of interest were analyzed 
with unadjusted and multivariable-adjusted regression analyses. In these 
analyses, fetal learning (HR-A), STM-1, STM-2 and LTM were the dependent 
variables and the relative proportions of the selected neonatal fatty acids LA, 
ALA, AA, DHA, ObA, MA, DHMA and MA+DHMA measured in PLs of the 
umbilical artery wall were the independent variables. Parity, SES (parental 
education), maternal smoking and drinking habits during pregnancy and infant 
sex were included as potential confounders. 
 At first, the selected ePUFA status markers were validated, based on our 
own fatty acid data, using Spearman’s rank correlation test to check if it was 
appropriate to select these fatty acids as deficiency markers for the ePUFA 
status. For this test the markers (MA, DHMA, MA+DHMA and ObA) were 
correlated with LA, AA, DHA and the sums of the n-3 and n-6 fatty acids. 
Habituation rates of the various groups were correlated to GA using 
Spearman’s rank correlation test to check if habituation was GA-dependent. 
Since this was the not the case (p > 0.050), fetuses of groups 30-36 were 
combined to one group. However, as an extra check the variable ‘group’ was 
added to the list of potential confounders to correct for this factor, if appropriate.  
Distributions of the dependent variables appeared skewed (Shapiro-Wilk 
test). Therefore, the distributions were optimized towards normal by means of 
transformations of the various datasets (natural log, square root, square or 
1/square). Subsequently, obvious outliers (± 4 standard deviations (SD) outside 
the mean) were removed, after which the normality of the distributions was 
checked again. Since they still appeared not normal, the 4-SD outliers were 
inserted again and outliers were then removed if their values were more than 3 
interquartile ranges (IQR) below or above the median. Although these 
procedures improved the distributions, they did not normalize them. 
Nonetheless, linear regression analyses were performed, but since none of the 
residuals were normally distributed, results could not be accepted. Therefore, all 
dependent variables were dichotomized (≥ median vs. < median) and logistic 
regression analyses were performed.  
Unadjusted logistic regression analyses were carried out with the same 
subjects as included in the corresponding multivariable-adjusted regression 
analyses. Because of occasionally missing observations, this limited the 
number of cases for analysis. Therefore, to increase the number of available 
cases, irrelevant covariables were removed by stepwise backward 
multivariable-adjusted regression analyses, performed for each fatty acid-brain 
function combination. This procedure has been described in detail before 
(74)
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and the successive steps were continued until all remaining covariables were 
either significant or were characterized as confounders. For each particular 
combination of fatty acid and fetal learning or memory criterion, these various 
steps were performed with the same dataset. However, since removal of the 
irrelevant covariables implied less missing values and, consequently, a larger 
number of cases available for analysis, the ultimate regression analyses were 
finally repeated with the maximum number of complete cases available for each 
combination of fatty acid and fetal brain function.  
To check whether the relationships between dependent and independent 
variables were comparable for the added cases and the initial study population 
(a prerequisite for acceptance of this procedure), interaction analyses were 
performed as detailed before 
(74)
. If the added cases were significantly different, 
the final model with the larger number of cases could not be accepted. Since 
these interaction analyses revealed no significant differences between initial 
and additional cases, all final backward models could be approved. Cook’s 
distances were calculated to check for influential data points and data with 
Cook’s distances > 1 were removed.  
Subjects with incomplete information were nevertheless included. 
Therefore, not all data analyses were based on the same number of subjects. 
For both correlation studies, a p-value < 0.050 was considered significant. For 
all regression analyses, a p-value < 0.010 was required for significance, to 
correct for multiple testing, whereas a p-value < 0.050 was considered to 
indicate a (non-significant) trend. All statistical analyses were performed using 
the statistical package SPSS 11.5 for Windows (release 11.5, SPSS Inc., 
Chicago, Illinois). 
 
 
Results 
 
From the 80 participants included in groups 30-36, nine had to be excluded 
because of various pregnancy complications or because their fetuses did not 
react to the VAS at the initial habituation test of the first session (HR-A). Due to 
time restrictions, five of them could not be replaced, leaving 75 volunteers who 
completed the study. Three additional cases were excluded because cords 
could not be collected. Consequently, the data of 72 fetuses were left for 
analysis. In the control group (group 38), 2 fetuses were excluded because they 
did not react to the VAS at HR-A, remaining 18 fetuses instead of 20. All 
included neonates were in good health after birth, with a 5-minute Apgar score 
≥ 8 and a birth weight > 10
th
 percentile, and no congenital anomalies were 
detected.  
The relevant maternal and infant characteristics of groups 30-36 and the 
control group are listed in table 1. Results for fetal learning and memory are 
presented in table 2. The relative contents (% wt/wt) of the selected umbilical 
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artery wall PL fatty acids are reported in table 3. In most cases ALA levels were 
below the level of reliable detection and therefore ALA was left out of the 
statistical analyses. The unadjusted and multivariable-adjusted analyses were 
performed with the same number of complete cases (all (co)variables 
available). In general, increasing the power by including all available cases in 
the unadjusted regression analyses hardly affected the outcome of these 
analyses (results not shown).  
 
 
Table 1. Maternal and infant characteristics 
Group 30 - 36 Control group (group 38) 
Characteristics 
n 
Median 
(25
th 
- 75
th
 percentile) 
n 
Median 
(25
th 
- 75
th
 percentile) 
Maternal characteristics     
Age (years) 72 31 (28 - 34) 18 29.5 (27.5 - 32.3) 
Educational level 71 6 (5 - 8) 18 6.0 (4.0 - 8.0) 
Smoking during pregnancy  
(n) no/1-5 cigarettes per day 
72 70/2 18 18/0 
Alcohol use during pregnancy                  
(n) no/1 glass per week/2-7 
glasses per week 
72 63/7/2 18 17/1/0 
Parity (n) 0/1/2/3 72 39/21/10/2 18 9/7/2/0 
Infant characteristics     
Birth weight (g) 72 3540 (3058 - 3945) 18 3630 (3320 - 3825) 
Gestational age 
 at delivery (weeks) 
72 40.1 (39.3 - 40.7) 18 40.4 (39.9 - 41.0) 
Sex (n) male / female  72 25/47 18 10/8 
Apgar score after 5 minutes 71 10 (10 - 10) 18 10 (10 - 10) 
Data are given as median (25
th 
- 75
th
 percentile), unless otherwise mentioned.  
 
 
Thesis_Dirix_v2.pdf   40 6-4-2009   16:40:16
Fetal learning and memory and the early ePUFA status | 
41 
Table 2. Results for fetal learning and memory variables 
Variables n Median (25
th 
- 75
th
 percentile) 
Fetal learning 71 10.0 (5.0 - 16.0) 
STM-1 65 76.2 (53.4 - 88.9) 
STM-2 65 66.7 (22.9 - 90.9) 
LTM 66 53.6 (0 - 102.5) 
Fetal learning = non-transformed results of first habituation test outcome (HR-A); STM-1 and STM-2 
= fetal short-term (10 minutes) memory, calculated as the difference in habituation rates between 
two successive habituation rates measured with a 10-minutes interval in respectively the first (HR-A 
and HR-B) and second session (HR-C and HR-D), and expressed in % of HR-A and HR-C, 
respectively; LTM = long-term memory, defined as the HR difference (%) between HR-A and HR-C, 
corrected for the normal GA-associated brain development. 
 
 
Table 3. Relative contents (% wt/wt) of selected fatty acids isolated from arterial cord PLs (n = 72) 
Fatty acids Median (25
th 
- 75
th
 percentile) 
LA 1.15 (0.98 - 1.28) 
AA 13.7 (12.4 - 15.2) 
DHA 5.81 (5.13 - 6.52) 
ObA 3.19 (2.72 - 3.46) 
MA 2.96 (2.39 - 3.68) 
DHMA 1.57 (1.26 - 1.91) 
MA+DHMA 4.54 (3.81 - 5.49) 
PLs = phospholipids; LA = linoleic acid, 18:2n-6; AA = arachidonic acid, 20:4n-6; DHA = docosa-
hexaenoic acid, 22:6n-3; ObA = Osbond acid, 22:5n-6; MA = Mead acid, 20:3n-9; DHMA = dihomo-
Mead acid, 22:3n-9. 
 
 
Validation of the ePUFA status markers 
 
Using Spearman’s rank correlation test, it was observed that the ePUFA status 
markers MA, DHMA and MA+DHMA were significantly negatively correlated 
with LA, AA, DHA and the sums of n-3 and n-6 fatty acids (p < 0.001; .421 < r < 
.866). For the status marker ObA significant negative correlations were 
observed with LA (p = 0.029; r = .260), DHA (p = 0.047; r = .235) and the sum 
of n-3 fatty acids (p = 0.012; r = .294). These results clearly demonstrate the 
suitability of MA, DHMA and MA+DHMA as general ePUFA status markers. 
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ObA, on the other hand, appears a more specific status marker of n-3 
LCPUFAs in general, although the correlations were relatively weak. 
 
Relationship between fetal learning (HR-A) and selected fatty acids 
 
Neither in unadjusted, nor in fully adjusted or backward logistic regression 
analyses was fetal learning significantly associated with any of the fatty acids 
investigated, nor did they indicate a trend.  
 
Relationship between short-term (10 minutes) memory and selected fatty acids  
 
Unadjusted logistic regression analyses revealed trends between STM-1 and 
the fatty acids LA (n = 64; B = -2.067; p = 0.042; Odds Ratio (OR) = 0.127; 95 
% confidence interval (CI) = (0.017;0.926); r
2
 = 0.094), MA (n = 61; B = 0.714; p 
= 0.033; OR = 2.041; 95 % CI = (1.060;3.932); r
2
 = 0.106) and MA+DHMA (n = 
64; B = 0.430; p = 0.049; OR = 1.538; 95 % CI = (1.002;2.360; r
2
 = 0.085). 
However, after adjustment for all covariables all these trends disappeared. After 
removal of irrelevant covariables by the stepwise backward procedure two 
positive trends were observed again for MA (n = 65; B = 0.716; p = 0.026; OR = 
2.046; 95 % CI = (1.090;3.842); r
2
 = 0.108) and MA+DHMA (n = 65; B = 0.452; 
p = 0.039; OR = 1.571; 95 % CI = (1.024;2.410); r
2
 = 0.093). For these two 
backward analyses no covariables remained in the final model.  
No other associations or trends between short-term (10 minutes) memory 
and the neonatal fatty acids of interest were found. 
 
Relationship between long-term memory and selected fatty acids  
 
In the unadjusted logistic regression analyses between LTM and ObA a positive 
trend was observed (n = 61; B = 1.148; p = 0.032; OR = 3.153; 95 % CI = 
(1.105;8.991); r
2
 = 0.112). After full adjustment this positive association even 
became significant (n = 61; B = 2.740; p = 0.005; OR = 15.482; 95 % CI = 
(2.330;102.877); r
2
 = 0.183). After the stepwise backward procedure, ‘maternal 
drinking during pregnancy’ and ‘group’ were left as confounders, and a positive 
trend remained (n = 63; B = 1.808; p = 0.012; OR = 6.097; 95 % CI = 
(1.489;24.967); r
2
 = 0.137).   
No other associations or trends between long-term memory and the 
neonatal fatty acids of interest were found. 
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Discussion and conclusions 
 
The aim of this study was to investigate whether there are significant 
associations between fetal learning and memory, as assessed by fetal 
habituation measurements, and the fetal ePUFA status, reflected by the 
concentrations of AA, DHA, their dietary precursors and three ePUFA status 
markers, measured in cord artery wall PLs. We observed no distinct relations 
with AA or DHA, which are thought to be important LCPUFAs for brain 
development and function 
(37,38)
. Also no significant associations or trends were 
observed between LA and fetal learning or memory. On the other hand, positive 
trends were observed between fetal STM-1 and levels of the ePUFA status 
markers MA and MA+DHMA and between fetal LTM and the n-3 LCPUFA 
status marker ObA. If causal, these relationships indicate that fetal short-term 
(10 minutes) memory measured before 38 weeks GA may be better, the lower 
the ePUFA status of the fetus, as reflected by higher MA and MA+DHMA levels. 
Likewise, fetal long-term memory would be better the lower the n-3 LCPUFA 
status, as indicated by higher ObA concentrations 
(75)
. These interpretations are 
in striking contrast with current opinions, however. 
Several human studies investigated the associations between maternal or 
neonatal LCPUFA concentrations measured during pregnancy or directly after 
delivery and children’s brain development. In the majority of cases these studies 
addressed visual and cognitive development. Some of these studies observed 
positive associations, especially for DHA 
(76,77)
, whereas others found no 
significant relationships 
(78,79)
. Also from a number of reviews it can be 
concluded that there is evidence for potential benefits of LCPUFAs on visual 
and cognitive development, but results are limited and often inconsistent 
(3,80-82)
. 
It is difficult to compare these previous studies directly with our present one, 
since study designs and brain function measurements are so different. 
Furthermore, it must be kept in mind that the subjects of the present study were 
fetuses, whereas all other studies included infants in the age range from birth till 
a couple of years.  
As far as we know, only a few studies used a brain function assessment 
procedure (the Fagan Test of Infant Intelligence 
(83)
) more or less similar to the 
method we applied. In the habituation phase of this Fagan test, the investigator 
shows the infant two identical pictures of an infant’s face, until habituation is 
reached. In the test phase, the original stimulus is then paired with a novel 
stimulus (picture of second face) and the investigator records the infant’s 
looking direction and looking time at each stimulus. From these data the 
‘novelty preference’ is calculated (the percentage of the total test time in the test 
phase that the infant spent looking at the novel stimulus). This test reflects the 
infant’s ability to encode a stimulus into memory, to recognize that stimulus and 
to look preferentially at a novel stimulus. Oken and coworkers used this 
technique to assess associations between maternal fish and seafood intake 
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during the second trimester and infant cognition at 6 months of age. The results 
of this study showed that higher fish consumption of mothers during pregnancy 
was associated with better visual recognition memory of their infants at 6 
months of age, especially after adjustment for maternal hair mercury levels 
(84)
. 
Since a higher fish intake during pregnancy has been shown to be associated 
with a higher n-3 LCPUFA status of mothers and their neonates 
(85)
, this study 
suggests that the early availability of n-3 LCPUFAs may promote early brain 
development and function. Furthermore, also positive associations were found 
between cord plasma DHA concentrations and the Fagan test of novelty 
preference in a study of Jacobson et al. 
(86)
. On the other hand, in several 
LCPUFA supplementation studies no significant effect of n-3 LCPUFA 
supplementation of babies or pregnant and lactating women on the Fagan test 
(87-89)
 were observed, although O’Conner found a positive influence for 
supplements containing both DHA and AA 
(90)
.  
The Spearman rank correlation test outcome showed that the habituation 
rates were GA-independent and therefore fetuses of groups 30-36 were 
combined to one group. However, we added the variable ‘group’ as an extra 
check to the list of potential confounders to correct for this factor, if necessary. 
Indeed, in some multivariable analyses, ‘group’ appeared a confounder. Since 
habituation rates were GA-independent, this might indicate that other undefined 
factors besides gestational age are related with ‘group’ and influence the 
association between several forms of brain function and the selected fatty acids.  
One of the selected ePUFA status markers, ObA, is thought to be 
synthesized when there is a functional shortage of DHA 
(14,15)
. However, it 
needs to be realised that there is some evidence suggesting that ObA may not 
always be a useful biochemical measure of a low DHA status under all 
conditions 
(16)
. On the other hand, we observed negative correlations (p < 0.050) 
for the relationships between the concentrations of ObA and those of DHA and 
the sum of the n-3 fatty acids. This demonstrates that it was appropriate to 
choose ObA as a status marker for the sum of n-3 fatty acids in particular, but it 
must be kept in mined that results were rather weak. For MA, DHMA and 
MA+DHMA levels strong negative correlations were observed with all ePUFAs. 
These latter results show that it was a correct decision to use these fatty acids 
as markers for the ePUFA status. 
As mentioned before, in the present study only three trends were found for 
the associations between fetal brain functions and the early ePUFA availability. 
These trends imply negative associations between several fetal brain functions 
and the early ePUFA status, as reflected by higher concentrations of ObA, MA 
and MA+DHMA. Because of this small number of weak associations observed, 
our results might indicate that habituation-based brain functions are probably 
not related to the presence of the selected fatty acids, possibly because 
habituation is such a basic function, that it is optimal early in fetal development 
already. Indeed, these elementary forms of learning and memory are already 
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present in such primitive animals as worms and snails 
(91,92)
, which have a 
relatively simple neural network.  
In conclusion, since only a few trends were observed for the associations 
between habituation-related fetal brain functions and the early ePUFA status, 
we concluded that physiological differences in the availability of these fatty 
acids may probably not determine the differences in these primitive brain 
functions during the third trimester of fetal development. 
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Abstract 
 
Since birth dimensions have prognostic potential for later development and 
health, possible associations between neonatal birth dimensions and selected 
maternal plasma fatty acid contents were investigated, using data from 782 
mother-infant pairs of the Maastricht Essential Fatty Acid Birth cohort. 
Unadjusted an multivariable-adjusted regression analyses were applied to study 
the associations between birth weight, birth length or head circumference and 
the relative contents of docosahexaenoic acid (DHA), arachidonic acid (AA), 
dihomo-γ-linolenic acid (DGLA) and 18:1trans (18:1t) in maternal plasma 
phospholipids sampled during early, middle and late pregnancies, and at 
delivery. Where appropriate, corrections were made for relevant covariables. 
Significant positive associations were observed between maternal DHA 
contents (especially early in pregnancy) and birth weight (B = 52.10 g, 95 % CI 
= 20.40 - 83.80) and head circumference (B = 0.223 cm, 95 % CI = 0.074 - 
0.372). AA contents at late pregnancy were negatively associated with birth 
weight (B = -44.25 g, 95 % CI = -68.33 - -20.16) and birth length (B = -0.200 cm, 
95 % CI = -0.335 - -0.065). Significant negative associations were also 
observed for AA contents at delivery and birth weight (B = -27.08 g, 95 % CI = -
47.11 - -7.056) and birth length (B = -0.207 cm, 95 % CI = -0.330 - -0.084). 
Maternal DGLA contents at delivery were also significantly negatively 
associated with neonatal birth weight (B = -85·76 g, 95 % CI = -130.9 - -40.61) 
and birth length (B = -0.413 cm, 95 % CI = -0.680 - -0.146). No significant 
associations were observed for maternal 18:1t contents. We conclude that 
during early pregnancy, maternal DHA content may programme fetal growth in 
a positive way. Maternal AA and DGLA in late pregnancy might be involved in 
fetal growth limitation. 
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Introduction 
 
Increasing evidence suggests that birth dimensions have prognostic values for 
later development and health. Indeed, birth weight and birth length have been 
shown to be associated with later cardiovascular risk 
(93)
, whereas head 
circumference at birth seems a significant predictor of later intelligence 
(94)
. 
Although the causality of these associations has not yet been demonstrated, 
fetal growth should be optimized.  
The essential long-chain polyunsaturated fatty acids (LCPUFAs), 
docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (AA, 20:4n-6), are 
thought to be of critical importance for brain development and fetal growth, 
respectively 
(2,3)
. Therefore, the availability of DHA and AA to the fetus needs to 
be adequate. To obtain these fatty acids, fetuses depend on their mothers, as is 
indicated by the positive correlation between the maternal and neonatal 
LCPUFA status at birth 
(6-8)
. Mothers receive the LCPUFAs mainly from their 
diet or synthesize them from their respective precursors 
(95)
.  
Dietary trans fatty acids are unsaturated fatty acids with at least one double 
bond in the trans configuration. They mainly result from industrial hydrogenation 
of edible oils and cannot be synthesized by humans 
(18)
. As is the case for 
LCPUFAs, maternal and neonatal trans fatty acids are positively correlated 
(20,21)
, indicating that the neonatal trans status is also determined by the 
maternal trans intake. Dietary trans unsaturated fatty acids have been shown to 
inhibit the conversion of parent essential fatty acids (EFAs) into their LCPUFAs, 
especially when the EFA contents are low 
(22,23)
. They may also impair placental 
LCPUFA transfer 
(24)
. Thus, trans fatty acids may lower the fetal LCPUFA status 
and thereby they could compromise fetal development.  
Recently, the term birth weight appeared to be positively associated with 
most maternal n-3 LCPUFA proportions early in pregnancy 
(96)
. The relationship 
with maternal AA contents was found to be negative. Interestingly, maternal 
contents of the AA precursor dihomo-γ-linolenic acid (DGLA, 20:3n-6) is 
positively related to the term birth weight. The birth-weight relationship with 
elaidic acid (the main dietary trans fatty acid, 18:1n-9trans,) was negative in 
unadjusted analyses, but this association lost significance after adjustment for 
covariables. 
The aim of the present study was to extend and confirm these findings with 
three birth outcome measures (birth weight, birth length and head 
circumference at birth) and maternal plasma fatty acid proportions from four 
different sampling times (about 16, 22 and 32 weeks of pregnancy, and 
immediately upon delivery), available from a different birth cohort.  
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Subjects and methods 
 
General design of the study 
 
On the basis of distinct inclusion criteria, relevant data (dependent variables, 
independent variables and covariables) of eligible mothers and their infants 
were extracted from the database of the Maastricht Essential Fatty Acid Birth 
(MEFAB) cohort. This database contains the data of pregnant women and their 
newborns who participated in several observational studies, conducted in our 
institute between 1990 and 1997 
(1,7)
. In short, three antenatal clinics located in 
The Netherlands participated and recruited pregnant women at their first 
antenatal medical visit. Selection criteria for inclusion were a gestational age < 
16 weeks at study entry, singleton pregnancy, Caucasian race, diastolic blood 
pressure < 90 mm Hg and the absence of any metabolic, cardiovascular, 
neurological or renal disorder at the time of recruitment. Approval for these 
studies was obtained from the Medical Ethics Committee of the University 
Hospital Maastricht and the University of Maastricht, and all participating 
women gave their written informed consent. Unadjusted and multivariable-
adjusted linear regression analyses were conducted to study the associations 
between relative DHA, AA, DGLA and 18:1trans (18:1t) contents in 
phospholipids (PLs) of maternal plasma, collected at approximately 16, 22 and 
32 weeks of pregnancy, and directly after delivery (independent variables), and 
the birth outcome measures birth weight, birth length or head circumference 
(dependent variables). In multivariable-adjusted analyses, these relationships 
were corrected for relevant covariables.   
 
Inclusion of participants 
 
For the present study, clinical data of 1238 mothers and their infants were 
available in the MEFAB database. The mother-infant pairs were excluded if 
infants were born preterm (gestational age < 37 weeks, n = 90), mothers had 
diabetes (n = 35) or developed pregnancy-induced hypertension (n = 96), 
mothers had reported specific health problems in the past (e.g. diabetes 
mellitus, hypertension and heart, kidneys, liver, gall bladder or thyroid gland 
disorders, n = 128), one or both parents were non-Caucasians (n = 40) or 
values for any of the afore-mentioned exclusion criteria were missing (n = 73). 
The mother-infant pairs were also excluded if fatty acid analyses were not 
reported (n = 148) or values were missing for birth weight, birth length and head 
circumference (n = 3). After exclusion, the data of 782 mother-infant pairs were 
left for analysis.  
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Birth dimensions and fatty acid profiles 
 
Local hospital staff members recorded birth weight, birth length and head 
circumference on standardized datasheets. Maternal venous blood samples 
were collected in EDTA tubes at about 16, 22 and 32 weeks of pregnancy, and 
immediately after delivery. The plasma was separated from the blood cells by 
centrifugation (2000 g, 4 ºC, 15 min) and stored under nitrogen at -80 ºC until 
analysis. The fatty acid composition of plasma PLs was determined by gas-
liquid chromatography, as described previously 
(26)
. The separation of the 
various 18:1t isomers was incomplete; therefore, they are reported together as 
18:1t. The fatty acids are expressed as relative contents (percentage by weight 
of the total amount of identified fatty acids, % wt/wt).  
 
Covariables 
 
Maternal age 
(97)
, height and body mass index [BMI, weight (kg)/height (m
2
)] at 
study entry 
(98)
, parity 
(99)
, smoking and drinking during pregnancy 
(100)
, weight 
increase during pregnancy 
(101)
, socio-economic status (income) 
(102)
, gestational 
age 
(98)
 and infant sex 
(103)
 were included in the multivariable-adjusted analyses 
as potential confounding factors. These data were retrieved from the original 
study questionnaires and medical records. In the multivariable-adjusted 
regression analyses, two dummy variables for parity were used, one for parity = 
1 and the other for parity ≥ 2, with parity = 0 as reference category. Smoking 
and drinking during pregnancy were both categorized as 0 = no and 1 = yes and 
infant sex as boy = 0 and girl = 1. Exact information on socio-economic status 
(SES) was not available. Therefore, parental SES was measured by proxy, 
using ‘income' as an SES indicator, based on the parental postal code at the 
time of delivery (Geomarktprofiel; Wegener DM, Nieuwegein, The Netherlands). 
This information was classified into five groups ranging from 1 (twice or more 
modal income) to 5 (minimum income); SES values in the categories unknown 
(0) and diverse (6) were omitted and thus reported as missing values. 
Gestational age at birth was calculated from the self-reported first day of the last 
menstrual period. If the last menstrual period was uncertain, gestational age 
was based on early ultrasound measurements. 
 
Statistical analyses 
 
Associations between various birth outcome measures and the maternal fatty 
acid contents of interest were analyzed with unadjusted and multivariable-
adjusted linear regression analyses. In these analyses, birth weight, birth length 
and head circumference were the dependent variables and the relative 
proportions of the maternal fatty acids DHA, AA, DGLA and 18:1t measured in 
plasma PLs were the independent variables. In the multivariable-adjusted 
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models, the four fatty acids were included simultaneously to allow for their usual 
metabolic interactions 
(2,95)
. Furthermore, since fatty acids are reported in 
relative contents, any change in the proportion of one fatty acid will result in a 
change in the proportions of the other fatty acids included in the analysis. 
Maternal age, height, BMI at study entry, parity, weight increase during 
pregnancy, socio-economic status (income), smoking and drinking habits during 
pregnancy, gestational age and infant sex were included as potential 
confounders. Before starting the analyses, outliers (± 4 SD outside the mean) of 
the dependent variables were removed and the normality of their distributions 
was checked and confirmed by histograms.  
Unadjusted regression analyses were performed with the same subjects as 
included in the corresponding multivariable-adjusted regression analyses. 
These twelve regression analyses (three dependent variables and fatty acid 
contents at four time points) were performed in subjects with complete datasets 
for all (co)variables included in each of the respective regression models. 
Because of occasionally missing observations, the number of cases for analysis 
was limited. Ultimately, to remove irrelevant covariables (and thereby increase 
the number of available cases, see later), stepwise-backward multivariable-
adjusted regression analyses were performed for each of the twelve birth 
outcome-fatty acid combinations. Starting with the full multivariable-adjusted 
model, the covariable with the highest p-value was removed. If this removal 
resulted in a change in the B-value of 10 % or more for at least one of the four 
fatty acids included (DHA, AA, DGLA and 18:1t), and if this change amounted to 
20 % or more of the standard error of this B-value, then this variable was 
considered a confounder and retained in the regression model, even if it was 
not significant (p ≥ 0.050) 
(104)
. If the removal of the covariable resulted in a 
smaller change in the B-values for all the four fatty acids included and/or of their 
standard errors, then its removal was permanent. Subsequently, this procedure 
was repeated with the covariable with the next largest p-value and so on, until 
the remaining covariables were either significant (in which case they are called 
‘predictors’) or characterized as confounders. For each particular birth outcome-
fatty acid combination, these various steps were performed with the same 
dataset. However, since the removal of the irrelevant covariables implied less 
missing values and, consequently, a larger number of cases available for 
analysis, the ultimate regression analyses were finally repeated with the 
maximum number of complete cases available for that birth outcome-fatty acid 
combination.  
To check whether the relationships between dependent and independent 
variables are comparable for the added cases and the initial study population (a 
prerequisite for acceptance of this procedure), interaction analyses were 
performed. To this end, two new variables were introduced into the final 
regression model. The first variable, named A, was coded ‘0’ for cases from the 
initial (full) model and ‘1’ for the cases that were added after the deletion of the 
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irrelevant covariables. The second variable was the interaction term, calculated 
as ‘the respective independent fatty acid variable * variable A’. The significance 
of this interaction term (p < 0.010, to correct for multiple testing) implies that the 
regression models are fundamentally different for both sets of cases. In that 
case, the final model with the larger number of cases could not be accepted. 
Since these interaction analyses revealed no significant differences between 
initial and additional cases, all the final backward models could be approved. To 
check possible influential cases in the regressions, all data points were checked 
by calculating their Cook’s distance and removed if this value was ≥ 1. Such 
influential data points were not observed, however. 
For the regression analyses, p-values < 0.010 were considered statistically 
significant, to correct for multiple testing. A p-value < 0.050 was considered to 
indicate a (non-significant) trend. The values are reported as median (25
th 
- 75
th
 
percentile), unless specified otherwise. All statistical analyses were performed 
using SPSS 11.5 for Windows (SPSS Inc., Chicago, IL, USA). 
 
 
Results 
 
A total of 782 mother-infant pairs enrolled in the present study. Their relevant 
characteristics are listed in table 1. The relative contents (% wt/wt) of the four 
maternal plasma PL fatty acids of interest are reported in table 2. In tables 3-5, 
results of the unadjusted, multivariable-adjusted and final backward regression 
analyses are shown.  
 
Relationship between maternal 18:1t contents and birth dimensions 
 
None of the associations between relative maternal 18:1t contents and birth 
weight, birth length or head circumference reached statistical significance or 
indicated a trend (results not shown). In addition, the backward regression 
analyses demonstrated that for none of the twelve birth outcome-fatty acid 
combinations, 18:1t was either a predictor or a confounder. Since a 
considerable number of 18:1t values were missing from the database, which 
lowered the number of cases and, consequently, the power of the regression, it 
was decided to remove 18:1t from the dataset and to restrict further analyses to 
the combination of the three LCPUFAs DHA, AA and DGLA. This decision 
appeared justified after the last check, demonstrating that also in the final 
backward analyses with the three  LCPUFAs included, 18:1t was neither a 
confounder nor a predictor (data not shown).  
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Table 1. Subject characteristics
 
Maternal characteristics n  
Age (years) 782 29.0 (26.2 - 31.7) 
Height (cm) 740 167 (162 - 170) 
BMI at study entry (kg/m
2
) 709 23.0 (21.2 - 25.3) 
Parity (n) 0 / 1 / ≥ 2 782 574 / 173 / 35 
Weight increase during pregnancy (kg) 736 11.7 ( 9.2 - 14.3) 
Socio-economic status (income class)
a
  559 3 (2 - 3) 
Smoking during pregnancy (n) no / yes 778 570 / 208 
Alcohol during pregnancy (n) no / yes 779 761 / 18 
Infant characteristics   
Gestational age (weeks) 782 40.1 (39.3 - 41.0) 
Sex (n) male / female 782 421 / 361 
Birth weight (g) 780 3331 (448) 
Birth length (cm) 661 50.1 (2.2) 
Head circumference (cm) 580 34.2 (1.6) 
Birth weight, birth length and head circumference were normally distributed and are therefore 
expressed as mean ± SD. The distributions of the other characteristics were not checked for 
normality and are therefore given as median (25
th
 - 75
th
 percentile). 
a 
Ranges from minimum (5) to ≥ 
2 x modal (1). 
 
 
Relationship between maternal DHA contents and birth dimensions  
 
Unadjusted regression analyses revealed significant positive relationships 
between maternal DHA contents at week 16 of pregnancy and birth weight and 
head circumference (Table 3). After entering all covariables, these associations 
remained significant. After the removal of irrelevant covariables by the stepwise-
backward procedure, the final models explained 37.5 and 20.0 % of the 
variability in birth weight and head circumference, respectively. The 
contributions of DHA stayed significant, explaining 1.0 and 1.4 % of these 
variabilities, respectively.  
For birth length, unadjusted regression analyses revealed a significant 
positive association with maternal DHA, measured at 32 weeks pregnancy. This 
association just lost significance after adjustment for relevant covariables. The 
relationships between birth length and DHA proportions measured at 16 and 22 
weeks were of the same order of magnitude, but they only showed non-  
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significant positive trends in unadjusted analyses as well as after adjustment for 
relevant covariables. 
None of the birth outcome variables were significantly associated or showed 
trends with DHA values measured at delivery. 
 
Relationship between maternal AA contents and birth dimensions  
 
No significant associations were observed in unadjusted analyses between AA 
contents in maternal plasma PLs and birth outcome variables (Table 4). After 
adjustment for covariables, associations with neonatal head circumference 
hardly changed and remained insignificant. The adjustment did enhance most 
associations of birth weight and birth length with maternal AA proportions at 16 
and 22 weeks of pregnancy, but only non-significant negative trends became 
apparent between maternal AA contents at week 16 and 22 of pregnancy and 
birth weight and between AA contents at 22 weeks of pregnancy and birth 
length. When related to maternal AA proportions in late pregnancy (week 32) 
and at delivery, however, significant negative relationships were observed. The 
significant final multivariable-adjusted backward models (with only relevant 
covariables included) explained, respectively, up to 36.8 and 28.7 % of the 
variability in birth weight and birth length, up to 1.5 % of which was due to the 
contribution of AA.   
 
Relationship between maternal DGLA contents and birth dimensions  
 
Unadjusted regression analyses did not demonstrate any significant relationship 
between maternal DGLA contents and birth outcome variables (Table 5). 
However, after adjustment for only the relevant covariables, a negative trend 
was found for the relationship between maternal DGLA proportions at 32 weeks 
pregnancy and birth weight. After full adjustment, the maternal DGLA content at 
delivery was significantly and negatively associated with neonatal birth weight. 
The complete model explained about one-third (34.2 %) of the variability in birth 
weight, 1.4 % of which was contributed by DGLA. After the removal of the 
irrelevant covariables by the stepwise-backward procedure, the final model 
explained 36.7 % of the variability in birth weight and the contribution of DGLA 
(1.5 %) remained significant. For the association between maternal DGLA 
proportions at delivery and neonatal birth length, comparable results were 
obtained. The full multiple regression model explained 26.9 % of the variability 
in birth length with an almost significant contribution of 0.8 % from DGLA. This 
contribution increased to 1.3 % and became significant after the removal of 
irrelevant covariables by the backward regression analysis. 
Other associations between birth outcome variables and maternal DGLA 
contents were not significant and no trends were found either. 
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Discussion 
 
In the present study, with data of mother-infant pairs present in the MEFAB 
database, we observed that the plasma PL DHA contents of mothers, especially 
when measured early in pregnancy, were significantly and positively related to 
birth weight and head circumference of their neonates, whereas maternal AA 
and DGLA proportions in late pregnancy were negatively related to birth weight 
and birth length. No significant associations were observed for maternal 
contents of 18:1t, a group of industrial trans unsaturated fatty acid present in the 
diet.  
In the literature, most observational studies relating neonatal birth outcome 
to maternal n-3 fatty acid intake inferred from the intake of fish and marine 
mammals assessed using food frequency questionnaires. A few of these 
studies reported positive associations between n-3 fatty acids and birth 
dimensions 
(40,105,106)
, whereas other studies found no 
(41,107)
 or even negative 
associations 
(42)
. No significant associations were reported between birth weight 
or birth length and maternal DHA contents measured in plasma lipid fatty acids 
at 35 weeks of pregnancy 
(8)
 or the fatty acid ratio (EPA + DPA + DHA)/AA in 
erythrocytes sampled at 30 weeks of pregnancy and used as a biochemical 
marker of marine n-3 fatty acid intake 
(107)
.  
The reasons for these inconsistent results probably include the use of 
different methods to estimate the n-3 LCPUFA status of the women, as well as 
incomplete adjustment for covariables 
(8,40-42,105)
. Furthermore, most 
observational studies were restricted to relationships with maternal fatty acids in 
late pregnancy, whereas we observed significant associations with maternal 
DHA contents early in pregnancy only. This finding suggests a fetal growth 
programming potential of maternal DHA, especially, early in pregnancy, which 
(if confirmed) could imply that DHA supplementation after this period may not 
significantly affect birth dimensions anymore. Indeed, as initially observed by 
Olsen et al. 
(108)
 and recently confirmed by a meta-analysis containing five 
additional randomized controlled trials, no significant effects on birth weight or 
birth length are observed when n-3 LCPUFAs are supplemented from 15 to 30 
weeks of pregnancy onwards 
(109)
.  
The present results agree with those of van Eijsden et al. who observed a 
significant positive correlation between DHA proportions measured in maternal 
plasma PLs at 13 weeks of pregnancy and birth weight. However, this 
association lost significance after adjustment for covariables 
(96)
. It should be 
mentioned that, when compared with our volunteers, their (multi-ethnic) 
population had relatively high DHA values, and the association they observed 
was mainly present at the lower range of the DHA distribution.  
Previous observational studies suggested that AA has growth-promoting 
effects early in life both in preterm 
(110,111)
 and term neonates 
(8,112,113)
. By 
contrast, we observed negative associations between AA contents in maternal 
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plasma PLs and neonatal birth weight and length. Although present throughout 
pregnancy, these associations were only significant at late pregnancy and 
directly after delivery, which suggests involvement of AA in fetal growth 
limitation. These results confirm earlier observations of van Eijsden and co-
workers that higher AA proportions in plasma PLs of women at about 13 weeks 
of pregnancy are significantly related to lower birth weights of their neonates 
(96)
. 
At 16 weeks of pregnancy, the negative association we observed in the present 
study for birth weight was not quite significant (p = 0.037), which may have 
been due to the smaller study population (n = 665), compared with the study of 
van Eijsden (n = 3706).  
In general, maternal plasma contents of DGLA, the precursor of AA, were 
negatively associated with birth weight and birth length after correction for 
relevant covariables. Although not significant for fatty acid proportions early in 
pregnancy, the associations became significant as pregnancy progressed. From 
the literature, hardly anything is known about the possible association between 
maternal DGLA contents and birth outcome. In their (uncorrected) study, Elias 
and Innis did not observe a significant relationship with DGLA contents 
measured in maternal plasma PLs, triacylglycerol or cholesteryl esters at 35 
weeks of pregnancy for birth weight and birth length 
(8)
. It should be mentioned 
that in the present study, significant results for DGLA were observed only after 
correction for relevant covariables. van Eijsden and co-workers found a 
significant positive association between maternal DGLA proportions, measured 
early in pregnancy, and birth weight in unadjusted and multivariable-adjusted 
analyses (p < 0.010) 
(96)
. Although we tested several possible scenario’s, we 
were unable to reconcile these contrasting results. 
In agreement with the inhibitory effect of trans unsaturated fatty acids on the 
endogenous LCPUFA synthesis from their EFA precursors and on their 
placental transfer 
(22-24)
, 18:1t contents in maternal plasma PLs were found 
significantly and negatively associated with maternal DHA and AA proportions 
measured during pregnancy and directly after delivery (data not shown). 
Despite the rather strong relationships (p ≤ 0.011) and the significant 
associations we observed between maternal LCPUFA contents and birth 
dimensions, associations between maternal 18:1t proportions and the various 
birth outcome variables were not significant. This might be partly explained by 
the rather low 18:1t contents in the plasma PLs of the present study population 
(Table 2), resulting in a narrow exposure range, which usually impedes the 
detection of any association. As in the (unadjusted) analyses of Elias and Innis, 
the trans fatty acid proportions were also not significantly related to infant birth 
weight and birth length 
(8)
, it seems that any potential effect of industrial trans 
unsaturated fatty acids is either small or non-existing.  
One of the strengths of the present study is that plasma for fatty acid 
content measurement was collected at several time points during pregnancy 
and directly after birth. This allowed us to investigate the associations of these 
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fatty acids with birth dimensions from early pregnancy onwards until and 
including delivery. Second, the database of this cohort contains a relatively 
large number of maternal and neonatal covariables. However, as with all 
observational studies, residual confounding cannot be ruled out and it is not 
possible to decide whether or not the associations observed are causal.  
Even though significant correlations existed between DHA, AA, DGLA and 
18:1t, we regarded it justified to include them in the multivariable-adjusted 
analyses together, because the correlation coefficients between these fatty 
acids were ≤ 0.4. In addition, the multicollinearity checks revealed a tolerance 
value of > 0.1 and a variance inflation factor of < 10, which allowed us to make 
this decision 
(114)
. By including the fatty acids simultaneously, it was first 
possible to take into consideration their metabolic interactions 
(2,95)
. Second, 
since fatty acid contents are reported in proportions, any change in the 
proportion of one fatty acid will result in a change in the relative proportions of 
the other fatty acids included in the analysis. 
To check whether confounding was present and in what direction it worked, 
the same subjects were used in the unadjusted as well as the multivariable-
adjusted regression analyses. When unadjusted regression analyses were 
performed with the maximum number of cases available, the associations were 
considerably more significant than those reported in tables 3-5 (data not 
shown).  
The present results support earlier suggestions 
(96)
 that differences in 
maternal LCPUFA contents (irrespective of their causes) can have a significant 
impact on neonatal birth dimensions. Moreover, the present results can be 
taken to indicate that maternal DHA contents may programme fetal growth in a 
positive way, whereas maternal AA and DGLA later in pregnancy might be 
involved in fetal growth limitation. If these associations prove to be causal, they 
imply that birth dimensions can be optimized by the adaptation of the maternal 
LCPUFA intake during pregnancy, because circulating proportions of LCPUFA 
depend, at least partly, on LCPUFA intake. Thus, intervention studies clearly 
demonstrated that plasma contents of DHA, AA and DGLA, as well as their 
proportions, can be modified by changing the consumption of these LCPUFAs 
or their precursors 
(95,115-117)
, although non-dietary factors can also play a 
modulating role 
(118-120)
. Therefore, randomized clinical trials are needed to test 
the causality of the associations observed and to find the ideal maternal 
LCPUFA status for optimum fetal growth and infant development. As it is known 
that maternal and neonatal essential fatty acid contents are positively related 
with each other 
(6,7,26)
, such intervention studies would be especially appropriate 
if it can be confirmed that associations with birth dimensions, as observed in the 
present study for maternal LCPUFA contents during pregnancy, also exist for 
neonatal LCPUFA contents at birth. These studies are now underway. 
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Abstract 
 
Certain essential long-chain polyunsaturated fatty acids (LCPUFAs) are 
considered important for fetal growth and brain development, whereas industrial 
trans fatty acids (mainly 18:1trans) have been associated with negative effects. 
The aim of this study was to investigate associations between term birth 
dimensions and prenatal exposure to some of these fatty acids, reflected by 
neonatal fatty acid concentrations at birth. Data of up to 700 infant-mother pairs 
from the Maastricht Essential Fatty Acid Birth cohort were used for the present 
study. Unadjusted and multivariable-adjusted linear regression analyses were 
performed to investigate associations between birth weight, birth length or head 
circumference and relative concentrations of docosahexaenoic acid (DHA), 
arachidonic acid (AA), dihomo-γ-linolenic acid (DGLA) and trans-octadecenoic 
acids (18:1t) measured in phospholipids of the walls of umbilical arteries and 
veins, and in umbilical cord plasma and erythrocytes. After optimal adjustment, 
a significant negative association was observed between birth weight and 
umbilical plasma DHA concentrations. Negative associations were also found 
for AA concentrations measured in umbilical plasma and in arterial and venous 
vessel walls. Birth length was negatively related to arterial vessel wall AA 
concentrations only. A significant negative association was observed for the 
relationship between 18:1t in cord erythrocytes and birth weight. For DGLA no 
significant associations were observed. Results seem to preclude a role of DHA 
and AA as growth factors per se. Their negative relationships with birth 
dimensions may result from a limited maternal-fetal LCPUFA transfer capacity. 
Potential effects of 18:1t and DGLA on birth dimensions are probably small or 
non-existing. 
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Introduction 
 
The essential long-chain polyunsaturated fatty acid (LCPUFA) docosahexa-
enoic acid (DHA) is an important fetal nutrient, given its active accumulation in 
the developing brain and retina during the last trimester of gestation 
(10,121)
. 
Recent research also indicates maternal n-3 LCPUFAs to be important for the 
programming of fetal growth 
(74,96)
. The role of another LCPUFA, arachidonic 
acid (AA), in early growth is not clear, since both promoting 
(110,111)
 as well as 
limiting 
(74,96)
 potentials have been suggested. Although causality of these 
associations has not yet been ascertained, it seems important to optimize the 
neonatal LCPUFA status, since low birth weight is thought to be associated with 
later occurrence of coronary heart disease and other chronic illnesses 
(39)
.  
Dietary trans fatty acids, mainly formed during industrial hydrogenation of 
unsaturated edible oils, may interfere with the conversion of the parent essential 
fatty acids (EFAs) into their LCPUFAs, especially when the parent EFA 
concentrations are low 
(22,23)
. In this way, trans fatty acids may lower the fetal 
LCPUFA status and, thereby, affect fetal development. 
Rump et al. demonstrated that birth weight of term neonates was negatively 
related to DHA and AA concentrations in umbilical cord plasma phospholipids 
(PLs), whereas it was positively associated with concentrations of dihomo-γ-
linolenic acid (DGLA), the precursor of AA 
(122)
. In contrast, Elias and Innis, 
observed positive associations between neonatal triacylglycerol AA 
concentrations and birth weight and birth length, and between cholesteryl ester 
AA concentrations and birth weight 
(8)
. In addition, no significant associations 
were found between neonatal plasma trans fatty acid concentrations and birth 
weight and birth length. However, the applicability of this latter study is limited 
since no corrections were made for relevant covariables. Moreover, Rump et al. 
restricted their study to birth weight and to cord plasma polyunsaturated fatty 
acids and did not consider trans fatty acids 
(122)
. In addition, they only partially 
adjusted for potential confounders. Therefore, the present study was conducted 
to refine and extend these findings with additional birth outcome variables, fatty 
acid domains and relevant covariables. 
 
 
Subjects and methods 
 
General design of the study 
 
According to pre-specified inclusion criteria (see below), information with 
respect to birth outcome variables, fatty acid concentrations and clinical 
characteristics of eligible infants and their mothers was taken from the database 
of the Maastricht Essential Fatty Acid Birth cohort (MEFAB database 
(74)
). 
Associations between selected fatty acid concentrations in PLs of the walls of 
Thesis_Dirix_v2.pdf   67 6-4-2009   16:40:19
| Chapter 5 
68 
umbilical arteries and veins, and of umbilical cord plasma and erythrocytes 
(independent variables) and birth weight, birth length or head circumference 
(dependent variables) were studied by unadjusted and multivariable-adjusted 
linear regression analyses.  
 
Inclusion of participants 
 
The study was executed with data of pregnant women and their newborns who 
participated in several observational studies, conducted in our institute between 
1990 and 1997 in The Netherlands 
(1,7)
.  Approval for these studies was 
obtained from the Medical Ethics Committee of the University Hospital 
Maastricht and the University of Maastricht, and all participating women gave 
their written informed consent. Data of infant-mother pairs were included in the 
present study if the infants were born at term to healthy Caucasian parents after 
an uncomplicated pregnancy, as detailed before 
(74)
. In addition, PL fatty acid 
profiles of the four neonatal lipid domains needed to be available. This resulted 
in 703, 158, 484 and 479 cases available for regression analyses related to 
cord plasma, erythrocytes, arterial and venous walls, respectively.  
 
Birth dimensions and fatty acid analyses 
 
Birth weight, birth length and head circumference were recorded directly after 
birth on standardized sheets. Directly after delivery, umbilical cord blood 
samples were collected, plasma was separated from erythrocytes by 
centrifugation and after plasma collection the erythrocytes were washed with 
physiological saline. Furthermore, a piece of umbilical cord was collected and 
rinsed with saline (NaCl, 0.9 % w/v). Plasma, erythrocytes and umbilical tissue 
samples were stored under nitrogen at -80 °C until analysis. The fatty acid 
composition of PLs isolated from plasma, erythrocytes and cord vein and artery 
walls were determined as described earlier 
(68,123)
. Separation of the various 
trans isomers of octadecenoic acid (C18:1) was incomplete; therefore, they are 
reported together as 18:1t. Fatty acids are expressed as relative contents (% by 
wt of total amount of identified fatty acids). 
 
Covariables 
 
For reasons explained in the respective references provided below, the 
following covariables were included in the multivariable-adjusted analyses as 
potential confounding factors: maternal age 
(97)
, height and body mass index 
(BMI, weight (kg)/height (m)
2
) at study entry 
(98)
, parity 
(99)
, smoking and drinking 
during pregnancy 
(100)
, weight increase during pregnancy 
(101)
, socio-economic 
status (income) 
(102)
, gestational age 
(98)
 and infant sex 
(103)
. Methodological 
details have been described in detail before 
(74)
.  
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Statistical analyses  
 
Before starting the analyses, outliers (± 4 SD outside the mean) of the 
dependent variables were removed and the normality of their distributions was 
checked and confirmed by histograms. Thereafter, associations between 
various birth outcome measures (the dependent variables; birth weight, birth 
length and head circumference) and the neonatal fatty acid concentrations of 
interest, viz. DHA, AA, DGLA and 18:1t, were analyzed with unadjusted and 
multivariable-adjusted linear regression analyses. The unadjusted analyses 
were performed with the same subjects as included in the corresponding 
multivariable-adjusted analyses. Because of occasionally missing observations, 
this limited the number of cases for analysis. Therefore, to increase the number 
of available cases, irrelevant covariables were removed by stepwise backward 
multivariable-adjusted regression analyses, performed for each fatty acids-birth 
outcome combination. This procedure has been described in detail before 
(74)
 
and the successive steps were continued until all remaining covariables were 
either significant or were characterized as confounders. For each particular 
combination of fatty acids and birth outcome, these various steps were 
performed with the same dataset. However, since removal of the irrelevant 
covariables implied less missing values and, consequently, a larger number of 
cases available for analysis, the ultimate regression analyses were finally 
repeated with the maximum number of complete cases available for each 
combination. To check whether the relationships between the dependent and 
independent variables were comparable for the added cases and the initial 
study population (a prerequisite for acceptance of this procedure), interaction 
analyses were performed as detailed before 
(74)
. If the added cases were 
significantly different from the initially included ones, the final model with the 
larger number of cases could not be accepted. Since these interaction analyses 
revealed no significant differences between initial and additional cases, all final 
backward models could be approved. 
To determine possible influential cases in the regressions, all data points 
were checked by calculating their Cook’s distance and removed if values were ≥ 
1. Such influential data points were not observed, however. 
Associations with p-values < 0.010 were considered statistically significant, 
to correct for multiple testing. A p-value < 0.050 was regarded to indicate a 
(non-significant) trend. Variables are reported as median (25
th 
- 75
th
 percentile), 
unless specified otherwise. All statistical analyses were performed using SPSS 
11.5 for Windows (SPSS Inc., Chicago, IL, USA).  
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Results 
 
Table 1 shows the maternal and infant characteristics of the included 
participants. The relative concentrations (% wt/wt) of DHA, AA, DGLA and 18:1t 
in plasma, erythrocyte and umbilical tissue PLs are given in table 2. Outcomes 
of the regression analyses are shown in tables 3, 4 and 5. To reduce the 
complexity of these tables, only results are shown for those relationships in 
which significant associations and/or trends were found in either the unadjusted, 
multivariable-adjusted or final backward analyses. Full results are available on 
request.  
 
 
Table 1. Subject characteristics
 
Maternal characteristics n  
Age (years) 730 29.0 (26.1 - 31.7) 
Height (cm) 698 167 (162 - 170) 
BMI at study entry (kg/m
2
) 686 22.8 (20.9 - 25.1) 
Parity (n) 0 / 1 / ≥ 2 730 551 / 151 / 28 
Weight increase during pregnancy (kg) 687 11.8 (9.3 - 14.5) 
Socio-economic status (income class)
a
  576 3 (2 - 3) 
Smoking during pregnancy (n) no / yes 726 527 / 199 
Alcohol during pregnancy (n) no / yes 727 706 / 21 
Infant characteristics   
Gestational age (weeks) 730 40.1 (39.3 - 41.1) 
Sex (n) male / female 730 392 / 338 
Birth weight (g) 728 3323 (437) 
Birth length (cm) 629 50.0 (2.2) 
Head circumference (cm) 554 34.2 (1.6) 
Birth weight, birth length and head circumference were normally distributed and are therefore 
expressed as mean ± SD. The distributions of the other characteristics were not checked for 
normality and are, therefore, given as median (25
th
 - 75
th
 percentile).
a 
Ranges from minimum (5) to ≥ 
2 x modal (1). 
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Relationship between neonatal 18:1t concentrations and birth dimensions  
 
Unadjusted regression analyses revealed no significant associations between 
neonatal 18:1t concentrations in the four umbilical cord domains and the birth 
dimensions. However, after full adjustment a significant negative association 
was observed for the relationship between neonatal 18:1t in erythrocyte PLs 
and birth weight (p = 0.009). The complete model explained 39.2 % of the 
variability in birth weight (R
2
 = .392), 6 % of which was contributed by 18:1t (r
2
 = 
.060). In the final backward model the association remained significant and was 
of the same order of magnitude (p = 0.004, R
2
 = .334, r
2
 = .058). No other 
associations or trends were found between 18:1t concentrations and birth 
dimensions. 
 
Relationship between neonatal DHA concentrations and birth dimensions 
(Table 3) 
 
After adjustment for all covariables, a significant negative association was found 
for the relationship between DHA concentrations in umbilical plasma PLs and 
birth weight. After removal of irrelevant covariables by the stepwise backward 
procedure, this association remained significant and the model explained 40.8 
% of the variability in birth weight, 3.1 % of which was contributed by DHA.  
For DHA in umbilical vein wall PLs, unadjusted regression analyses revealed a 
positive trend with birth length. However, this trend disappeared after full 
adjustment and after correction for the relevant covariables only.  
With respect to DHA in erythrocyte PLs, a negative trend was found in the 
final backward model for birth weight.  
Other associations between birth dimensions and neonatal DHA 
concentrations were not significant and no additional trends were observed 
either.  
 
Relationship between neonatal AA concentrations and birth dimensions (Table 
4) 
 
For umbilical plasma PL AA concentrations, a significant negative relationship 
with birth weight was observed in unadjusted regression analyses. This 
negative association remained significant after correction for all covariables. 
The complete model explained 42.4 % of the variability in birth weight and the 
contribution of AA was 2.4 %. After removal of the irrelevant covariables, the 
final model explained 40.8 % of the variability in birth weight, and the 
contribution of AA (1.7 %) remained significant.  
Although unadjusted regression analyses did not demonstrate any 
significant relationship between AA concentrations measured in arterial wall PLs 
and birth outcome variables, adjustment for covariables revealed significant  
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negative associations between neonatal AA levels and birth weight and birth 
length. The final multivariable models (with relevant covariables included only) 
explained 43.3 and 32.9 % of the variability in birth weight and birth length, 
respectively. The contributions of AA were 4.8 % (for birth weight) and 2.3 % 
(for birth length). For the association between arterial wall AA concentrations 
and head circumference, a negative trend was found after full adjustment. The 
complete model explained 29.2 % of the variability in head circumference with 
an almost significant contribution of 2.9 % of AA. After adjustment for only the 
relevant covariables results remained the same.  
In unadjusted regression analyses negative trends were observed for the 
associations between neonatal AA concentrations measured in umbilical vein 
PLs and birth weight and head circumference. After entering all covariables, 
these trends became clearly stronger but only for the association with birth 
weight it became significant. The complete model explained 44.7 % of the 
variability in birth weight and the contribution of AA was 4.0 %. In the final 
backward model, results were comparable.  
In erythrocyte PLs, only a trend was observed between neonatal AA 
concentrations and birth length in the unadjusted and multivariable-adjusted 
models, which remained after the stepwise backward procedure.  
No other associations between birth dimensions and neonatal AA 
concentrations showed trends or were significant. 
 
Relationship between neonatal DGLA concentrations and birth dimensions 
(Table 5) 
 
In unadjusted analyses only a positive trend was found for the association 
between birth weight and DGLA concentrations measured in plasma PLs. After 
adjustment for all covariables as well as for the relevant covariables only, this 
trend was lost.  
In arterial walls, positive trends were observed for the DGLA associations 
with birth weight and birth length in the multivariable-adjusted models. Only the 
trend for birth weight remained after removal of irrelevant covariables by 
backward regression analysis.  
Other associations between birth outcome variables and neonatal DGLA 
concentrations were not observed. 
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Discussion 
 
In the present study, we investigated in an infant-mother birth cohort the 
associations between several birth dimensions and selected fatty acid 
concentrations in four neonatal domains. These fatty acids are considered to 
reflect the prenatal exposure of the fetus, since it was observed that fetuses do 
not possess a different EFA status than infants directly after birth at a 
comparable gestational age 
(124)
. For DGLA no significant associations were 
observed. Umbilical plasma PL DHA and AA concentrations appeared 
negatively related to birth weight, just like AA concentrations in the PLs of 
arterial and venous umbilical walls. For umbilical erythrocyte PL concentrations 
of 18:1t, the main industrially produced trans unsaturated fatty acid present in 
the diet, also a significant negative association was found with birth weight. 
Birth length was only significantly associated (in a negative way) with AA 
concentrations in cord artery wall PLs.  
For AA these results are not in line with the general opinion that this 
LCPUFA stimulates fetal growth. However, this opinion is based on studies in 
preterm infants 
(110,111)
. Studies in term babies gave inconsistent results 
(8,122)
. 
Thus, Elias and Innis observed no significant associations between plasma PL 
AA concentrations and birth weight and birth length 
(8)
. Interestingly, significant 
positive associations were found between infant plasma cholesteryl ester AA 
and birth weight and between infant triacylglycerol AA and birth weight and birth 
length. For the other LCPUFAs no significant results were seen. However, in 
that study no corrections were made for potential confounders, which could 
have influenced the study outcomes. Rump and coworkers showed in their 
study significant negative relations between AA and DHA concentrations in 
umbilical cord plasma PLs and birth weight 
(122)
. These results are in line with 
our findings, which could be expected since we used the same database 
(although extended) as Rump et al. However, we included the fatty acids of 
interest simultaneously, which enabled an additional correction for their mutual 
interactions (see below). Furthermore, we included more potential confounders 
and our analyses were broadened by including fatty acids measured in different 
umbilical domains. 
 In the present study, 18:1t levels in neonatal PLs (mainly elaidic acid, 
but including some minor positional isomers also) were negatively associated 
with most LCPUFA concentrations (data not shown, but available on request). 
Interestingly, the neonatal trans status was hardly associated with birth 
dimensions, since in our multivariable-adjusted analyses only one significant 
(negative) association was observed (between 18:1t in erythrocyte PLs and 
birth weight). In the uncorrected study of Elias and Innis, no associations were 
found between trans fatty acids in cord plasma of term infants and birth weight 
and birth length 
(8)
. On the other hand, Koletzko observed significant negative 
associations between birth weight and trans fatty acid concentrations measured 
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in various neonatal plasma lipid fractions 
(22)
. However, the latter study was 
performed in preterm infants, which may explain the difference with the results 
of Elias and Innis. Furthermore, in both studies no corrections were made for 
any possible confounder. Van Houwelingen and Hornstra observed significant 
negative correlations between 18:1n-9t concentrations in umbilical artery wall 
PLs and birth weight and head circumference, but this was a relatively small 
study (n = 37) and correction for potential confounders was incomplete 
(125)
. 
Also several animal studies have been reported and, overall, no adverse effects 
of trans fatty acids on fetal growth were observed 
(17,126)
. These rather 
inconsistent results indicate that under the present dietary conditions any 
potential effect of dietary trans unsaturated fatty acids on birth outcome is either 
small or non-existing. 
A strong aspect of our study is that fatty acid concentrations were measured 
in several umbilical cord domains, reflecting the fetal LCPUFA status over 
various gestational periods. Thus, cord plasma PLs reflect the LCPUFA 
availability at the very end of gestation, whereas the vessel wall and erythrocyte 
PLs, with presumably a lower turnover than plasma PLs 
(127)
, represent a 
longer-term reflection of the fetal LCPUFA status during pregnancy. 
Furthermore, use of the MEFAB database enabled the selection of a relatively 
large number of neonatal and maternal covariables. On the other hand, this was 
an observational study and, therefore, residual confounding can not be 
excluded.  
Relative high drop-out rates in cohort studies due to missing values can 
bias the results. The high drop-out rate in the present study, especially in the 
erythrocytes domain, is mainly the consequence of the lower number of fatty 
acid analyses performed for this domain. However, no major effects of this high 
drop-out rate on the results were observed for the mean birth dimensions and 
the median fatty acid values. Even for the maximum drop-out rate the group 
means of the three birth dimensions differed less than 3 % (ranging from 0.9 to 
2.7 %) for the cases who did or did not participate in the regression analyses. It 
is unlikely that these small birth outcome differences are of clinical relevance. 
For the fatty acids DGLA, AA, DHA and 18:1t these differences were between 
2.5 to 4.4 %, averaged over the four fatty acid domains. These differences are 
relatively small and well within the reproducibility range of our fatty acid analysis 
(in plasma PL, coefficients of variations were 11.7, 6.1, 9.0 and 29.9 % for 
DGLA, AA, DHA and 18:1t, respectively).  
As mentioned before, we included all four selected fatty acids in the 
regression models simultaneously, thereby taking into account their mutual 
metabolic interactions 
(2,95)
. Furthermore, fatty acid contents are reported in 
relative concentrations and any change in the concentration of one fatty acid will 
result in a change in the relative concentrations of the other fatty acids included 
in the analysis. Although correlation coefficients between the selected fatty 
acids in the several umbilical domains varied between 0.082 and 0.796, the 
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multicollinearity checks revealed a tolerance value of > 0.1 and a variance 
inflation factor of < 10, which allowed us to make this decision 
(114)
.  
Fetuses depend on their mothers to obtain the LCPUFAs needed for 
optimal development, as is supported by the positive correlations between 
maternal and fetal LCPUFA concentrations during pregnancy 
(124,128)
 and 
between maternal and neonatal LCPUFA concentrations at birth 
(6,7,85)
. 
Therefore, maternal plasma fatty acids measured during pregnancy can be 
taken to reflect the LCPUFA status of the children during the prenatal period 
also. In two previous studies, associations between maternal fatty acid 
concentrations, measured during pregnancy, and birth weight, birth length or 
head circumference have been investigated 
(74,96)
. In both studies significant 
negative associations were observed between maternal AA concentrations and 
some birth outcomes, which is in line with results of the present study. For DHA 
concentrations, however, contrasting study results were found when birth 
dimensions were related to maternal (positive associations) or to neonatal fatty 
acid levels (negative association). The negative association in the present 
neonatal study might be explained by the assumption that the placental 
LCPUFA transfer is limited. As a result, a larger fetus might have less LCPUFAs 
available per mass unit than a smaller fetus. Further studies are needed to test 
this hypothesis.  
In the present study the unadjusted and multivariable-adjusted analyses 
were performed with the same number of complete cases (all (co)variables 
available). In general, stronger associations were observed when unadjusted 
regression analyses were executed with the maximum number of cases 
available, thereby increasing the power of the analyses. For DGLA in cord 
plasma PLs this resulted in a significant positive association (p = 0.001) with 
birth weight, as observed before by Rump and coworkers 
(122)
. In addition, birth 
length appeared negatively associated with AA in cord plasma PLs (p < 0.000). 
No significant associations were observed in the unadjusted analyses of the 
relationships between neonatal DHA concentrations and birth weight, but 
significant positive relationships were found with birth length (p < 0.005 for 3 
lipid domains). Although this is in line with the positive trend we observed in the 
initial unadjusted regression analysis for vein wall DHA (see table 3), this trend 
disappeared after adjustment for relevant covariables. Therefore, it seems 
rather unlikely that DHA has a promoting effect on birth length. Increasing the 
power of the unadjusted regression analyses by including all available cases did 
not result in other major differences (results not shown).  
In conclusion, DHA and AA concentrations measured in various umbilical 
domains and considered to reflect fetal LCPUFA availability during late 
gestation are mainly negatively related to birth weight and birth length. Although 
these fatty acids, as essential membrane constituents, are required to allow 
fetal growth to take place, our results seems to preclude their role as growth 
factors per se. The negative relationships observed may result from a limited 
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maternal-fetal LCPUFA transfer capacity. Associations with birth dimensions 
are weak or non-existing for 18:1t and DGLA. 
 
 
Acknowledgements 
 
This study was financially supported by the Malaysian Palm Oil Board, Kuala 
Lumpur, Malaysia. The study sponsor had no involvement in the study design, 
in the collection, analysis and interpretation of data; in the writing of the 
manuscript; and in the decision to submit the manuscript for publication.  
 
Thesis_Dirix_v2.pdf   80 6-4-2009   16:40:20
81 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6 
 
 
Dietary arachidonic acid dose-
dependently increases the arachidonic 
acid concentration in human milk 
 
Antje R. Weseler, Chantal E.H. Dirix, Maaike J. Bruins and Gerard Hornstra 
 
Based on: The Journal of Nutrition 2008;138:2190-2197 
Thesis_Dirix_v2.pdf   81 6-4-2009   16:40:21
| Chapter 6 
82 
Abstract  
 
Lactation hampers normalization of the maternal arachidonic acid (AA) status, 
which is reduced after pregnancy and can further decline by the presently 
recommended increased consumption of n-3 long-chain polyunsaturated fatty 
acids (n-3 LCPUFAs). This may be unfavorable for breast-fed infants, because 
they also require an optimum supply of n-6 LCPUFAs. We therefore 
investigated the LCPUFA responses in nursing mothers upon increased 
consumption of AA and n-3 LCPUFAs. In a parallel, double-blind, controlled 
trial, lactating women received for 8 weeks (wks) no extra LCPUFAs (Control 
group, n = 8), 200 (low AA group, n = 9) or 400 (high AA group, n = 8) mg/d AA 
in combination with n-3 LCPUFAs (320 mg/d docosahexaenoic acid (DHA), 
80 mg/d eicosapentaenoic acid (EPA) and 80 mg/d other n-3 fatty acids), or this 
dose of n-3 LCPUFAs alone (DHA + EPA group, n = 8). Relative concentrations 
of AA, DHA and sums of n-6 and n-3 LCPUFAs were measured in milk total 
lipids (TLs) and erythrocyte phospholipids (PLs) after 2 and 8 wks and changes 
were compared by ANCOVA. The combined consumption of AA and n-3 
LCPUFAs caused dose-dependent elevations of AA and total n-6 LCPUFA 
concentrations in milk TLs and did not significantly affect the DHA and total n-3 
LCPUFA increases caused by n-3 LCPUFA supplementation only. This latter 
treatment did not significantly affect breast milk AA and total n-6 LCPUFA 
concentrations. AA and DHA concentrations in milk TLs and their changes were 
strongly and positively correlated with their corresponding values in erythrocyte 
PLs (r
2
 = 0.27 - 0.50; p ≤ 0.002). We thus concluded that the consumption by 
lactating women of AA in addition to extra n-3 LCPUFAs dose-dependently 
increased the AA concentration of their milk TLs.   
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Introduction 
 
Arachidonic acid (AA, 20:4n-6) and docosahexaenoic acid (DHA, 22:6n-3) are 
the most abundant long-chain polyunsaturated fatty acids (LCPUFAs) in the 
membrane phospholipids (PLs) of neural tissues, including brain 
(129-131)
. 
Especially during rapid neurodevelopment of the fetus in the last trimester of 
pregnancy and in the early postnatal period, AA and DHA accumulate in large 
amounts in neural tissues 
(66)
, where they serve as important structural and 
functional components in the development of neural and synaptic networks 
(132)
.  
Although newborn infants are capable of synthesizing AA and DHA from 
precursor fatty acids, this capacity seems insufficient to meet the high demands 
of the developing tissues 
(29,30)
. Consequently, for these LCPUFAs, infants 
largely depend on an adequate dietary supply, preferably from breast milk.  
Pregnancy is associated with a reduction in the relative concentrations of 
AA and DHA (after an initial increase) in maternal plasma PLs, because the 
maternal-fetal LCPUFA transfer is insufficiently compensated for by increased 
maternal LCPUFA consumption 
(133,134)
. During lactation, women continue the 
transfer of their own LCPUFAs to their infants, but this does not compromise the 
restoration of their relative plasma PL AA concentrations 
(5)
. The relative DHA 
concentrations in plasma PLs of lactating mothers, however, become lower than 
those of non-lactating mothers and also lower than those before conception 
(27)
. 
To support maternal DHA concentrations and to stimulate the n-3 LCPUFA 
intake of their infants, an international working party recently recommended 
increased maternal consumption of n-3 LCPUFAs during pregnancy and 
lactation of ~200 mg/d 
(135)
. Because recommendations for the general 
population are noticeably higher 
(136,137)
, the n-3 LCPUFA consumption of 
pregnant and lactating women can be expected to increase considerably in the 
near future. However, an increase in the consumption of n-3 LCPUFAs often 
causes a concomitant decrease of circulating n-6 LCPUFA concentrations and 
of AA in particular 
(9,138)
, although this is not a consistent finding 
(139)
. AA is 
considered important for fetal and infant growth and development 
(31,32)
, possibly 
because of its multiple physiological function such as involvement in eicosanoid 
synthesis 
(140)
, diacylglycerol cell-signaling pathways 
(141)
 and transcription 
regulation of fat metabolizing enzymes 
(142)
.  
Observational studies indicate that AA concentrations in human milk are 
less variable than DHA levels 
(143)
, which may be due to its putative resistance 
to changes in the consumption of AA and its precursors 
(144-146)
. However, data 
from supplementation studies are limited. We thus decided to further investigate 
the responsiveness of human milk to the additional supply of n-3 and n-6 
LCPUFAs. For this purpose, we first investigated the impact of the added 
consumption of 400 mg/d DHA + eicosapentaenoic acid (EPA) on the 
concentrations of AA and other LCPUFAs in breast milk total lipids (TLs) of 
lactating mothers. Subsequently, we studied the influence of co-consumption of 
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200 or 400 mg/d AA. To check the effects of these supplemental LCPUFAs on 
the general LCPUFA status of the women, we also measured LCPUFA 
concentrations in their erythrocyte PLs. 
 
 
Subjects and Methods 
 
Subjects 
 
A total of 52 healthy women in week (wk) 34 or 35 of pregnancy and intending 
to breast-feed their babies for at least 3 months were recruited at the University 
Hospital Maastricht and the Atrium Hospital Heerlen (both The Netherlands) 
through their obstetricians or midwives during their regular checks and by public 
relation activities. Further inclusion criteria for study entry were: pregnant for the 
first, 2nd or 3rd time; apparently healthy; pre-pregnancy BMI between 18 and 
27 kg/m
2
; no vegetarian lifestyle, fish consumption < 2 times/wk, no use of 
supplements or products rich in LCPUFAs and an alcohol consumption of ≤ 63 
g/wk; no use of medication, drugs or supplements (iron and folic acid allowed); 
smoking ≤ 5 cigarettes/d; no participation in another study < 2 months ago. 
Reasons for exclusion after enrolment were delivery before wk 37 or after wk 43 
of gestation, failure to comply with the demands of the study and suffering from 
an adverse event that might impair the reliability of the results. Subjects 
donated a blood sample in wk 36 of pregnancy to check their essential fatty acid 
status and were randomly assigned to 1 of the 4 test groups at wk 3 after 
delivery. The study was approved by the Medical Ethics Committee of the 
University Hospital Maastricht and conducted in accordance with the Helsinki 
Declaration. A written informed consent was obtained from each subject before 
enrolment. 
 
Dietary supplementation 
 
The subjects were asked to consume twice per day 200 mL of 1 of the 4 milk 
powder-based test drinks (in the morning and in the evening). For a 200-mL test 
product, a portion of 38 g powder was dissolved in a glass (~180 mL) of tepid 
water (Table 1). Per 38 g, all powders (Friesland Coberco Dairy Foods) 
contained ~5.7 g protein, 21.5 g carbohydrate, 5.5 g fat and vitamins and 
minerals. The control group received a control product without added 
LCPUFAs. Subjects allocated to the 3 treatment groups (DHA + EPA, low AA 
and high AA groups) received the control product enriched with n-3 LCPUFAs 
from Dry n-3 (BASF Health and Nutrition). The test products of the low and high 
AA groups contained also AA from Optimar single-cell oil (DSM Food 
Specialties). The consumption of 2 portions of the test drinks per day resulted in 
an additional daily intake of 320 mg DHA, 80 mg EPA and 80 mg of other n-3 
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fatty acids (all 3 treatment groups), and 200 mg/d AA (low AA group) or 400 
mg/d AA (high AA group). Treatment compliance was assessed on the 
difference between distributed full and returned (partly) empty cans and 
expressed in percentage.  
 
 
Table 1. Composition of the 4 test products per portion
1
  
 
Control 
group
2
 
DHA + EPA 
group
 3
 
Low AA 
group
 4
 
High AA 
group
 5
 
 Unit/200 mL 
Milk protein (g)
 
5.5 5.9 5.7 5.6 
Carbohydrate
6
 (g) 22.4 20.7 21.2 21.7 
Total fat
7
 (g) 5.6 5.5 5.4 5.4 
Saturated fat (g)
  
 2.6 2.5 2.5 2.4 
Unsaturated fat (g)
  
 2.9 2.9 2.9 3.0 
18:2n-6 (LA) (mg) 622 633 587 543 
20:4n-6 (AA) (mg) - - 100 200 
18:3n-3 (ALA) (mg) 89 93 93 93 
20:5n-3 (EPA) (mg) - 40 40 40 
22:6n-3 (DHA) (mg) - 161 161 161 
1
 One portion = 38 g powder dissolved in ~180 mL water yielding ~200 mL test product; 2 portions 
were consumed each day. 
2
 Intake per day: no LCPUFA. 
3
 Intake per day: 320 mg DHA + 80 mg 
EPA + 80 mg other n-3 fatty acids. 
4
 Intake per day: as DHA + EPA group + 200 mg AA. 
5
 Intake per 
day: as DHA + EPA group + 400 mg AA. 
6 
33 % Lactose, 50 % sucrose syrup and 17 % sucrose.
 
7 
87 % Fat blend FFOO (Friesland Coberco Dairy Foods), 12 % medium-chain triglyceride oil and 1 
% milk fat.  
 
 
Study visits and sample collections  
 
At wk 3 post-delivery (baseline) and 2 and 8 wks later (i.e. at wk 5 and 11 post-
delivery), the women were visited at their homes to assess their well-being and 
that of their children, to check the potential occurrence of adverse events and to 
determine their treatment compliance. During these visits, blood from a forearm 
vein was sampled into EDTA-containing tubes. Moreover, the mothers had 
been asked beforehand to collect, midway during the morning feeding, ~10 mL 
milk from each breast by manual expression into 2 collection tubes and store 
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these in a refrigerator. The blood and breast milk samples were kept in a cool-
box during transportation to the laboratory.   
 
Sample processing and fatty acid analysis 
 
Blood was processed and erythrocytes and plasma were stored until analysis 
as detailed before 
(147)
. The breast milk samples from both tubes were pooled 
and redistributed over 2 new tubes, which were tightly closed under nitrogen 
and stored at -80 °C until analysis.  
All erythrocyte samples of a given subject were analyzed within the same 
analysis to ensure uniformity of the analytical conditions. The same strategy 
was applied to the analysis of the breast milk samples.  
Lipids were extracted, PLs isolated and fatty acid methyl esters prepared as 
described earlier 
(147)
. Fatty acid compositions were analyzed by capillary gas 
chromatography with flame-ionization detection using a polar and a non-polar 
column (50-m BPX70 polar column, 0.22 x 0.25 µm and 50-m BP1 non-polar 
column, 0.22 x 0.10 µm, SGE, Bester BV) and optimized injection, oven, and 
detection temperatures 
(96)
. Helium was used as carrier gas.  
Fatty acids were quantified by the amount of internal standard recovered 
and expressed in absolute concentrations (g/L erythrocyte suspension or breast 
milk) and relative concentrations as g/100 g of total identified fatty acids in 
erythrocyte PLs and milk TLs.  
In total, 45 and 42 different fatty acids were identified and quantified in milk 
TLs and erythrocyte PLs, respectively. For this study, we concentrated on the 
following fatty acids and fatty acid combinations: AA (20:4n-6), DHA (22:6n-3), 
sum of n-6 LCPUFAs (∑n-6 LCPUFAs: calculated as the sum of 20:3n-6, 20:4n-
6, 22:4n-6 and 22:5n-6) and sum of n-3 LCPUFAs (∑n-3 LCPUFAs: calculated 
as the sum of 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3). Based on 8 samples of a 
single milk pool that were analyzed together with the study samples, we 
calculated coefficients of variation (CV) values of 1.16 % for AA and 0.66 % for 
DHA. By means of 6 erythrocyte pool samples, we determined CV values of 
0.78 % for AA and 1.07 % for DHA, respectively. 
 
Statistics 
 
We checked fatty acid data for the presence of outliers by using the Studentized 
deleted residual test 
(148)
. Subsequently, variables not following normal 
distribution were log-transformed.  
Differences between the 4 groups, with respect to the clinical variables and 
baseline fatty acid concentrations, were tested for statistical significance by 
ANOVA with Tukey’s continuation to locate differences, if any. For variables not 
normally distributed, the Kruskal-Wallis test was applied and continued by a 
Bonferroni-corrected Mann-Whitney test. ANCOVA was used to compare the 
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differences between groups regarding selected fatty acid concentrations after 2 
and 8 wks of intervention. Baseline values of the respective variables were used 
as covariates in these ANCOVAs. Because the linoleic acid (LA) status is 
known to affect uptake and/or incorporation of n-3 LCPUFAs upon 
supplementation 
(149,150)
, LA concentrations of erythrocyte PLs measured at 
baseline (ranging between 8.47 and 11.08 g/100 g) were applied as covariates 
for these ANCOVAs as well. Significant differences between the groups were 
located by Tukey’s post hoc testing. Within each group, changes in fatty acid 
concentrations between baseline and after 2 and 8 wks of supplementation 
were tested for significance by Student’s paired samples t-test (normal 
distribution) or Wilcoxon’s signed-rank test (distribution not normal). Differences 
were considered significant at p < 0.050, unless indicated otherwise. These 
statistics were performed with and without outliers.  
Relationships between AA and DHA concentrations in breast milk TLs and 
erythrocyte PLs at baseline and their changes after 2 and 8 wks of intervention 
were studied in the combined data of all 4 test groups by linear regression 
analyses. Normal distributions of the residuals were required for acceptance of 
the regression outcomes. 
All statistical analyses were performed using SPSS 12.0.1 for Windows 
(SPSS Inc., Chicago, USA). Results are expressed as group means ± SD, 
unless otherwise specified.  
 
 
Results 
 
Characteristics of the study population at baseline  
 
Fifty-two subjects were randomly allocated to the 4 test groups. Thirty-four 
subjects completed the study [n = 9 (control and low AA groups) or 8 (DHA + 
EPA and high AA groups)], whereas 18 withdrew. Reasons for withdrawal were 
mainly related to problems with breast-feeding or illness of the child. In general, 
compliance was adequate (88-98 %) and did not differ between the groups. 
However, 1 subject from the control group was excluded from all data analyses 
because of an irregular intake of the supplement.  
Baseline characteristics did not differ among the groups with the exception 
of age at delivery, which was significantly lower in the DHA + EPA group than in 
other groups (Table 2).  
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Table 2. Baseline characteristics of the 4 test groups
1
 
Characteristic 
Control 
group 
DHA + EPA 
group 
Low AA 
group 
High AA 
group 
p 
n 8 8 9 8  
Age at delivery (years)
 
 33.9 ± 1.1 28.8* ± 3.2 32.3 ± 3.8 31.9 ± 2.6 0.008 
Pre-pregnancy weight 
(kg)
 
 
65.5 ± 7.4 70.2 ± 7.2 63.3 ± 6.4 66.6 ± 6.9 0.251 
Height (m) 1.70 ± 0.07 1.71 ± 0.06 1.69 ± 0.05 1.71 ± 0.07 0.829 
Pre-pregnancy BMI 
(kg/m
2 
) 
22.6 ± 2.5 23.9 ± 1.8 22.1 ± 1.7 22.9 ± 3.0 0.492 
Systolic blood 
pressure (mm Hg) 
114.3 ± 7.4 120.4 ± 10.5 109.4 ± 8.3 113.6 ± 5.9 0.077 
Diastolic blood 
pressure (mm Hg)
 
 
68.2 ± 6.6 69.3 ± 8.1 64.5 ± 5.7 70.0 ± 3.4 0.280 
Pregnancies (n)
 
 1.8 ± 0.9 1.9 ± 0.6 1.9 ± 0.6 1.6 ± 0.5 0.842 
Total fatty acids in milk 
TLs
2
 (g/L) 
33.7 ± 16.7 38.2 ± 8.6 23.2 ± 7.3 36.5 ± 15.2 0.085 
Total fatty aids in 
erythrocyte PLs
2
 (g/L) 
1.2 ± 0.1 1.2 ± 0.1 1.2 ± 0.1 1.2 ± 0.2 0.625 
1
 values are means ± SD. * Different from the other groups (ANOVA followed by Tukey’s posthoc 
test, p < 0.050).
2
 Week 3 after parturition. 
 
 
Fatty acid composition of breast milk TLs  
 
At baseline (wk 3 post-delivery), breast milk total fatty acid concentrations did 
not differ among the groups (p = 0.085; Table 2). AA, Σn-6 LCPUFA, DHA and 
Σn-3 LCPUFA concentrations also did not differ significantly among the 4 
groups (p > 0.050; Table 3). 
 
Effect of DHA + EPA consumption on AA and Σn-6 LCPUFA concentrations. As 
demonstrated by the control group, lactation was associated with significant 
reductions of the AA (p = 0.011 after 2 wks, p = 0.0004 after 8 wks) and ∑n-6 
LCPUFA (p = 0.028 after 8 wks) concentrations (Figures 1A, B). Comparison 
between the control and the DHA + EPA groups revealed that the extra 
consumption of 400 mg/d DHA + EPA did not affect breast milk AA or ∑n-6 
LCPUFA concentrations after 2 or 8 wks of lactation (p > 0.050; Table 3).  
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Table 3. Selected fatty acid concentrations in milk TLs of lactating women at baseline and after 2 
and 8 wks of dietary intervention with different doses of AA and n-3 LCPUFAs
1
 
Variable Time 
Control 
group 
DHA + EPA 
group 
Low 
AA group 
High 
AA group 
n  8 8 9 8 
g/100 g total fatty acids 
B 0.52 ± 0.03 0.45 ± 0.08 0.50 ± 0.11 0.47 ± 0.08 
2 0.45 ± 0.06
a
 0.43 ± 0.09
a,x
 0.53 ± 0.08
y
 0.55 ± 0.09
y
 AA 
8 0.41 ± 0.06
a
 0.40 ± 0.04
a,x
 0.49 ± 0.10
y
 0.56 ± 0.07
z
 
      
B 1.12 ± 0.05 1.08 ± 0.08 1.04 ± 0.18 1.01 ± 0.17 
2 1.06 ± 0.10
a
 1.05 ± 0.12
a,x
 1.06 ± 0.19
x
 1.08 ± 0.19
x
 
∑n-6 
LCPUFAs 
8 0.89 ± 0.10
a
 0.90 ± 0.11
a,x
 0.99 ± 0.19
x,y
 1.04 ± 0.14
y
 
      
B 0.30 ± 0.06 0.34 ± 0.10 0.30 ± 0.11 0.34* ± 0.19 
2 0.25 ± 0.08
x
 0.55 ± 0.23
y
 0.60
# 
± 0.26
y
 0.46 ± 0.13
y
 DHA 
8 0.24 ± 0.08
x
 0.53 ± 0.13
y
 0.54 ± 0.17
y
 0.50 ± 0.14
y
 
      
B 0.64 ± 0.08 0.74 ± 0.15 0.62 ± 0.16 0.68** ± 0.29 
2 0.65 ± 0.20
x
 0.99 ± 0.35
x,z
 1.02
## 
± 0.42
y,z
 0.80 ± 0.19
x,z
 
∑n-3 
LCPUFAs 
8 0.57 ± 0.17
x
 0.88 ± 0.18
y
 0.92 ± 0.26
y
 0.84 ± 0.22
y
 
1
 Values are means ± SD. Means in a row with superscripts without a common letter a, b or c 
(ANCOVA, control and DHA + EPA groups) or x, y or z (ANCOVA, DHA + EPA, low AA and high AA 
groups or all 4 groups) differ, p < 0.050. * Includes 1 outlier; results after removal: 0.28 ± 0.10 (n = 
7). 
# 
Includes 1 outlier; results after removal: 0.52 ± 0.11 (n = 8). ** Includes 1 outlier; results after 
removal: 0.59 ± 0.10 (n = 7). 
## 
Includes 1 outlier; results after removal: 0.89 ± 0.21 (n = 8). B, 
baseline. 
 
 
Effect of low AA and high AA consumption on AA and Σn-6 LCPUFA 
concentrations. Compared with the consumption of the extra n-3 LCPUFAs only 
(DHA + EPA group), the additional AA intake increased the AA concentration in 
breast milk TLs (low AA and high AA groups; p < 0.050; Table 3). For both AA 
doses, the effect was already significant after 2 wks and persisted during the 
entire study period of 8 wks. The effect of the high AA dose was greater than 
that of the low AA dose at 8 wks (p < 0.050).  
Although the differences in ∑n-6 LCPUFA concentrations between the 3 
experimental groups followed a pattern comparable to the differences in AA, 
most were not significant (p > 0.050). One exception was the concentration after  
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Figure 1. Changes in concentrations (g/100 g fatty acids) of AA (A), total n-6 LCPUFAs (B), DHA 
(C) and total n-3 LCPUFAs (D) in breast milk TLs of lactating women receiving no additional 
LCPUFAs (control group, n = 8), 320 mg DHA + 80 mg EPA + 80 mg other n-3 fatty acids per day 
(DHA + EPA group, n = 8), 480 mg n-3 fatty acids + 200 mg/d AA (low AA group, n = 9) or 480 mg 
n-3 fatty acids + 400 mg/d AA (high AA group, n = 8). Values are means ± SD after 2 and 8 wks of 
supplementation. Change from baseline (paired samples t-test): + 0.050 ≤ p < 0.100; *0.010 < p ≤ 
0.050; **0.001 < p ≤ 0.010; ***p ≤ 0.001. 
 
 
8 wks in the group receiving the high AA dose, which was higher than that in the 
women receiving additional n-3 LCPUFAs only (p < 0.050). 
 
Effect of low AA and high AA consumption on DHA and Σn-3 LCPUFA 
concentrations. In contrast to the n-6 LCPUFA concentrations, the DHA and ∑n-
3 LCPUFA concentrations did not differ during the course of lactation (Figures 
1C, D; control group: p = 0.254 and 0.930 (at wk 2), p = 0.148 and 0.224 (at wk 
8) for DHA and ∑n-3 LCPUFAs, respectively). Compared with this group, the 
additional consumption of 400 mg/d DHA + EPA significantly increased the DHA 
concentration (Table 3). This increase was already maximal after 2 wks of 
intervention and co-administration of 200 or 400 mg/d AA did not significantly 
affect it after either 2 or 8 wks. This outcome was completely independent of 2 
DHA values identified as outliers.  
After 8 wks of intervention, results for ∑n-3 LCPUFAs (which also included 2 
outliers due to the outlying DHA concentrations) were virtually identical to the 
DHA outcomes, showing a significant increase after the consumption of 
additional n-3 LCPUFAs, which was not significantly altered by AA co-
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administration. Again, this outcome was independent of inclusion or exclusion of 
both outliers.  
Also after 2 wks, the results for the ∑n-3 LCPUFAs were qualitatively 
comparable to the findings for DHA. The only exception was the significant 
increase in ∑n-3 LCPUFA concentration in the low AA group compared with the 
control group. However, this significant increase could be attributed to an 
outlier, because after its removal significance was lost. 
 
Fatty acid composition of erythrocyte PLs 
 
At baseline (wk 3 post-delivery), total amounts of fatty acids associated with 
maternal erythrocyte PLs did not differ among the groups (p > 0.050; Table 2). 
The same was true for the relative amounts of selected LCPUFAs and their 
sums (Table 4). 
 
 
Table 4. Selected fatty acid concentrations in erythrocyte PLs of lactating women at baseline and 
after 2 and 8 wks of dietary intervention with different doses of AA and n-3 LCPUFAs
1
 
Variable Time 
Control  
group 
DHA + EPA 
group 
Low  
AA group 
High  
AA group 
n  8 8 9 8 
g/100 g total fatty acids 
B 10.19 ± 0.75 10.00 ± 0.76 9.71 ± 1.10 9.60 ± 0.66 
2 10.20 ± 0.85
a
 9.92 ± 0.64
a,x
 10.05 ± 1.15
y
 10.15 ± 0.66
y
 AA 
8 10.47 ± 0.93
a
 9.98 ± 0.55
a,x
 10.51 ± 0.96
y
 10.65 ± 0.95
y
 
      B 14.84 ± 0.96 14.68 ± 1.30 13.93 ± 1.56 14.22 ± 0.99 
2 14.87 ± 0.98
a
 14.43 ± 1.09
b,x
 14.14 ± 1.70
y
 14.63 ± 0.99
y
 
∑n-6 
LCPUFAs 
8 15.00 ± 1.10
a
 14.13 ± 0.98
b,x
 14.42 ± 1.27
y
 14.89 ± 1.46
y
 
      B 4.36 ± 0.43 4.08 ± 0.87 4.11 ± 0.62 4.16 ± 0.73 
2 3.96 ± 0.37
x
 4.04 ± 0.77
y,z
 4.15 ± 0.59
y
 4.02 ± 0.68
z
 DHA 
8 3.41 ± 0.36
x
 4.35 ± 0.60
y
 4.26 ± 0.60
y,z
 3.98 ± 0.47
z
 
      B 6.74 ± 0.53 6.49 ± 1.04 6.31 ± 0.88 6.34 ± 0.84 
2 6.42 ± 0.44
x
 6.53 ± 0.98
y,z
 6.50 ± 0.86
y
 6.24 ± 0.74
x,z
 
∑n-3 
LCPUFAs 
8 6.17 ± 0.61
x
 7.00 ± 0.83
y
 6.70 ± 0.91
y,z
 6.27 ± 0.58
x,z
 
1
 Values are means ± SD. Means in a row with superscripts without a common letter a, b or c 
(ANCOVA, control and DHA + EPA groups) or x, y or z (ANCOVA, DHA + EPA, low AA and high AA 
groups or all 4 groups) differ, p < 0.050. B, baseline.  
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Effect of DHA + EPA consumption on AA and Σn-6 LCPUFA concentrations. As 
demonstrated by the control group, lactation did not significantly reduce the 
concentrations of AA and ∑n-6 LCPUFAs compared with baseline values (AA: p 
= 0.829 after 2 wks and 0.064 after 8 wks; ∑n-6 LCPUFAs: p = 0.782 and 0.315 
after 2 and 8 wks, respectively; Figures 2A, B). The consumption of 400 mg/d 
DHA + EPA did not significantly affect the AA concentrations after either 2 or 8 
wks (comparison between control and DHA + EPA groups; Table 4; p > 0.050). 
However, consumption of the extra n-3 LCPUFAs significantly reduced the ∑n-6 
LCPUFA concentrations, both after 2 wks as well as after 8 wks. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Changes in concentrations (g/100 g fatty acids) of AA (A), total n-6 LCPUFAs (B), DHA 
(C) and total n-3 LCPUFAs (D) in erythrocyte PLs of lactating women receiving no additional 
LCPUFAs (control group, n = 8), 320 mg DHA + 80 mg EPA + 80 mg other n-3 fatty acids per day 
(DHA + EPA group, n = 8), 480 mg n-3 fatty acids + 200 mg/d AA (low AA group, n = 9) or 480 mg 
n-3 fatty acids + 400 mg/d AA (high AA group, n = 8). Values are means ± SD after 2 and 8 wks of 
supplementation. Change from baseline (paired samples t-test): + 0.050 ≤ p < 0.100; *0.010 < p ≤ 
0.050; **0.001< p ≤ 0.010; ***p ≤ 0.001. 
 
 
Effect of low AA and high AA consumption on AA and Σn-6 LCPUFA 
concentrations. Compared with the consumption of the extra n-3 LCPUFAs only 
(DHA + EPA group), co-administration of AA increased the AA concentration (p 
< 0.050; Table 4). For both AA doses, the effect was already significant after 2 
wks and persisted during the entire study period of 8 wks. At both points in time, 
the effect of the high AA dose did not differ from that of the low AA dose (p > 
0.050; Table 4).  
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Results for ∑n-6 LCPUFA concentrations were identical to those observed 
for AA, showing significant increases after 2 as well as 8 wks of intervention that 
were not significantly different for both AA doses (Table 4).  
 
Effect of low AA and high AA consumption on DHA and Σn-3 LCPUFA 
concentrations. In the control group, receiving no additional LCPUFAs, the DHA 
concentration strongly decreased during lactation (p < 0.001 after 2 wks, p < 
0.001 after 8 wks; Figure 2C). Comparable changes were observed for total n-3 
LCPUFAs, although less pronounced (p < 0.001 and 0.0126 after 2 and 8 wks, 
respectively; Figure 2D).  
Compared with the control group, the additional consumption of 400 mg/d 
DHA + EPA significantly increased the DHA concentration after 2 and 8 wks of 
intervention (Table 4). This effect was not significantly altered by co-
administration of 200 mg/d AA. Co-consumption of 400 mg/d AA, however, 
attenuated this DHA increase, although the difference with the control group 
was still significant. Co-consumption of the high AA dose resulted in a 
significant difference compared with the low AA dose after 2 wks and compared 
with the DHA + EPA group after 8 wks.  
Results for the Σn-3 LCPUFAs were largely comparable (Table 4). After 2 
and 8 wks, the daily administration of 400 mg DHA + EPA significantly 
increased the ∑n-3 LCPUFA concentration compared with the control group. 
Co-administration of 200 mg/d AA did not significantly influence this effect. In 
contrast, the daily co-administration of 400 mg AA considerably reduced the ∑n-
3 LCPUFA increase, as demonstrated by the absence of a significant difference 
with the control group but significant differences with the DHA + EPA group (at 
8 wks only) and the low AA group (at 2 wks). 
 
Relationships between breast milk TLs and erythrocyte PLs with respect to AA 
and DHA concentrations and their changes. 
 
When data of all 4 test groups were combined, linear regression analyses 
revealed significant relationships between erythrocyte PLs and breast milk TLs 
for AA and DHA concentrations at baseline (p < 0.001; Figures 3A, B) as well 
as after 2 and 8 wks of LCPUFA consumption (data not shown). Significant 
relationships between both domains were also observed for changes in AA and 
DHA concentrations both over the first 2 wks of intervention (p < 0.001; Figures 
3C, D) as well as over the entire intervention period of 8 wks [p = 0.002 (AA 
change), p = 0.001 (DHA change); Figures 3E, F]. 
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Figure 3. Correlations between fatty acid concentrations in breast milk TLs and erythrocyte PLs of 
lactating women. Results are presented for AA (A) and DHA (B) at baseline and for changes in AA 
and DHA concentrations after 2 (C, D) and 8 (E, F) wks of supplementation with preparations 
containing either or not (control group) additional LCPUFAs. Fatty acid concentrations and 
concentration changes are given in g/100 g fatty acids. 
 
 
Discussion  
 
Because of their multiple health benefits, it can be expected that the intake of n-
3 LCPUFAs will increase in the general population and in pregnant and lactating 
women, in particular. Elevated n-3 LCPUFA consumption often coincides with a 
decreased AA status of an individual. In pregnant and lactating women, 
however, this may not be desirable, because AA is considered essential for fetal 
and neonatal development 
(31,32)
. Hence, in a group of lactating women we 
investigated the effects of the extra consumption of 320 mg/d DHA and 80 mg/d 
EPA on the n-6 and n-3 LCPUFA concentrations in their milk over a period of 8 
wks. In addition, we studied the effects of 200 and 400 mg/d AA added to these 
n-3 LCPUFAs. To monitor changes in the general LCPUFA status of the 
participating women, the response of the LCPUFA concentrations were 
measured in erythrocyte PLs.        
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Compared with the control product without added LCPUFAs, the daily 
consumption of 400 mg extra n-3 LCPUFAs did not significantly alter the AA 
and n-6 LCPUFA concentrations in breast milk TLs (Table 3). Consistent with 
earlier reports 
(151-153)
, we observed that the milk DHA concentrations 
significantly increased within 2 wks upon the intake of 320 mg/d DHA and 80 
mg/d EPA. The extra consumption of 200 or 400 mg/d AA significantly 
increased the AA concentration in breast milk TLs both after 2 and 8 wks of 
intervention in a dose-dependent manner. However, it required > 2 wks before 
the dose effect became significant, which might have been due to the rather 
small sizes of our test groups. The Σn-6 LCPUFA concentrations of breast milk 
TLs also increased upon AA consumption. This effect was only significant for 
the high AA dose and an intake period of > 2 wks (Table 3).  
Based on indirect evidence, it has been suggested that maternal AA intake 
influences the AA content of breast milk only to a minor extent 
(144,146)
. However, 
the effect of AA consumption on breast milk AA concentration has hardly been 
investigated. The only study we are aware of was performed by Smit et al. 
(145)
, 
who supplied lactating women with 300 mg AA either alone or in combination 
with 400 mg DHA and 110 mg EPA per day for 1 week . No significant effects 
were found on the AA concentration of breast milk TLs, which was recently 
attributed to the short study period 
(154)
.  
In general, the LCPUFA responses in breast milk TLs were in good 
agreement with those observed in erythrocyte PLs (Table 4), but not in all 
aspects. Although consumption of extra n-3 LCPUFAs did not significantly affect 
AA concentrations in erythrocyte PLs, the Σn-6 LCPUFA concentrations 
progressively decreased. This decline appeared mainly attributed to the 
significantly decreasing concentrations of adrenic acid (AdrA, 22:4n-6; results 
not shown, but available on request), the elongation product of AA.  
As expected, the DHA and Σn-3 LCPUFA concentrations increased 
significantly in the red blood cell PLs upon the consumption of the extra n-3 
LCPUFAs (Table 4). Interestingly, the concomitant intake of AA attenuated this 
effect considerably, which indicates that AA may compete with DHA for 
incorporation into erythrocyte membrane PLs. Such a competition likely 
explains results, reported by Nelson et al. 
(155)
, that the daily consumption of 1.5 
g AA for 50 d significantly lowers the DHA content of erythrocyte PLs. In our 
study, the extra AA also raised the AA status of the women, as demonstrated by 
the AA increase in their erythrocyte PLs. 
During the entire study period, breast milk TL concentrations of AA and 
DHA as well as their diet-induced changes were positively and significantly 
correlated with AA and DHA concentrations and changes in erythrocyte PLs 
(see figure 3). Dietary AA and DHA are generally acknowledged to directly 
affect the AA and DHA concentrations in erythrocyte PLs and the correlation 
with concentrations and changes in milk TLs could suggest that they may also 
directly influence the breast milk concentrations of these LCPUFAs.  
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Remarkably, the regression slopes for the diet-induced changes, both after 
2 and after 8 wks of intervention, were about twice as steep for DHA as for AA. 
Prima facie this could be taken as evidence for a less efficient incorporation of 
AA into breast milk TLs compared with DHA, which would be in agreement with 
most observational studies 
(143)
. However, this interpretation would ignore the 
considerable differences between the intercepts of the AA and DHA 
regressions. Moreover, different incorporation efficiencies are not supported by 
our observation that a comparable daily LCPUFA intake [400 mg AA (high AA 
group) or 320 mg DHA + 80 mg EPA (DHA + EPA group)] raised the breast milk 
AA and DHA concentrations after 8 wks by about the same extent (~0.2 g/100 g 
compared with the control group; see figure 1A, high AA vs. control group for 
AA and figure 1C, DHA + EPA vs. control group for DHA). This observation 
rather suggests that the incorporation efficacies of dietary AA and DHA in 
breast milk TLs are of the same magnitude. To fully elucidate, however, the 
efficiency by which dietary AA is incorporated into breast milk TLs, studies with 
stable isotope-labeled AA are required.  
In line with earlier studies 
(156-158)
, breast milk total fatty acid concentrations 
decreased considerably during the course of lactation (Table 3). In the control 
group, AA and the Σn-6 LCPUFAs also declined (Figures 1A, B). Although 
these changes were not significant for DHA and the Σn-3 LCPUFAs (Figures 
1C, D), the breast milk AA:DHA and Σn-6:Σn-3 LCPUFA ratio’s (1.81 ± 0.37 and 
1.77 ± 0.21 at baseline, respectively) remained essentially unchanged. From 
the 3 experimental groups, it became obvious that additional LCPUFA 
consumption can substantially alter these ratios. Thus, the extra intake of 400 
mg/d DHA + EPA resulted in a reduction of the AA:DHA ratio of 45.8 % within 
the 8-wks intervention, which brings it within the lower range of the AA:DHA 
ratio distribution worldwide 
(143)
. In the same period, the Σn-6:Σn-3 LCPUFA 
ratio declined by 31.3 %. The extra intake of 400 mg/d AA attenuated the 
decreases of both ratios to 28.6 and 22.1 %, respectively, but did not prevent 
them. Whether these ratio changes in breast milk composition are of any 
functional importance, needs to be considered in future studies. 
In conclusion, we demonstrated that the consumption by lactating women of 
additional AA and n-3 LCPUFAs increased the AA and DHA concentrations of 
their milk TLs. For AA, this effect appeared dose-dependent. Nonetheless, 
higher amounts of AA than DHA would be required to keep the breast milk 
AA:DHA ratio constant at habitual values upon DHA supplementation.  
 
 
Acknowledgements 
 
We thank José Breedveld-Peters for her unfailing assistance during the 
subjects’ visits and Arnold Kester for his excellent support during the statistical 
analyses.  
Thesis_Dirix_v2.pdf   96 6-4-2009   16:40:23
97 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7 
 
 
Prenatal arachidonic acid exposure and 
selected immune-related variables in 
childhood 
 
Chantal E.H. Dirix, Janneke G.F. Hogervorst, Patrick Rump, Johannes J.E. 
Hendriks, Maaike J. Bruins and Gerard Hornstra 
 
Based on: The British Journal of Nutrition (in press) 
 
Thesis_Dirix_v2.pdf   97 6-4-2009   16:40:23
| Chapter 7 
98 
 
Abstract   
 
Arachidonic acid (AA) is considered essential in fetal development and some of 
its metabolites are thought to be important mediators of the immune responses. 
Therefore, we studied whether prenatal exposure to AA is associated with some 
immune-related clinical conditions and plasma markers in childhood. In 280 
children aged 7 years, atopy, lung function and plasma inflammation markers 
were measured and their relationships with early AA exposure were studied by 
linear and logistic regression analyses. AA exposure was deduced from AA 
concentrations in plasma phospholipids (PLs) of the mothers collected at 
several time points during pregnancy and at delivery, and in umbilical cord 
plasma and arterial and venous wall PLs. In unadjusted regression analyses, 
significant positive associations were observed between maternal AA 
concentrations at 16 and 32 weeks of pregnancy (proxies for fetal AA exposure) 
and peak expiratory flow decline after maximal physical exercise and plasma 
fibrinogen concentrations of their children, respectively. However, after 
correction for relevant covariables, only trends remained. A significant negative 
relationship was observed between AA concentrations in cord plasma 
(reflecting prenatal AA exposure) and the average daily amplitude of peak 
expiratory flow at rest, which lost significance after appropriate adjustment. 
Because of these few, weak and inconsistent relationships, a major impact of 
early-life exposure to AA on atopy, lung function and selected plasma 
inflammation markers of children at 7 years of age seems unlikely. 
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Introduction 
 
There is increasing evidence that exposure to nutritional factors, such as n-6 
and n-3 polyunsaturated fatty acids (PUFAs), during the perinatal period may 
influence the development of the immune system and subsequent immune 
competence 
(4)
. The n-6 and n-3 PUFAs are important structural components of 
cell membranes and particularly arachidonic acid (AA) is prominently present in 
immune cell membrane phospholipids (PLs) 
(159,160)
. AA may influence the 
developing immune system because it is the precursor of prostaglandin E2 
(PGE2), which is thought to be an important mediator of immune responses 
(44,45)
. During pregnancy, the maternal essential fatty acid (EFA) status declines 
and because the EFA status of the neonate is strongly correlated with the EFA 
status of its mother 
(26)
, the AA supply to the developing fetus and its immune 
system may not always be optimal.  
Previous studies investigated the relationship between the maternal intake 
of n-3 long-chain polyunsaturated fatty acids (LCPUFAs) during pregnancy and 
immune-related variables of their offspring 
(161,162)
. However, only a few studies 
considered the relationship between the prenatal n-6 LCPUFA status, especially 
AA, and immune-related variables, such as atopy later in life. Galli and 
coworkers observed that babies who developed atopic disease after 1 year of 
birth had 20-40 % lower levels of AA in their serum cord blood cells in 
comparison with non-atopic babies 
(163)
. In contrast, Yu et al. found no 
significant differences in any of the fatty acid levels, measured in umbilical 
venous blood samples, of babies who did or did not develop allergic diseases 
during the first 6 years of life 
(164)
. Furthermore, Newson et al. studied the 
relationship between levels of various n-3 and n-6 series fatty acids, including 
AA, in erythrocyte PLs of women in late pregnancy and in erythrocyte PLs of the 
umbilical cord of their children, and the prevalence of wheezing and eczema of 
the child from birth until 6 months and from age 30-42 months 
(165)
. No 
significant associations were observed after adjustment for covariables. Thus, 
the relationship between prenatal AA concentrations and later immune-related 
variables remains relatively unexplored. Therefore, we investigated in a mother-
child cohort the associations between the AA levels of maternal plasma PLs, 
during early, middle and late pregnancy (as proxies for fetal AA exposure), and 
several immune-related clinical conditions and inflammation markers of the child 
at 7 years of age. In addition, we also investigated if these immune-related 
variables were associated with PL AA concentrations collected in cord plasma 
and vessel walls of the newborns, all assumed to reflect prenatal AA exposure.  
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Subjects and methods 
 
Study population and design 
 
The Maastricht Essential Fatty Acid Birth (MEFAB) cohort resulted from 
observational studies performed during 1990-1997, which investigated the 
associations between maternal or neonatal EFA status during pregnancy and 
pregnancy outcome in approximately 1200 pregnant women and most of their 
infants 
(1,7)
. In 1997, the parents of the 750 singleton infants born between 1990 
and 1994 were approached for an extensive follow-up and eventually 305 
children participated in these studies between 1997 and 2000 
(166,167)
. Results of 
this follow-up were also entered in the MEFAB database, which provided all 
data for the present study. Children with an unknown gestational age at birth or 
who were born before 37 weeks gestational age or after 43 weeks of pregnancy 
were excluded (n = 25). Ultimately, the data of 280 children and their mothers 
were available for the present statistical analysis. Unadjusted and multivariable-
adjusted regression models were applied to explore if maternal or neonatal AA 
concentrations, measured during pregnancy and/or directly after delivery, are 
related to childhood immune-related variables. 
 
Blood and tissue sampling and fatty acid measurements 
 
Maternal venous blood samples were collected in EDTA tubes around the 16th, 
22nd and 32nd week of pregnancy, and immediately after delivery. Umbilical 
cord blood and a piece of the umbilical cord were obtained immediately
 
after 
parturition. About 7 years later, after an overnight fast, venous blood from the 
children was collected by venepuncture in EDTA-treated evacuated tubes. 
Plasma was separated from blood cells by centrifugation. Plasma and umbilical 
tissue samples were stored under nitrogen at -80 °C until analysis. The fatty 
acid composition of PLs isolated from plasma and cord vein and artery walls 
was determined by capillary gas-liquid chromatography as described elsewhere 
(26,68)
. Fatty acids are expressed as relative values (% by weight of total 
identified PL-associated fatty acids, % wt/wt). 
 
Explanatory variables 
 
Four explanatory neonatal variables were taken to reflect prenatal AA exposure, 
i.e. the relative AA concentrations of PLs isolated from umbilical plasma and 
from the walls of the cord vein and artery, and the difference between these 
latter two concentrations, which we considered a proxy for fetal AA consumption 
(75)
. The AA concentrations of maternal plasma PLs at approximately 16, 22 and 
32 weeks of gestation and at delivery were applied as four additional 
explanatory variables. These variables are taken to reflect the AA status of the 
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fetus during gestation, since the maternal and neonatal EFA statuses are 
strongly correlated 
(26)
.  
 
Dependent variables 
 
The following immune-related variables were modelled as dependent variables 
in the regression analyses: presence of atopic clinical conditions, peak 
expiratory flow (PEF) outcomes and plasma concentrations of a number of 
inflammation markers (all described later).  
Atopy assessment. For the atopy assessment of the children, parents 
completed an atopy questionnaire, based on the ‘Maastricht Atopy List’ 
(168)
 and 
the well-validated 
(169,170)
 ‘International Study of Asthma and Allergies in 
Childhood (ISAAC)’ questionnaire 
(171)
. This questionnaire included queries 
about typical atopy-related symptoms, categorized per atopic organ 
(172)
, such 
as ‘Has your child ever had allergic complaints such as eczema, hay fever, 
and/or food allergy?’, ‘Has your child ever had asthma or asthmatic bronchitis?’, 
and ‘Has your child ever had wheezing or whistling in the chest’. In addition, the 
following question about allergy tests was included: 'Has your child ever 
undergone an allergy test like a skin-prick test, radioallergosorbent test (RAST), 
elimination test or otherwise? If yes, what was the test result?'. From these 
questionnaires, the presence of atopy was evaluated by a paediatric 
pulmonologist (JJEH), and scored ‘yes’ or ‘no’ when, respectively, more than 
one or none of the above-mentioned clinical conditions were conclusively 
manifest. Children whose diagnosis was inconclusive (scoring only one of the 
above-mentioned clinical conditions) were excluded from analysis to prevent 
bias introduced by misclassification.  
Peak flow measurements. Asthma is a chronic inflammatory disorder of the 
airways in which many different cell types play a role. In susceptible individuals 
this inflammation causes symptoms which are usually associated with 
widespread but variable airflow obstruction, that is often reversible either 
spontaneously or with treatment, and causes an associated increase in airway 
responsiveness to a variety of stimuli 
(173)
.  PEF measurements are often used 
in everyday clinical and epidemiological environments for measuring the 
severity in airflow obstruction of asthma, to characterize the clinical trial 
population and to describe the response to treatment 
(174)
. In addition, 
investigators of previous studies observed that in children with asthmatic 
symptoms atopy was associated with a greater within-day and between-day 
variation in PEF 
(175,176)
. To assess pulmonary function in the present study, 
PEF was measured using a Mini-Wright peak flow meter. Measurements were 
carried out at rest (at home) and before and after maximal physical exercise (at 
the laboratory), both after instructions of the research team. Under the 
supervision of the parents, PEF measurements at rest were performed for 2 
weeks, five times per day during the morning (between 07.00 and 09.00 hours) 
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and five times per day during the evening (between 19.00 and 21.00 hours). 
Each day, the highest PEF value in the morning and the highest value in the 
evening were recorded. To increase the reliability of the measurements, these 
values were only accepted if at least two other PEF values (of that series of five 
measurements) fell within a range of 10 % of that highest value. If this was not 
the case, this procedure was repeated with the next highest PEF value, etc. 
until two PEF values fell within the 10 % range of that next highest PEF value, 
otherwise a missing value was generated. The average highest PEF value at 
rest in the morning (PEF morning) was calculated for the 2-week measurement 
period. In addition, the PEF daily amplitude was calculated as the difference 
between the highest morning and highest evening PEF value and expressed as 
a percentage of the mean 
(177)
. The average daily PEF amplitude (PEF 
amplitude) was calculated over the 2-week measurement period. To measure 
PEF decline after exercise provocation (PEF exercise), PEF measurements 
were performed at the laboratory three times before, and three times at 2, 5, 10 
and 15 minutes after reaching maximal exercise with the Bruce treadmill test 
(178,179)
, of which the highest PEF value was recorded each time. PEF decline 
after exercise provocation was calculated as: {(PEF highest value before 
exercise - PEF lowest value after maximal exercise) / PEF highest value before 
exercise} x 100 % 
(180)
.  
Plasma inflammation markers. The following factors are involved in different 
processes of the inflammatory response and were therefore chosen as 
dependent variables: fibrinogen (g/L) 
(181)
, C-reactive protein (CRP; mg/L) 
(182)
, 
leptin (µg/L) 
(183)
 and von Willebrand factor (vWF) concentrations 
(184)
. In 
addition, total leucocyte counts (x 10
9
/L blood) were measured, as well as the 
absolute and relative amounts of lymphocytes, granulocytes and monocytes (% 
of total leucocytes) 
(185)
.  
Fibrinogen was assayed by the Clauss method 
(186)
 and CRP was measured 
with an in-house ELISA using polyclonal antibodies as catching and tagging 
antibodies labelled with horseradish peroxidase (DAKO, Glostrup, Denmark). 
Plasma leptin concentrations were measured with a commercial human leptin 
radioimmunoassay kit (Linco Research, St Charles, MO, USA) according to the 
manufacturer's instructions. The relative plasma content of vWF was measured 
by the Cejka method 
(187)
. The inter-assay and intra-assay variation coefficients 
were 3.3 and 3.6 % (fibrinogen), 6.5 and 3.2 % (CRP), 8.2 and 6.0 % (leptin), 
5.1 and 5.7 % (vWF). Total leucocyte counts and relative granulocyte, 
lymphocyte, and monocyte counts were determined on a Coulter Counter 
(Coulter® GEN.S; Beckmann Coulter Inc. Fullerton, CA) following the 
manufacturer’s instructions.  
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Covariables 
 
The following variables were considered potential confounders: socio-economic 
status (SES) 
(188)
, parity (none, one or ≥ two children) at study entry 
(7,189)
, 
maternal smoking during pregnancy and anyone smoking at home during the 7-
year follow-up period (both measured as total number of cigarettes/1000) 
(190)
, 
breast-feeding (number of months) 
(191)
, maternal age at study entry (years) 
(192)
, 
infant sex 
(193)
, gestational age (weeks) 
(7,26)
, parent ethnicity (Caucasian or not) 
(193)
, birth season (divided into quarters) 
(194)
, season of follow-up measurements 
(divided into quarters) 
(195)
, day-care attendance (total number of days/100) 
(196)
, 
parental history of atopy (none, one of the parents, or both) assessed at follow-
up 
(191)
 and weight gain during first year of life corrected for infant sex and age 
(SD scores) 
(197)
. The relative dihomo-γ-linolenic acid (DGLA), EPA and DHA 
concentrations in umbilical cord plasma and vein and artery wall PLs, and in 
maternal plasma PLs, as well as the relative AA concentration of plasma PLs of 
the children at follow-up were also selected as potential covariables 
(43)
. Exact 
information on SES was not available. Therefore, parental SES was measured 
by proxy, using ‘income' as an SES indicator, based on the parental postal code 
at the time of delivery (Geomarktprofiel; Wegener DM, The Netherlands). This 
information was classified in five groups ranging from 1 (twice or more modal 
income) to 5 (minimum income); SES values in the categories unknown (0) and 
diverse (6) were omitted and, thus, reported as missing values. Children who 
never received breast milk were classified as formula-fed and the remaining 
children as breast-fed. The following covariables were considered confounders 
in the models with PEF-related outcomes only: endurance time (time required 
until maximal exercise was reached, abstracted from the Bruce treadmill test) 
(178)
, site of first PEF measurement (at the laboratory with extensive instructions 
by the research team or at home, with written instructions only) and children’s 
height and weight at follow-up (age 7 years) 
(198)
.  
 
Data evaluation and statistical analysis 
 
All data are presented as medians and interquartile ranges (IQR), unless 
otherwise mentioned. Unadjusted and multivariable-adjusted linear and logistic 
regressions were performed to test the associations between maternal and 
neonatal AA concentrations and the immune-related variables. Before this, data 
distributions of the dependent variables were checked by means of the Shapiro-
Wilk test; in case of skewness transformation was applied (natural log, square 
root, square or 1/square) to optimize the data distribution towards normal. When 
transformation improved but did not normalize the distribution, linear regression 
analyses were still performed, but results were accepted only if the residuals 
were normally distributed. If this was not the case, the variables were 
dichotomized and logistic regression analyses were performed. In the 
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regression analyses with maternal AA levels this appeared the case for 
absolute monocyte counts and leptin concentrations. Therefore, these variables 
were analyzed as dichotomous variables (≥ median vs. < median). The same 
was done for fibrinogen and leptin concentrations in relation to neonatal AA 
concentrations. The vWF values were biphasically distributed with the point of 
overlap situated at 68 %. Therefore, this variable was analyzed as a 
dichotomous variable also (≥ 68 vs. < 68 %). Because the PEF exercise 
variable had a non-parametric distribution, this variable was also dichotomized. 
Children without an asthmatic condition usually have a smaller PEF decline (< 
15 %) after exercise 
(173)
, because they will develop less bronchoconstriction 
compared with their asthmatic counterparts. Therefore, this value was selected 
as the threshold for dichotomisation (≥ 15 vs. < 15 %). 
Values of normally distributed variables (either before or after transfor-
mation) were considered outliers and removed from the dataset if they were 
more than four standard deviations (SD) away from the mean. Values of not 
normally distributed variables, even after optimal transformation, were 
considered outliers and were removed from the dataset if their values were 
more than three IQR below or above the median. 
Insufficient complete cases were available to allow inclusion of all the 
above-mentioned covariables in the analyses. Therefore, for each of the fifteen 
dependent variables and each covariable, bivariable regression analyses were 
performed which included one dependent variable, one explanatory variable 
and one covariable. These analyses were used to determine which of the 
covariables contributed to the relationships between dependent and explanatory 
variables, either as a significant predictor (p < 0.050) or as a confounder (if its 
removal caused the B-value to change at least 10 %, and 20 % or more of the 
standard error of this B-value) 
(104)
. Only covariables that appeared predictors or 
confounders were included in the various multivariable-adjusted analyses. For 
practical reasons, bivariable analyses were only done for AA concentrations in 
maternal plasma PLs at 32 weeks gestation and for AA concentrations in cord 
artery wall PLs. The selected covariables were subsequently included in all 
models with corresponding maternal or neonatal AA variables. For all 
unadjusted and multivariable-adjusted regression analyses the same complete 
dataset was used. Data points suspected of being overly influential were 
checked by calculation of their Cook’s distances and removed if their values 
were > 1. Such influential data points were observed in four multivariable-
adjusted regression models, but exclusion of these data points did not alter the 
final results.  
Atopy and the three pulmonary function variables were regarded as the 
dependent variables of primary interest. Relationship studies with these 
variables were, therefore, considered the primary analyses. All other 
relationships were regarded of secondary interest. The significance level for the 
primary analyses was set at a threshold of p < 0.050, with p < 0.100 indicating a 
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non-significant trend. Secondary relationships were considered significant at p < 
0.010, to correct for multiple comparisons, and p < 0.050 indicated a non-
significant trend.  
SPSS 11.5 for Windows (SPSS, Inc., Chicago, IL, USA) was used for all 
statistical analyses. 
 
 
Results 
 
An overview of the parental and infant characteristics screened as covariables 
are shown in tables 1 and 2. The immune-related parameters of the children 
measured at 7 years of age are presented in table 3. The relative 
concentrations of the maternal and neonatal fatty acids of interest is given in 
table 4. In tables 5 and 6, results of the regression analyses are only shown for 
combinations of dependent and explanatory variables with significant or trend 
contributions of AA to either the unadjusted or multivariable-adjusted models. 
Full results are available on request. 
 
 
Table 1. Maternal and child characteristics used as continuous covariables 
Characteristics n Median (25
th 
- 75
th
 percentile) 
Maternal age at study entry (years) 280 29.5 (26.9 - 32.4) 
Gestational age at birth (weeks) 280 40.1 (39.3 - 41.0) 
Infant weight gain during first year of life (SD) 247 1.0 (0.3 - 1.7) 
Height at 7-year follow-up (cm) 275 127.0 (123.2 - 130.4) 
Weight at 7-year follow-up (kg) 275 24.5 (22.2 - 27.6) 
Day-care attendance during 
7-year follow-up (total days/100) 
272 0.08 (0.08 - 0.12) 
Breast-feeding (months) 278 0.00 (0.00 - 3.00) 
Maternal smoking during pregnancy 
 (total cigarettes/1000) 
280 0.00 (0.00 - 0.54) 
Anyone smoking at home during  
7-year follow-up (total cigarettes/1000) 
276 5.29 (0.00 - 25.6) 
Endurance time at 7-year follow-up (min)* 248 10.5 (10.0 - 11.2) 
* Time required to reach maximal exercise, calculated from the Bruce test results 
(178)
 and  
considered a measure of physical fitness. 
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Table 2. Frequency and code for relevant discrete parental and infant covariables 
 n % 
Parental covariables   
Parents’ SES grade (income)   
High (1) 4 1.4 
Above modal (2) 23 8.2 
Modal (3) 44 15.7 
Below modal (4) 74 26.4 
Low (5) 31 11.1 
Missing 104 37.1 
Total 280 100 
Parental atopy, positive   
None 148 52.9 
Father 44 15.7 
Mother 64 22.9 
Both 19 6.8 
Missing 5 1.8 
Total 280 100 
Parity   
0 193 68.9 
1 68 24.3 
>2 19 6.8 
Missing 0 0 
Total 280 100 
Parents’ ethnicity   
Caucasian (0) 270 97.1 
All other (1) 8 2.9 
Missing 0 0 
Total 280 100 
Infant covariables   
Infant sex   
Male (0) 152 54.3 
Female (1) 128 45.7 
Missing 0 0 
Total  280 100 
Birth season quartiles*   
1 71 25.4 
2 49 17.5 
3 71 25.4 
4 88 31.4 
Missing 1 0.4 
Total 280 100 
Season of measurement quartiles*   
1 97 34.6 
2 75 26.8 
3 61 21.8 
4 47 16.8 
Missing 0 0 
Total 280 100 
Site of first PEF measurement   
At laboratory (0) 106 37.9 
At home (1) 152 54.3 
Missing 22 7.9 
Total 280 100 
SES = socio-economic status; PEF = peak expiratory flow. * 1 = January - March, 2 = April - June, 
3 = July - September, 4 = October - December. 
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Table 3. Immune-related variables measured in children at follow-up at age 7 years
 
Variable Unit n Median (25
th
 - 75
th
 percentile)* 
no 183 (65.4 %) n.a. 
uncertain 45 (16.1 %) n.a. Atopy 
yes 52 (18.6 %) n.a 
PEF morning L/min 257 214.58 (193.96 - 242.50) 
PEF amplitude % 255 7.89 (5.80 - 10.28) 
PEF exercise % 257 5.26 (0.00 - 10.53) 
Leucocytes ×10
9
/L 243 6.60 (5.80 - 7.70) 
Monocytes ×10
9
/L 243 0.40 (0.30 - 0.50) 
Granulocytes ×10
9
/L 245 3.60 (2.80 - 4.60) 
Lymphocytes ×10
9
/L 246 2.50 (2.10 - 3.00) 
Monocytes % 245 6.20 (4.65 - 8.00) 
Granulocytes % 244 53.95 (47.83 - 62.50) 
Lymphocytes % 246 38.95 (32.00 - 44.43) 
CRP mg/L 232 0.19 (0.07 - 0.58) 
Leptin µg/L 245 2.85 (2.07 - 3.93) 
Fibrinogen g/L 233 2.60 (2.40 - 2.80) 
vWF % 233 81.00 (71.00 - 84.00) 
n.a. = not applicable;
 
PEF = peak expiratory flow; PEF morning = average PEF in the morning; PEF 
amplitude = average PEF daily amplitude; PEF exercise = PEF decline after exercise provocation; 
CRP= C-reactive protein; vWF= von Willebrand factor. *
 
For all variables non-transformed values 
are given. 
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Associations between maternal arachidonic acid status and childhood immune-
related clinical parameters  
 
A negative trend was observed for the unadjusted association between the 
natural log-transformed PEF amplitude and maternal AA levels at the 22nd 
week of pregnancy (R
2 
= 0.016, p = 0.069), but this trend was no longer present 
in the multivariable-adjusted analysis (Table 5) .  
A significant positive association and a positive trend were observed for the 
unadjusted relationships between PEF exercise values and the AA levels in 
maternal plasma at 16 weeks of pregnancy (p = 0.033) and directly after 
delivery (p = 0.097), respectively. In these unadjusted models, differences in AA 
concentrations explained 4.5 and 2.8 % of the variance in PEF exercise, 
respectively. After adjustment of both models for relevant covariables, only a 
positive trend remained for the first relationship (p = 0.059), in which AA 
explained 3.5 % of the variation in PEF exercise.  
For all other combinations of maternal AA concentrations and immune-
related clinical parameters no significant associations or trends were found. 
 
Associations between the maternal arachidonic acid status and childhood 
immune-related plasma variables  
 
The only significant relationship observed in the unadjusted analyses was a 
positive association between the AA levels at week 32 of pregnancy and 
fibrinogen concentrations in children’s plasma at follow-up (linear regression 
analysis after quadratic transformation of fibrinogen concentrations, p = 0.006) 
(Table 5). After adjustment for the child’s AA concentration at follow-up, the 
association lost significance (p = 0.014, which is higher than 0.010 that was set 
for the secondary analyses) and differences in maternal AA concentrations 
explained 2.9 % of the variance in fibrinogen levels.  
Negative trends were observed for the unadjusted associations of the 
relative and absolute monocyte counts with AA concentrations at the 16th week 
of pregnancy. The models explained 2.1 and 4.5 % of the variance in relative (p 
= 0.030) and absolute (p = 0.034) monocyte counts, respectively. These trends 
persisted after adjustment for the appropriate covariables, which resulted in 
models in which the AA concentrations explained 1.8 % (relative monocyte 
values, p = 0.039) and 4.4 % (absolute monocyte counts, p = 0.030) of the 
monocyte variance.  
All other regression analyses revealed no significant associations or trends. 
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Associations between neonatal arachidonic acid status and childhood  immune-
related clinical parameters  
 
Unadjusted regression analysis showed a significant negative association 
between natural log-transformed PEF amplitude values and AA concentrations 
in neonatal plasma PLs (R
2
 = 0.026, p = 0.020) (Table 6). However, after 
adjustment for relevant covariables, this association was reduced and no longer 
significant.  
A positive trend was observed for the unadjusted relationship between PEF 
exercise and the difference in AA concentrations between the walls of cord 
arteries and cord vein (p = 0.087), which explained 4.6 % of the variance in PEF 
exercise. This positive trend disappeared, however, after adjustment for the 
appropriate covariables.  
No significant associations or trends were observed for the other 
combinations of neonatal AA concentrations and clinical immune-related 
variables. 
 
Associations between neonatal arachidonic acid status and childhood immune-
related plasma variables  
 
In unadjusted regression analyses, only a positive trend was observed for the 
relationship between absolute lymphocyte counts (square root-transformed) of 
the children at follow up, and their plasma PL AA concentrations at birth (R
2
 = 
0.018, p = 0.038), but this trend did not survive after adjustment for DGLA and 
DHA concentrations in neonatal plasma PLs (Table 6).  
In multivariable-adjusted analyses, a negative trend was found for the 
relationship between the natural log-transformed plasma CRP levels of the 
children at follow up and the AA concentrations measured in the PLs of their 
cord artery walls (p = 0.019). In this model, AA explained 3.7 % of the CRP 
variance.  
A positive trend (p = 0.049) was observed for the multivariable-adjusted 
relationship between children’s natural log-transformed absolute leucocyte 
counts at age 7years and the AA levels of their cord vein wall PLs. In this 
relationship, AA explained 2.3 % of the variance in leucocyte count.  
No other important associations or trends were noted. 
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Discussion 
 
In the unadjusted primary analyses of this prospective mother-child cohort, 
negative associations were observed between the average PEF daily amplitude 
(PEF amplitude) of 7-year-old children and the AA concentrations in plasma 
PLs of their mothers at 22 weeks gestation (reflecting fetal exposure to AA) and 
in umbilical plasma PLs (reflecting prenatal AA exposure). On the other hand, 
positive associations were observed between the PEF decline after maximal 
exercise (PEF exercise) and maternal AA concentrations at 16 weeks of 
pregnancy and directly after delivery, respectively. These positive associations 
are in concordance with the positive non-significant trend between PEF 
exercise and neonatal vein-artery AA differences, which we consider a proxy of 
fetal AA consumption. For these associations and trends, variations in AA levels 
explained no more than 0.8 to 3.5 % of the variability of these immune-
associated variables, strongly suggesting that the prenatal AA status of an 
individual hardly contributes to these immune-related aspects at 7 years of age. 
This is also supported by the finding that the associations are not only 
functionally inconsistent but contrasting as well. Since values for PEF amplitude 
and/or PEF exercise are usually increased in subjects with an asthmatic 
condition 
(173)
, the negative associations we observed with AA exposure imply a 
beneficial effect of AA on lung function, if relations are causal. In contrast, the 
positive relationships between AA exposure and PEF exercise indicate a 
potentially adverse effect of AA. Finally, in the multivariable-adjusted analyses 
most significant results and trends disappeared.   
Concerning the secondary analyses with the immune-related plasma 
markers, one significant positive association was shown between maternal AA 
concentrations at 32 weeks of pregnancy and plasma fibrinogen concentrations 
of the children at 7 years of age. For some other associations only trends were 
revealed but, like the primary analyses, no more than about 4 % of the 
functional variability was explained by differences in AA concentration. 
Moreover, observed associations and trends were functionally inconsistent 
again and therefore a major influence of early AA exposure on these immune-
related plasma markers at age 7 years seems unlikely.  
Relationships between early-life exposure to n-3 and n-6 fatty acids and 
immune-related clinical conditions measured during childhood have been 
previously studied 
(199-202)
. However, as far as we know, only a few studies 
investigated the associations between prenatal n-6 fatty acid exposure and 
various indicators of immune function in childhood. Newson and co-workers did 
not report any significant association between relative AA concentrations in 
erythrocyte PLs of umbilical cord blood and maternal blood collected in a period 
between 20 weeks of pregnancy and delivery and the prevalence of wheezing 
or eczema up to 42 months of age after adjustment for confounders 
(165)
. 
Furthermore, Yu et al. also observed no difference in the relative AA levels of 
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umbilical cord blood PLs of children who did or did not develop allergic disease 
during the first 6 years of life 
(164)
. Both findings are in line with our observation 
that plasma AA concentrations before and around birth are not strongly 
associated with atopic disease in later childhood. Since these previously 
mentioned studies used shorter periods between fatty acid exposure 
measurements and assessment of immune-related variables, it can probably be 
excluded that the interval period of 7 years in the present study was too long to 
explain the non-significant results.   
Galli and co-workers selected fifty-seven neonates at high risk for 
developing atopy and reported that all thirteen newborns who developed atopic 
disease during the first 12 months of follow-up had significantly (20-40 %) lower 
AA levels in their cord blood PLs at birth as compared with their non-atopic 
counterparts 
(163)
. However, no correction was made for potential confounders 
which may have biased their results. In addition, Sausenthaler et al. suggested 
that intake of n-6 fatty acid-rich foods, such as margarines and vegetable oils, 
during the last 4 weeks of pregnancy was associated with an increased risk of 
allergic diseases in children at the age of 2 years 
(162)
. Although these foods 
contain a high content of linoleic acid (LA), the increased risk could also be 
related to one of the many other components of these products. Furthermore, it 
is known from a previous study that a higher maternal intake of LA does not 
relate to higher AA concentrations in maternal and umbilical plasma PLs 
(203)
.  
A strong aspect of the present study is that maternal and neonatal fatty acid 
concentrations were obtained repeatedly during pregnancy and at parturition, 
respectively. Since maternal and neonatal LCPUFA concentrations are strongly 
correlated 
(7)
, this enabled us to investigate the associations between the child’s 
immune-related variables at age 7 years and the AA exposure from the second 
trimester of pregnancy on.  
Although we tested all relevant variables included in the database for their 
confounding or predicting potentials, residual confounding cannot be excluded, 
which is a general shortcoming of observational studies. Due to the absence of 
relevant data, we were unable to correct our analyses for differences in the 
postnatal AA consumption of the children, which may have contributed to the 
inter-individual differences in immune outcome variables at age 7 years. 
However, we did correct for the plasma PL AA concentration at age 7 years, 
which can be considered a proxy for the postnatal AA intake, since there is a 
positive relationship between dietary AA intake and plasma PL AA 
concentration 
(204,205)
.  
The use of a parent questionnaire to assess the atopic state of the children 
is clearly inferior to a full clinical evaluation. However, in large-scale 
observational studies, questionnaires are often the only practical option to 
gather clinical information. It should be added that the questionnaire we used 
was based on the ISAAC questionnaire 
(171)
, which has been properly validated 
(169,170)
, showing sensitivity and specificity of at least 77 and 81 %, respectively. 
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Furthermore, as mentioned before all questionnaires were ‘scored’ by an 
experienced clinician (JJEH). Therefore, although not optimal, we consider our 
atopy-assessment method adequate for the present observational study. 
Finally, we cannot exclude response bias in this cohort study, since informed 
consent for the 7-year follow-up was obtained for only 300 out of the 750 
eligible mother-child pairs.  
In the present study, no clear associations were observed between atopy at 
age 7 years and prenatal AA exposure as reflected by maternal AA 
concentrations during pregnancy and at delivery and neonatal AA values at 
birth. In theory, this may result from too-narrow ranges in AA concentrations 
and/or a too-low atopy incidence in our study population in relation to our 
sample size. However, the AA concentrations measured in our study population 
compare very well with maternal 
(96,206)
 and neonatal 
(206,207)
 values observed in 
other studies, whereas the atopy incidence in our population is relatively high as 
compared with the atopy prevalence reported in a world-wide study 
(208)
. Since 
the Odds Ratio’s for the atopy risk as a function of the AA concentrations in the 
various domains are all close to 1 (0.79-1.11 for the eight domains studied) and 
their 95 % confidence intervals are rather tight around 1 (the widest interval 
being 0.66-1.33), we consider the power of the present study sufficient for a 
reliable conclusion. Comparable conclusions can be drawn for most other 
immune-associated variables. This supports the absence of relevant 
associations between the perinatal AA availability and selected aspects of the 
immune status at the age of 7 years. 
In the present study, the same cases were used in the unadjusted as well 
as the multivariable-adjusted regression models, enabling us to check whether 
confounding was present and in which direction confounding influenced the 
model. In general, results were comparable when unadjusted regression 
analyses were performed with the maximum number of cases available (data 
not shown).   
Finally, in the present study outliers were removed before statistical 
analyses were applied. Usually an outlier should only be omitted from the 
statistical analyses if there is a biological explanation as to why this value is 
inappropriate. Repeating the statistical analyses with the outliers included did 
not fundamentally alter the results: non-significant results did not become 
significant and vice versa. So, the final results and the conclusions of this study 
did not change when the outliers were added in the analyses. 
In conclusion, we investigated whether normally occurring differences in 
prenatal AA availability could be of importance for the later presence of atopy, 
lung function and plasma inflammation markers. From the results obtained, 
such an influence seems rather unlikely since physiological differences in 
prenatal exposure to AA show few, weak and inconsistent associations with 
differences in several immune-related clinical conditions and plasma markers at 
7 years of age. Genetic predisposition and in utero exposure to other factors are 
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possibly more important determinants of these variables than prenatal AA 
concentrations. However, because of the limitations of the present 
observational study (mentioned above), the involvement of early AA status in 
the development of the immunological system cannot be excluded.  
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Introduction  
 
During pregnancy and the first years of life many developmental milestones are 
reached and it is crucial that high quality nutrition can be supplied to the fetus 
and thereafter to the infant to ensure that all essential nutrients are provided. Of 
these nutrients, the essential long-chain polyunsaturated fatty acids (LCPUFAs) 
docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (AA, 20:4n-6) are 
thought to be of critical importance for brain development and fetal growth, 
respectively 
(2,3)
. Mothers receive the LCPUFAs mainly from their diet or 
synthesize them from their respective precursors 
(95)
. To obtain these fatty 
acids, fetuses depend on their mothers, as is indicated by the positive 
correlation between the maternal and neonatal LCPUFA status at birth 
(6-8)
. 
However, pregnancy is thought to be associated with a decrease in the 
maternal LCPUFA status, which may have consequences for fetal development. 
Two studies described in this thesis were therefore carried out to assess 
fetal brain function on the basis of habituation measurements and to explore if 
these specific brain functions, i.e. fetal learning and memory, are associated 
with the early fetal availability of essential fatty acids (EFAs) and their 
LCPUFAs, collectively named the essential PUFAs (ePUFAs) 
(1)
.  
Since some LCPUFAs are thought to be important factors for fetal growth, 
two studies were conducted in a mother-child pregnancy-birth cohort to explore 
whether some selected birth dimensions are associated with fetal exposure to 
LCPUFAs and trans fatty acids, reflected by maternal and neonatal LCPUFA 
and trans fatty acid concentrations measured during pregnancy and/or directly 
after birth.  
In lactating women a decline of the relative DHA levels is found when 
lactation progresses 
(27)
, which may not be optimal for infant development. This 
decline can probably be prevented by maternal DHA supplementation, but 
elevated n-3 LCPUFA consumption often coincides with a decrease in the AA 
concentrations of an individual. In pregnant and lactating women, however, this 
may not be desirable, since AA is considered essential for fetal and infant 
development 
(31,32)
. Therefore, a study was carried out to investigate whether it 
is possible to prevent a DHA decline without lowering the AA levels by 
supplementing lactating women with a combination of n-3 LCPUFAs and AA.  
Finally, since studies revealed that the relative maternal AA concentrations 
decrease during pregnancy 
(26)
, the neonatal AA status may not be optimal. AA 
is the precursor of an important immune response mediator, prostaglandin E2 
(PGE2) 
(44,45)
, and therefore we investigated, in the above mentioned mother-
child cohort, if prenatal AA exposure is associated with some immune-related 
clinical conditions measured at 7 years of age.  
This chapter will provide the main conclusions of the studies described in 
this thesis, in relation to various methodological considerations, and will give 
some suggestions for further research.  
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Fetal habituation and the ePUFA status 
 
Habituation is a decrease leading to cessation of a behavioural response that 
occurs when an initially novel stimulus is repeatedly presented 
(35)
. It is often 
considered to represent a form of learning and probably requires an intact and 
functioning central nervous system (CNS) 
(35)
. In this thesis, fetal habituation 
was used to assess two forms of brain function, i.e. fetal memory and learning, 
and to relate these functions to the early ePUFA status of the fetus.  
In these habituation tests, every 30 seconds a 1-second stimulus was 
applied to the maternal abdomen above the fetal legs. Movements of the fetus 
within 1 second after application of the stimulus were considered a positive 
response. Disappearance of the response for four consecutive stimuli was 
taken to demonstrate habituation. The habituation rate (HR) was defined as the 
number of consecutive stimuli applied before habituation was established. The 
initial habituation tests (HR-A) at 30, 32, 34, 36 or 38 weeks gestational age 
(GA), considered as a measure of the fetal learning capacity at the moment of 
the habituation measurements, were repeated 10 minutes later. For groups 30-
36, both measurements were replicated during a second session at GA 38. The 
different time periods between habituation tests were used to assess fetal short-
term memory (10-minutes intervals) and long-term memory (2-8 weeks 
intervals).   
In each group, with the exception of group 32, we observed a significant 
decline between the initial and repeated habituation tests in both sessions, 
which indicates the presence of a short-term (10 minutes) memory. This short-
term memory appeared GA-independent, just like fetal learning. In addition, 
there were some indications that fetuses of 34 weeks GA can already store 
information and retrieve it 4 weeks later, see chapter 2. However, the presence 
of this long-term memory measured in fetuses of 38 weeks GA was not very 
strong, because the habituation data of these fetuses at 38 weeks GA were not  
significantly different from the data of fetuses of the same age who were never 
tested before.  
One suggestion for further research on this long-term memory is related to 
the concern that in the present study the longest interval was tested in the 
youngest fetuses. Therefore, it would be better in further research to start the 
first session with fetuses of the same age. Since it is observed that fetuses 
between 37 and 40 weeks GA have a memory of at least 24 hours 
(48)
, whereas 
an other study did not observe significant differences when 34-35 week old 
fetuses were re-tested 7 days after the first session 
(52)
, it might be an option to 
start memory-intervals from 1 day on and build these up to 1 week, 2 weeks, 
etc.  
As we already mentioned in chapter 2, a limitation of our study was that we 
did not include a test necessary to distinguish habituation from receptor 
adaptation or effector fatigue. Habituation can be distinguished from adaptation 
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or fatigue by the recovery of a habituated response on presentation of a new 
stimulus (dishabituation) and faster habituation upon re-presentation of the 
original stimulus 
(33,35)
. It needs to be mentioned that in a study of Leader et al. it 
was observed that dishabituation could only be observed in up to 79 % of the 
normal fetuses tested 
(63)
. Furthermore, it appears difficult to apply a novel 
stimulus that is sufficiently different from the original stimulus, because any new 
stimulus that is too similar to the original stimulus will not elicit a recovery of the 
response 
(34,63)
. Therefore, it seems useful to develop other methods than 
dishabituation as described here to indicate when habituation has occurred.  
We used the described habituation technique to investigate if fetal learning 
and memory were associated with the early ePUFA status, see chapter 3. The 
results suggest that, if associations are causal, fetal short-term (10 minutes) 
memory measured before 38 weeks GA may be better the lower the ePUFA 
status of the fetus, as reflected by higher MA and MA+DHMA levels. 
Furthermore, fetal long-term memory would be better the lower the n-3 LCPUFA 
status, as indicated by higher ObA concentrations. These findings are not in line 
with the current opinion that ePUFAs, especially AA and DHA, are important for 
brain development and function 
(37,38)
. Because we only observed a few trends 
between the habituation-related fetal brain functions and the early ePUFA 
status, we concluded that physiological differences in the availability of these 
fatty acids may probably not determine the differences in these primitive brain 
functions during the third trimester of fetal development. The question then is 
whether the power of our study was sufficient to come to reliable conclusions. 
Since the 95 % confidence intervals of the fetal learning and memory variables 
as a function of the ePUFA status include ‘1’ and are rather wide, we conclude 
that our study can not reliably demonstrate the absence of relevant associations 
between these forms of brain function and the ePUFA status because the 
power is too low. For the observed trends we can also conclude that the power 
is too low to make reliable statements about the magnitude of the associations. 
As far as we know, this is the first time that these forms of fetal brain functions, 
measured by the habituation technique, are linked to the ePUFA status of these 
fetuses. Therefore, it was not possible to make power calculations in advance 
because the size of the effects was not known. 
 
 
LCPUFAs and fetal growth 
 
In our study, maternal plasma phospholipid (PL) DHA concentrations, especially 
when measured early in pregnancy, were significantly and positively associated 
with birth weight and head circumference, whereas maternal AA and dihomo-γ-
linolenic acid (DGLA, 20:3n-6) concentrations in late pregnancy were negatively 
related to birth weight and birth length. In chapter 4, these results are 
extensively discussed in relation to other peer-reviewed articles.  
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Our findings suggest that, if results are causal, maternal AA and DGLA later 
in pregnancy might be involved in fetal growth limitation and that maternal DHA 
contents may programme fetal growth in a positive way, especially early in 
pregnancy. This latter could imply that DHA supplementation only before or 
during early pregnancy may significantly affect birth outcomes. However, in a 
recently published study of Drouillet et al., it was investigated whether fetal 
growth is associated with maternal fatty acid intake before and during the last 3 
months of pregnancy of French women included in the EDEN mother-child 
cohort study 
(209)
. Of these pregnant women, 74.3 % had a body mass index 
(BMI) < 25 kg/m
2
 before pregnancy. No significant associations were observed 
between birth dimensions and the proportion of n-3 fatty acids in total PUFA 
intake (measured by a food frequency questionnaire (FFQ)) before and at the 
end of pregnancy. These results were observed in multivariable-adjusted 
regression analyses, which were corrected for BMI among others. 
Nevertheless, a significant role for DHA early in pregnancy cannot be precluded 
since n-3 fatty acids were not measured separately but assessed as an n-3 fatty 
acid package, including DHA, docosapentaenoic acid (DPA, 22:5n-3) and 
eicosapentaenoic acid (EPA, 20:5n-3). For the n-6 fatty acids also no significant 
associations were found in the same population. In addition, no specification 
was given in the article about the included fatty acids accounting for the n-6 
fatty acids. Although the used FFQ is closely related to a validated FFQ used in 
the Fleurbaix-Laventie Ville Santé Study 
(210,211)
, additional not-validated 
questions were added for a more specific assessment of the intake of foods rich 
in n-3 fatty acids and seafood. This could mean that the FFQ was not sensitive 
enough to measure the fatty acid status.  
In chapter 5, we reported that DHA and AA concentrations measured in 
various umbilical domains and considered to reflect fetal LCPUFA availability 
during late gestation were mainly negatively related to birth weight and birth 
length. Our results seem to preclude their role as growth factors per se, but the 
negative relationships observed may result from a limited maternal-fetal 
LCPUFA transfer capacity. 
 
 
Arachidonic acid and immune function 
 
In chapter 7, we investigated whether prenatal exposure to AA is associated 
with some immune-related variables in childhood. From our results it can be 
concluded that such an influence seems rather unlikely since we only found 
few, weak and inconsistent associations between prenatal exposure to AA and 
several immune-related clinical conditions and plasma markers at 7 years of 
age. 
For the multivariable-adjusted regression analyses of this study we selected 
relevant covariables based on bivariable regression analyses. These analyses 
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were used to determine which of the covariables contributed to the relationships 
between dependent and explanatory variables, either as a significant predictor 
or as a confounder. One of these variables was ‘AA concentration in children’s 
plasma PLs at follow-up’, now abbreviated as ‘AA at follow-up’. We included this 
variable because we wanted to correct for differences in the postnatal AA 
consumption of the children, which may have contributed to the inter-individual 
differences in immune outcome variables at age 7. However, these data were 
not available and therefore we corrected for the plasma PL AA concentrations 
at 7 years of age, which can be considered a proxy for the postnatal AA intake, 
since there is a positive relationship between dietary AA intake and plasma PL 
AA concentrations 
(204,205)
. However, significant tracking in this cohort has 
recently been observed for the plasma PL AA levels between age 7 (=X) and 
birth (Y = 6.31 + 0.17X, r = 0.231, n = 249, p = 0.0002; G. Hornstra, to be 
published). Therefore, it is probably not appropriate to correct for AA levels at 
follow-up in our analyses because this may reduce the fetal exposure range of 
AA, the explanatory variable in the regression analyses and, thereby, the power 
of the study. As a consequence, we considered it necessary to remove this 
variable from all regression analyses in which it was involved either as a 
predictor or as a confounder, viz.: 
 
1) Neonatal AA vs. CRP 
2) Maternal AA vs. PEF exercise 
3) Maternal AA vs. fibrinogen 
4) Maternal AA vs. CRP    
 
The outcomes indicate that removal of the variable ‘AA at follow-up’, results in 
stronger and significant positive associations between the peak expiratory flow 
decline after maximal exercise (PEF exercise) and maternal AA concentrations 
at 16 weeks of pregnancy (reflecting fetal exposure to AA) and between 
fibrinogen and maternal AA concentrations at 32 weeks GA. If these 
associations are causal, these results indicate a stronger negative effect of AA 
on these immune-related variables, than described in chapter 7. Although, 
stronger associations are observed still not more as 4.5 % of the variability of 
these immune-associated variables is explained by variations in maternal AA 
levels. Regarding the neonatal AA levels, the trend between AA concentrations 
measured in the PL of the cord artery walls and CRP was lost after removal of 
the ‘AA at follow-up’ variable.   
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Methodological considerations 
 
MEFAB cohort and study design 
 
Three studies described in this thesis can be identified as observational 
historical cohort studies. In this kind of research, populations are defined based 
on data collected at a given time in the past. These three studies used data of 
the Maastricht Essential Fatty Acid Birth (MEFAB) cohort. This cohort originated 
from observational studies performed during 1990-1997, which investigated the 
associations between the maternal and neonatal essential fatty acid statuses 
during pregnancy and pregnancy outcome in approximately 1200 pregnant 
women and most of their infants 
(1,7)
. Between 1997 and 2000, a follow-up study 
was initiated and from the 750 eligible children, born between 1990 and 1994, 
around 300 children participated at 7 years of age 
(166,167)
. Results of this follow-
up were also entered in the MEFAB database, which provided all data for the 
studies described in chapters 4, 5 and 7.  
Given the growing recognition of the importance of the life course approach 
for the risk assessment of chronic diseases, birth cohort studies are becoming 
increasingly important. The MEFAB cohort contains invaluable information 
about mothers and their children from pregnancy onwards. This can be used to 
disentangle essential questions about the prenatal LCPUFA status, which is 
related to the maternal diet, and its relation in child development and the state 
of health at a later age. If significant associations are observed, and if results 
are causal, then there is the possibility to contribute to optimal development, 
prevent illnesses and promote health of these children through proper maternal 
diet adjustments. Furthermore, because of the large array of variables, this 
cohort proofed also suitable for observational studies with respect to body 
weight 
(212,213)
, physical activity 
(214)
 and insulin resistance 
(215)
. In addition, the 
MEFAB database has been used to study problem behaviour of children in 
relation to their early LCPUFA exposure 
(216)
.   
Biological relationships, for example between the intake of an essential 
nutrient and functions dependent on that nutrient, are probably not linear, but 
plateau at intakes above need 
(217)
. However, in most of our statistical analyses 
linear regression models were used, which imply that as the value of X (the 
explanatory variable) increases so the value of Y increases by an amount equal 
to the regression coefficient. Also for our data, relations are most probably 
monotonous, which means that they either increase or decrease over the whole 
range of X. However, it was not advisable to check if non-linear models were 
more appropriate because the associations were, in overall, not very strong. 
This makes it hardly feasible to explore more complicated relations than linear, 
since each association would then have to be modelled by one or more extra 
variables. The same argument holds against modelling the association using 
dummy variables for three or more categories of X. Moreover, such modelling 
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would often fail since the number of variables in the model would get too large 
for the number of cases in the analysis. 
A limitation of observational studies is that residual confounding cannot be 
ruled out because associations can be influenced by effects of unmeasured 
variables or by imperfectly measured relevant variables. The data for these 
current studies, however, were retrieved from a database containing a relatively 
large number of maternal and neonatal variables, which reduces the chance to 
observe an association based on a not-included variable. Furthermore, data 
from the original and the follow-up studies in 1997-2000 were embedded in the 
same research line, in which hypotheses were closely related to the ones in the 
present thesis. This latter decreases the probability of less perfectly measured 
variables.  
 
Absolute versus relative fatty acid concentrations 
 
Fatty acid data can be expressed in absolute amounts (mg/L erythrocyte 
suspension/plasma or mg/g dry tissue) as well as relative concentrations (% of 
total fatty acids). Both expression methods have their own limitations. When 
relative concentrations are used, the problem is created that an increase in one 
fatty acid automatically results in decreases in all other relative fatty acid 
proportions, because the sum of all known fatty acids is 100 %. This 
methodological problem is hard to overcome, but in our studies we chose to 
express the fatty acids as relative amounts to take into account potential 
differences in the total lipid pool sizes of mothers and their fetuses. 
Furthermore, because pregnancy is associated with hyperlipidemia, pool sizes 
in maternal blood are changing considerably over time during pregnancy. 
Moreover, because metabolic interactions between fatty acids occur, it is the 
amount of a given fatty acid relative to the other fatty acids present that 
determines the rate of this reaction in the specific environment. Therefore, from 
a metabolic perspective it is important to report fatty acids as relative values. In 
addition, measurement errors of the analytical procedure between different 
laboratories are in general smaller when fatty acids are expressed as relative 
amounts. 
 
Using maternal and neonatal fatty acid concentrations as a proxy for fetal fatty 
acid exposure 
 
Since maternal and neonatal EFA and LCPUFA plasma PL contents are 
positively correlated at birth 
(218)
, it can be suggested that maternal fatty acids 
during pregnancy reflect the prenatal fatty acid exposure. Van Houwelingen and 
colleagues collected human fetal tissue after elective abortions in the first 
trimester and determined the fatty acid composition of the fetal tissue. At the 
same time of the abortion, a maternal blood sample was obtained to measure 
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the fatty acid composition in maternal erythrocytes PLs 
(128)
. For the sum of n-6 
fatty acids, LA, the sum of n-3 fatty acids and DHA significant positive 
correlations were observed between maternal and fetal fatty acid levels.  
In another study, the fatty acid composition of umbilical plasma samples 
obtained by fetal blood sampling during ongoing pregnancies in the second and 
third trimester, was compared to the fatty acid composition of umbilical cord 
blood samples, collected immediately after birth of infants of the same 
gestational age 
(124)
. It was observed that fetuses do not possess a different 
EFA status than infants directly after birth at a comparable gestational age. This 
suggests that the EFA status measured at birth appears a reasonably adequate 
reflection of the fetal EFA status. Moreover, most relative maternal plasma PL 
fatty acid values, collected at the same time, were highly correlated with the 
fetal fatty acid concentrations, confirming that maternal fatty acid concentrations 
can be used as a proxy for fetal fatty acid exposure. 
 
 
Practical implications of our findings  
 
The studies described in this thesis have various practical implications, which 
are briefly pointed out below. 
 
• Measurement of fetal learning and memory could lead to a better 
understanding of the normal development of the fetal CNS. However, fetal 
habituation is probably not a suitable method to investigate whether the 
maternal diet can influence these primitive forms of fetal brain function 
(Chapter 3). 
 
• If the observed association between maternal DHA concentrations and birth 
weight in chapter 4 is causal and if a low birth weight is a predictor for a 
poor prognosis later in life, than it is prudent to promote maternal DHA intake 
before pregnancy. Just like it is nowadays advised to take folic acid to 
prevent neural tube defects.  
 
• In the study described in chapter 4, negative associations were observed 
between maternal AA concentrations and birth weight and birth length. 
Based on these results, it seems prudent for now not to increase the AA 
levels of pregnant women, to reduce the change of a probably negative 
influence of AA on birth weight.  
 
• Trans fatty acids may compromise fetal development by lowering the fetal 
LCPUFA status. In our studies, effects of maternal or neonatal 18:1t, the 
main industrially produced trans unsaturated fatty acid present in the diet, 
were either small or non-existing (Chapters 4 and 5). This might be partly 
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explained by the rather low 18:1t contents in the plasma phospholipids of our 
study population. However, for populations with a high habitual trans 
consumption it seems necessary to further investigate the potential role of 
trans fatty acids on birth outcome in these populations. These populations 
often include humans of underprivileged groups in developed countries and 
humans in developing countries.  
 
• Several studies indicated that an increase in the consumption of n-3 
LCPUFAs often causes a concomitant decrease of circulating n-6 LCPUFA 
concentrations and of AA in particular. However, we observed in chapter 6 
that consumption of extra DHA + EPA by lactating women increased the 
sum of n-3 LCPUFA and DHA concentrations in their breast milk total lipids, 
whereas no measurable effect was observed for breast milk AA or the sum 
of n-6 LCPUFAs. Thus, if it is felt necessary during the lactation period to 
improve the maternal LCPUFA status, and especially the DHA status, than it 
is possible to consume more DHA without affecting the AA levels in breast 
milk. 
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Summary 
 
Essential fatty acids and their longer-chain more unsaturated derivatives, the 
LCPUFAs, are collectively named ‘essential PUFAs’. These fatty acids belong, 
according to the position of the first double bond, to the n-6 or n-3 fatty acid 
family. Especially arachidonic acid (AA, 20:4n-6) and docosahexaenoic acid 
(DHA, 22:6n-3) are LCPUFAs which are thought to be important for fetal growth 
and brain development, respectively. Therefore, the availability of these fatty 
acids for the fetus needs to be adequate. To obtain these fatty acids, fetuses 
depend on their mother’s essential PUFA consumption and metabolism as well 
as on the placental transfer of these fatty acids. Since pregnancy is associated 
with a decrease in the biochemical LCPUFA status of the mother, the fetal and 
neonatal LCPUFA status may not be optimal and this may affect fetal and 
neonatal development.  
 
In order to investigate if fetal brain functions are associated with the early 
essential PUFA status, a method was used which measures fetal habituation. 
From these measurements several aspects of fetal brain function, such as fetal 
learning and memory, can be deducted. 
In chapter 2, we used fetal habituation to explore from which gestational 
age fetal learning and memory can be established, how long fetal memory lasts 
and whether fetal learning and memory depend on fetal age. Ninety-three 
pregnant women were recruited to assess fetal learning and memory between 
30-38 weeks gestational age, by recurrent habituation tests. Our results showed 
that fetal learning appeared to be gestational age independent. Furthermore, it 
was observed that fetuses have a short-term (10 minutes) memory from a 
gestational age of at least 30 weeks onwards which also appeared to be 
independent of the fetal age, when measured for the first time. In addition, we 
presented some evidence that 34 week old fetuses are able to store information 
and retrieve it 4 weeks later. 
In chapter 3, these brain functions, i.e. fetal learning, fetal short-term 
memory and long-term memory, were related to the early essential PUFA status 
of 72 fetuses. The essential PUFA status was deduced from concentrations of 
AA and DHA, from their essential fatty acid dietary precursors [linoleic acid (LA, 
18:2n-6) and α-linolenic acid (ALA, 18:3n-3)], from Mead acid (MA, 20:3n-9), 
dihomo-Mead acid (DHMA, 22:3n-9) and MA+DHMA and from Osbond acid 
(ObA, 22:5n-6). The levels of these fatty acids were measured in the 
phospholipids of the umbilical artery walls. The presence of relatively high 
contents of MA, DHMA and MA+DHMA indicate a poor essential PUFA status 
and these fatty acids are therefore defined as the general essential PUFA 
status markers. Large contents of ObA point to a poor n-3 LCPUFA status and 
as a result ObA is indicated as an n-3 LCPUFA status marker. For AA, DHA 
and LA no significant associations were observed with fetal learning or memory. 
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On the other hand, positive trends were found for the relationships between 
fetal short-term memory and concentrations of the general essential PUFA 
status markers MA and MA+DHMA. Furthermore, a positive trend was also 
observed for the association between fetal long-term memory and levels of 
ObA, a marker of the n-3 LCPUFA status. If causal, these relationships indicate 
that fetal short-term memory measured before 38 weeks gestational age may 
be better, the lower the essential PUFA status of the fetus, as reflected by 
higher MA and MA+DHMA concentrations. Likewise, fetal long-term memory 
would be better the lower the n-3 LCPUFA status, as indicated by higher ObA 
concentrations. These interpretations are in striking contrast with current 
opinions. Moreover, these associations are rather weak and therefore we 
suggested that physiological differences in essential PUFA availability may 
probably not determine the differences in these primitive brain functions during 
the third trimester of fetal development.  
 
Since there are indications that low birth weight is associated with negative 
health outcomes later in life, it is sensible to optimize fetal growth.  
In chapter 4, the data of 782 mother-infant pairs of the Maastricht Essential 
Fatty Acid Birth (MEFAB) cohort were used to study the associations between 
birth weight, birth length or head circumference and the relative contents of 
DHA, AA, dihomo-γ-linolenic acid (DGLA, 20:3n-6) and trans-octadecenoic acid 
(18:1t) in maternal plasma phospholipids sampled during early, middle and late 
pregnancies, and at delivery. With multiple linear regression analyses, 
significant positive associations were observed between maternal DHA levels 
(especially early in pregnancy) and birth weight and head circumference. 
Significant negative associations were found between maternal AA levels, 
measured at late pregnancy and directly after delivery, and birth weight and 
birth length. Also significant negative associations were observed between 
maternal DGLA concentrations, measured at delivery, and birth weight and birth 
length. No significant associations were found for maternal 18:1t contents. We 
concluded that, if these relationships are causal, maternal DHA during early 
pregnancy may programme fetal growth in a positive way. Maternal AA and 
DGLA in late pregnancy might be involved in fetal growth limitation. 
In chapter 5, we investigated with linear regression analyses if birth weight, 
birth length or head circumference are associated with the prenatal exposure to 
relative concentrations of DHA, AA, DGLA and 18:1t measured in phospholipids 
of the walls of umbilical arteries and veins, of umbilical cord plasma and of 
erythrocytes. For this study the data of up to 700 infant-mother pairs from the 
MEFAB cohort were used. After optimal adjustment, a significant negative 
association was observed between birth weight and umbilical plasma DHA 
concentrations. Significant negative associations were also found for the 
relationships between birth weight and AA levels measured in umbilical plasma, 
and in arterial and venous vessel walls. For birth length, a significant negative 
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association was observed with arterial vessel wall AA concentrations only. A 
significant negative association was also found for the relationship between 
18:1t in cord erythrocytes and birth weight. For DGLA no significant 
associations were observed. These results seem to preclude a role of DHA and 
AA as growth factors per se. Their negative relationships with birth dimensions 
may result from a limited maternal-fetal LCPUFA transfer capacity. Potential 
effects of 18:1t and DGLA on birth dimensions are probably small or non-
existing.  
 
In lactating women a decline of the relative DHA levels is found in plasma 
phospholipids when lactation progresses. These levels become even lower than 
those of non-lactating mothers and also lower than those before conception. 
Since DHA seems to be important for brain and retina development and 
function of young infants, this may jeopardize the optimal developmental 
potentials of breastfeeding. Recommended increased consumption of n-3 
LCPUFAs may lower the AA status of lactating women, which may be 
unfavorable to their infants also, since AA is considered essential for fetal and 
infant development.  
In chapter 6, we therefore studied the effects of n-3 LCPUFA consumption, 
with or without AA, on DHA and AA levels in breast milk and erythrocytes of 
lactating women. A total of 52 healthy pregnant women were included in the 
study. During the lactation period, these women were randomly allocated to four 
different groups, a control group receiving no additional LCPUFAs, a low or a 
high AA group in combination with n-3 LCPUFAs, or a group who received n-3 
LCPUFAs alone. Blood and breast milk samples were collected to measure the 
relative concentrations of AA, DHA and sums of n-6 and n-3 LCPUFAs in 
erythrocyte phospholipids and in milk total lipids. The combined consumption of 
AA and n-3 LCPUFAs caused dose-dependent elevations of AA and total n-6 
LCPUFA concentrations in milk total lipids and did not significantly affect the 
DHA and total n-3 LCPUFA increases caused by the n-3 LCPUFAs in the 
supplement. Treatment with n-3 LCPUFAs only did not significantly affect breast 
milk AA and total n-6 LCPUFA concentrations. AA and DHA concentrations in 
milk total lipids and their changes were strongly and positively correlated with 
their corresponding values in erythrocyte phospholipids. We concluded that the 
consumption by lactating women of additional AA and n-3 LCPUFAs increased 
the AA and DHA concentrations of their milk total lipids. For AA, this effect 
appeared dose-dependent, which is a novel finding not reported before.   
 
AA is the precursor of prostaglandin E2, which is thought to be an important 
mediator of immune responses. Since the AA status becomes reduced during 
pregnancy, the neonatal AA status may not be optimal which may have 
consequences for the developing immune system.  
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In chapter 7, we explored if prenatal exposure to AA as represented by 
maternal or neonatal AA concentrations, measured during pregnancy and/or 
directly after delivery, is related to several immune-related variables. For this 
investigation the data of 280 children and their mothers were retrieved from the 
MEFAB database. Linear and logistic regression analyses were used to study if 
the early exposure to AA is related to lung function, presence of atopy and 
inflammation markers in the 7-year-old children. In the unadjusted regression 
analyses several significant associations were observed. However, after 
correction for relevant covariables, only trends remained. Since most observed 
associations and trends were functionally inconsistent, a major influence of 
early AA exposure on these immune-related clinical conditions and plasma 
markers at 7 years of age seems unlikely.  
 
In chapter 8, the experimental results are extensively discussed. The 
conclusions and their practical implications are briefly pointed out below. 
 
• Measurement of fetal learning and memory could lead to a better 
understanding of the normal development of the fetal central nervous 
system. However, fetal habituation is probably not a suitable method to 
investigate whether the maternal diet can influence these primitive forms of 
fetal brain function.  
 
• If the observed association between maternal DHA concentrations and birth 
weight is causal and if a low birth weight is a predictor for a poor prognosis 
later in life, than it is prudent to promote maternal DHA intake before 
pregnancy.  
 
• Since negative associations were observed between maternal AA 
concentrations and some birth dimensions, it seems prudent for now not to 
increase the AA levels of pregnant women.  
 
• In our studies, effects of maternal trans fatty acid consumption on fetal 
growth appeared either small or non-existing. This might be partly explained 
by the rather low 18:1t contents in the plasma phospholipids of our study 
population. However, for populations with a high habitual trans consumption 
it seems necessary to further investigate the potential role of trans fatty acids 
on birth outcome.  
 
• Finally, if it is felt necessary during the lactation period to improve the 
maternal LCPUFA status, and especially the DHA status, than it is possible 
to consume more DHA without affecting the AA levels in breast milk. 
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Samenvatting 
 
Essentiële vetzuren en hun langere-keten hoger-onverzadigde afgeleiden, de 
LCPUFAs, worden samen ook wel ‘essentiële PUFAs’ genoemd. Deze vetzuren 
behoren, volgens de positie van de eerste dubbele binding, tot de n-6 of n-3 
vetzuur familie. Met name arachidonzuur (AA, 20:4n-6) en docosahexaeenzuur 
(DHA, 22:6n-3) zijn LCPUFAs waarvan wordt gedacht dat ze belangrijk zijn 
voor, respectievelijk, de foetale groei en hersenontwikkeling. Daarom is het 
belangrijk dat de foetus voldoende van deze vetzuren tot zijn beschikking heeft. 
Om deze vetzuren te verkrijgen zijn de foetussen afhankelijk van hun moeders 
essentiële PUFA consumptie en metabolisme als ook van de overdracht van 
deze vetzuren via de placenta. Aangezien zwangerschap geassocieerd is met 
een daling in de biochemische LCPUFA status van de moeder is de foetale en 
neonatale LCPUFA status wellicht niet optimaal en dit kan gevolgen hebben 
voor de foetale en neonatale ontwikkeling.  
 
Om te onderzoeken of foetale hersenfuncties geassocieerd zijn met de vroege 
essentiële PUFA status maakten we gebruik van een methode die foetale 
habituatie meet. Van deze meetresultaten kunnen meerdere aspecten van 
foetale hersenfunctie, zoals foetaal leervermogen en geheugen, worden 
afgeleid.  
In hoofdstuk 2 hebben we foetale habituatie gebruikt om te onderzoeken 
vanaf welke zwangerschapsduur foetaal leervermogen en geheugen kunnen 
worden vastgesteld, hoe lang foetaal geheugen voortduurt en of foetaal 
leervermogen en geheugen afhankelijk zijn van de foetale leeftijd. 
Drieënnegentig zwangere vrouwen werden geworven om met behulp van 
herhaalde habituatie testen het foetale leervermogen en geheugen, tussen 
week 30 en 38 van de zwangerschap, te meten. Onze resultaten toonden aan 
dat het foetale leervermogen onafhankelijk blijkt te zijn van de foetale leeftijd. 
Verder werd geconstateerd dat foetussen in ieder geval vanaf week 30 van de 
zwangerschap een korte termijn geheugen hebben van 10 minuten, dat 
onafhankelijk blijkt te zijn van de foetale leeftijd wanneer het voor de eerste keer 
wordt gemeten. Onze resultaten suggereerden ook dat 34 weken oude 
foetussen in staat zijn om informatie op te slaan en die 4 weken later terug te 
halen.  
In hoofdstuk 3 werden deze hersenfuncties, te weten het foetale leer-
vermogen, het foetale korte termijn en lange termijn geheugen, gerelateerd aan 
de vroege essentiële PUFA status van 72 foetussen. De foetale essentiële 
PUFA status werd afgeleid van de concentraties van AA en DHA, van hun 
essentiële vetzuur voorlopers [linolzuur (LA, 18:2n-6) en alfa-linoleenzuur (ALA, 
18:3n-3)], van Meadzuur (MA, 20:3n-9), dihomo-Meadzuur (DHMA, 22:3n-9) en 
MA+DHMA en van Osbondzuur (ObA, 22:5n-6). De concentraties van deze 
vetzuren werden gemeten in de fosfolipiden van de wanden van de 
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navelstrengarteriën. De aanwezigheid van relatief grote hoeveelheden MA, 
DHMA en MA+DHMA wijst in de richting van een ongunstige essentiële PUFA 
status en deze vetzuren worden daarom ook wel aangeduid als de algemene 
essentiële PUFA status markers. Grote hoeveelheden ObA duiden daarentegen 
op een ongunstige n-3 LCPUFA status en daarom wordt ObA ook wel gezien 
als een n-3 LCPUFA status marker. Voor AA, DHA en LA werden er geen 
significante associaties waargenomen met het foetale leervermogen en 
geheugen. Wel werden er positieve trends gevonden voor de relaties tussen het 
foetale korte termijn geheugen en concentraties van de algemene essentiële 
PUFA status markers MA en MA+DHMA. Verder werd er ook een positieve 
trend gevonden voor de associatie tussen het foetale lange termijn geheugen 
en de n-3 LCPUFA marker, ObA. Indien deze relaties causaal zijn dan duiden 
ze aan dat het foetale korte termijn geheugen, gemeten vóór week 38 van de 
zwangerschap, beter kan zijn naarmate de essentiële PUFA status van de 
foetus lager is, zoals weerspiegeld wordt door hogere MA en MA+DHMA 
niveaus. Ook zou het foetale lange termijn geheugen beter zijn naarmate de n-3 
LCPUFA status lager is, zoals geïndiceerd door de hogere ObA concentraties. 
Deze verklaringen druisen in tegen de heersende opvattingen. Bovendien zijn 
deze associaties nogal zwak en daarom suggereerden we uiteindelijk dat 
fysiologische verschillen in de essentiële PUFA beschikbaarheid waarschijnlijk 
niet de verschillen in deze primitieve hersenfuncties kunnen bepalen gedurende 
het derde trimester van de foetale ontwikkeling. 
 
Aangezien er aanwijzingen zijn dat een laag geboortegewicht geassocieerd is 
met negatieve gezondheidsuitkomsten, later in het leven, is het verstandig om 
de foetale groei bij geboorte te optimaliseren.  
In hoofdstuk 4 werden de gegevens van 782 moeder-kind paren van het 
‘Maastricht Essential Fatty Acid Birth’ (MEFAB) cohort gebruikt om de relaties te 
bestuderen tussen geboortegewicht, geboortelengte of hoofdomtrek en de 
relatieve concentraties van DHA, AA, dihomo-γ-linoleenzuur (DGLA, 20:3n-6) 
en trans-octadeceenzuur (18:1t). Deze vetzuren zijn aanwezig in de fosfolipiden 
van moederlijk plasma verzameld tijdens de vroege, middelste en late periode 
van de zwangerschap en direct na de bevalling. Met meervoudige lineaire 
regressie analyses werden significante positieve associaties waargenomen 
tussen moederlijke DHA concentraties (met name vroeg in de zwangerschap) 
en geboortegewicht en hoofdomtrek. Significante negatieve associaties werden 
gevonden tussen moederlijke AA concentraties, gemeten tijdens de late 
zwangerschap en direct na de bevalling, en geboortegewicht en geboorte-
lengte. Ook werden er significante negatieve associaties gevonden tussen 
moederlijke DGLA concentraties, gemeten direct na de bevalling, en 
geboortegewicht en geboortelengte. Er werden geen significante associaties 
waargenomen voor moederlijke 18:1t concentraties. We concludeerden dat, 
indien deze relaties causaal zijn, moederlijk DHA gedurende de vroege 
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zwangerschap foetale groei op een positieve manier kan programmeren. 
Moederlijk AA en DGLA zijn tijdens de late zwangerschap wellicht betrokken bij 
foetale groeibeperking. 
In hoofdstuk 5, onderzochten we met lineaire regressie analyses of 
geboortegewicht, geboortelengte of hoofdomtrek geassocieerd zijn met de 
prenatale blootstelling aan relatieve concentraties van DHA, AA, DGLA en 
18:1t. Deze vetzuren zijn gemeten in fosfolipiden geïsoleerd uit de wanden van 
de navelstrengarteriën en -venen en uit navelstrengplasma en erytrocyten. Voor 
deze studie werden de gegevens van 700 moeder-kind paren van het MEFAB 
cohort gebruikt. Na optimale correctie werd een significante negatieve 
associatie waargenomen tussen geboortegewicht en DHA concentraties 
gemeten in navelstrengplasma. Significante negatieve associaties werden ook 
gevonden voor de relaties tussen geboortegewicht en AA concentraties 
gemeten in navelstrengplasma en in de wanden van de navelstrengarteriën en -
venen. Voor geboortelengte werd alleen een significante negatieve associatie 
gevonden met AA concentraties uit de wand van de navelstrengarterie. Een 
significante negatieve associatie werd ook waargenomen tussen 18:1t in 
navelstreng erytrocyten en geboortegewicht. Voor DGLA werden er geen 
significante associaties gevonden. Deze resultaten lijken een rol voor DHA en 
AA als groeifactoren uit te sluiten. Hun negatieve relaties met geboorte-
uitkomsten kunnen voortvloeien uit een beperkte LCPUFA overdrachts-
capaciteit tussen de moeder en de foetus. Potentiële effecten van 18:1t en 
DGLA op geboorte-uitkomsten zijn waarschijnlijk klein of bestaan niet.  
 
Bij vrouwen die borstvoeding geven is in plasma fosfolipiden een afname 
gevonden van de relatieve DHA concentraties. Deze concentraties zijn zelfs 
lager dan bij moeders die geen borstvoeding geven. Wanneer de borstvoeding 
voortduurt worden de DHA concentraties zelfs lager dan de niveaus gemeten 
vóór de zwangerschap. Aangezien DHA belangrijk lijkt te zijn voor de 
ontwikkeling en functie van de hersenen en retina kan dit wellicht de optimale 
ontwikkelingsmogelijkheden van borstvoeding in gevaar brengen. Als de 
consumptie van n-3 LCPUFAs toeneemt, zoals wordt aanbevolen, dan kan de 
AA status in vrouwen die borstvoeding geven dalen. Dit is wellicht ongunstig 
voor hun kinderen aangezien AA wordt geacht essentieel te zijn voor de 
ontwikkeling van de foetus en het kind.  
In hoofdstuk 6 hebben we daarom de effecten onderzocht van n-3 
LCPUFA consumptie, met of zonder AA, op DHA en AA concentraties in 
moedermelk en erytrocyten van vrouwen die borstvoeding geven. In totaal 
werden er 52 gezonde zwangere vrouwen in de studie geïncludeerd. Deze 
vrouwen werden tijdens de borstvoedingsperiode willekeurig ingedeeld in 4 
verschillende groepen, een controle groep die geen additionele LCPUFAs 
kreeg, een lage of een hoge AA groep in combinatie met n-3 LCPUFAs, of een 
groep die alleen n-3 LCPUFAs kreeg. Bloed en moedermelk monsters werden 
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verzameld om de relatieve concentraties van AA, DHA en de som van n-6 en n-
3 LCPUFAs te meten in de fosfolipiden van erytrocyten en in totaal melkvet. De 
gecombineerde consumptie van AA en n-3 LCPUFAs zorgde voor dosis-
afhankelijke verhogingen van AA en totale n-6 LCPUFA concentraties in totaal 
melkvet en had geen significante invloed op de DHA en totale n-3 LCPUFA 
toenames, veroorzaakt door de n-3 LCPUFAs in het supplement. Toediening 
van n-3 LCPUFAs alleen had geen significante invloed op moedermelk AA en 
totale n-6 LCPUFA concentraties. AA en DHA concentraties in totaal melkvet en 
hun veranderingen waren sterk en positief gecorreleerd met hun 
corresponderende waarden in erytrocyt fosfolipiden. Uit de resultaten hebben 
we geconcludeerd dat, bij vrouwen die borstvoeding geven, de consumptie van 
extra AA en n-3 LCPUFAs ervoor zorgt dat de AA en DHA concentraties van 
hun totaal melkvet worden verhoogt. Voor AA blijkt dit effect dosis-afhankelijk te 
zijn. Dit is een nieuwe bevinding die niet eerder gerapporteerd is.  
 
AA is de voorloper van prostaglandine E2 waarvan gedacht wordt dat het een 
belangrijke mediator is van immunologische processen. Aangezien de AA 
status tijdens de zwangerschap daalt is de neonatale AA status wellicht niet 
optimaal. Dit kan misschien consequenties hebben voor het in ontwikkeling 
zijnde immuunsysteem.  
In hoofdstuk 7 onderzochten we of prenatale blootstelling aan AA, afgeleid 
van moederlijke of neonatale AA concentraties, gemeten gedurende de 
zwangerschap en/of direct na de bevallig, is gerelateerd aan meerdere immuun-
gerelateerde variabelen. Voor deze studie werden de gegevens van 280 
kinderen en hun moeders gehaald uit de MEFAB database. Lineaire en 
logistische regressie analyses werden gebruikt om na te gaan of de vroege 
blootstelling aan AA gerelateerd is aan de longfunctie van 7-jarige kinderen. Bij 
dezelfde kinderen werd ook gekeken naar de relatie tussen AA en de 
aanwezigheid van atopische aandoeningen. Als laatste werd er nog gekeken 
naar de relatie tussen AA en ontstekingsmarkers in plasma. In de niet 
gecorrigeerde regressie analyses werden meerdere significante associaties 
gevonden. Maar na correctie voor de relevante covariabelen bleven alleen 
trends over. Aangezien de meeste associaties en trends functioneel gezien 
inconsistent waren, lijkt een belangrijke invloed van vroege AA blootstelling op 
deze immuun-gerelateerde klinische condities en ontstekingsmarkers op 7 
jarige leeftijd onwaarschijnlijk. 
 
In hoofdstuk 8 zijn de experimentele resultaten uitgebreid bediscussieerd. De 
conclusies en hun praktische toepassingen staan hieronder puntsgewijs 
beschreven. 
 
• Meting van het foetale leervermogen en geheugen kan bijdragen aan 
een beter inzicht in de normale ontwikkeling van het foetale centraal 
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zenuwstelsel. Maar foetale habituatie is waarschijnlijk niet geschikt als 
basis voor een methode om te onderzoeken of de voeding van de 
moeder deze primitieve vormen van foetale hersenfunctie kan 
beïnvloeden. 
 
• Als de gevonden associatie tussen moederlijke DHA concentraties en 
het geboortegewicht van het kind causaal is en als een laag geboorte-
gewicht een voorspeller is voor een slechte prognose later in het leven, 
dan is het verstandig om vóór de zwangerschap een toename van de 
DHA consumptie aan te bevelen.  
 
• Aangezien negatieve associaties werden waargenomen tussen moeder-
lijke AA concentraties en sommige geboorte-uitkomsten, lijkt het 
verstanding om geen maatregelen te nemen die de AA status van 
zwangere vrouwen zouden kunnen verhogen. 
 
• In onze studies bleken effecten van moederlijke transvetzuur 
consumptie op de foetale groei klein of niet aanwezig te zijn. Dit kan 
waarschijnlijk voornamelijk verklaard worden door de behoorlijk lage 
18:1t concentraties in de plasma fosfolipiden van onze studiepopulatie. 
Voor populaties met een hoge trans consumptie lijkt het echter nodig 
om verder onderzoek te verrichten naar de mogelijke rol van trans-
vetzuren op geboorte-uitkomsten.  
 
• Ten slotte, als het nodig wordt geacht om tijdens de borstvoedings-
periode de moederlijke LCPUFA status te verbeteren, en dan 
voornamelijk de DHA status, dan is het mogelijk om meer DHA te 
consumeren zonder dat het de AA concentraties in moedermelk 
beïnvloedt.  
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Abbreviations 
 
18:1t   trans isomers of octadecenoic acid 
AA    arachidonic acid (20:4n-6) 
AdrA   adrenic acid (22:4n-6) 
ALA   α-linolenic acid (18:3n-3) 
ANCOVA  analysis of covariance 
ANOVA  analysis of variance 
β    standardized regression coefficient of B 
B    unstandardized regression coefficient 
BL    birth length 
BMI   body mass index 
BW    birth weight 
C    carbon 
CH3   methyl 
CI    confidence interval 
CNS    central nervous system 
COOH   carboxyl 
CRP   C-reactive protein 
CV    coefficients of variation 
DGLA   dihomo-γ-linolenic acid (20:3n-6) 
DHA   docosahexaenoic acid (22:6n-3) 
DHMA   dihomo-Mead acid (22:3n-9) 
DPA   docosapentaenoic acid (22:5n-3) 
EDTA   ethylenediaminetetraacetic acid 
EFA(s)   essential fatty acid(s) 
ELISA   Enzyme-Linked Immuno Sorbent Assay 
EPA   eicosapentaenoic acid (20:5n-3) 
ePUFA(s)  essential polyunsaturated fatty acid(s) 
FFQ   food frequency questionnaire 
GA    gestational age 
HC    head circumference 
HR    habituation rate 
IQR   interquartile ranges 
ISAAC   International Study of Asthma and Allergies in Childhood 
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LA     linoleic acid (18:2n-6) 
LCPUFA(s) long-chain polyunsaturated fatty acid(s) 
LIN    linear regression 
ln    natural log 
LOG   logistic regression 
LTM   long-term memory 
MA    Mead acid (20:3n-9) 
MEFAB  Maastricht Essential Fatty Acid Birth  
MUMC   Maastricht University Medical Centre 
n    number of subjects 
n.a.   not applicable 
NaCl   natrium (sodium) chloride  
n.d.   not detectable 
ObA   Osbond acid (22:5n-6) 
OR    Odds Ratio 
p-value   probability value 
PEF   peak expiratory flow 
PGE2   prostaglandin E2  
PL(s)   phospholipid(s) 
pm    post meridiem 
PUFA(s)  polyunsaturated fatty acid(s) 
R
2      
coefficient of determination of total model 
r
2
     square of the semi-partial correlation coefficient  
RAST   radioallergosorbent test 
SD    standard deviation 
SES   socio-economic status 
SPSS   Statistical Package for the Social Sciences 
STM   short-term memory 
TL(s)   total lipid(s) 
VAS    vibroacoustic stimulus 
viz.    videlicit (that is to say) 
vWF   von Willebrand factor 
wt    weight 
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Dankwoord 
 
Na het bewandelen van een wel heel bijzonder promotietraject is het zover: mijn 
proefschrift is af! Ook al staat mijn naam op de kaft, zonder de hulp van 
anderen was dit boekje nooit tot stand gekomen. Graag wil ik dan ook alle 
personen bedanken die een bijdrage hebben geleverd aan dit proefschrift. Een 
aantal van hen wil ik hier met name noemen. 
 
Als eerste wil ik beginnen bij mijn promotores Prof. em. dr. Gerard Hornstra en 
Prof. dr. Jan Nijhuis.  
Beste Gerard, we hebben elkaar leren kennen toen jij op zoek was naar een 
stagiaire voor een afstudeeronderzoek dat (hoe kan het ook anders) betrekking 
had op vetzuren. Na het afronden van mijn studie was jij inmiddels met 
‘pensioen’ maar gaf je wel te kennen mij dagelijks te willen begeleiden tijdens 
mijn promotietraject. Ook al was je sinds het begin van mijn aanstelling niet 
meer werkzaam op de universiteit, toch heb ik dat niet als een minpunt ervaren. 
Altijd kon ik bij je terecht, zelfs toen een van de vrijwilligers beviel op het 
moment dat ik niet de mogelijkheid had om direct het materiaal op te halen en jij 
voor mij in de plaats bent gegaan. Na de praktische werkzaamheden begon de 
schrijfperiode, alles wat ik produceerde werd altijd snel doch heel kritisch 
beoordeeld en ik zal de woorden ‘voortschrijdend inzicht’ en ‘is hier ook een 
referentie van?’ niet snel vergeten. Mede dankzij jouw enthousiasme en kritisch 
wetenschappelijke blik zijn alle puzzelstukjes uiteindelijk op de juiste plaats 
gevallen en is het een mooi geheel geworden!  
Beste Jan, ook wij hebben elkaar leren kennen tijdens mijn afstudeerstage 
waar een begin is gemaakt met de onderzoeken die in dit proefschrift staan 
beschreven. De mogelijkheid en het vertrouwen dat jij me hebt gegeven om een 
vervolg te geven aan mijn afstudeeronderzoek is de eerste stap geweest op 
weg naar mijn promotie. Ik wil je bedanken voor de fijne samenwerking, het 
vasthouden van de rode draad en de altijd positieve en stimulerende e-mails als 
stukken weer eens verbeterd moesten worden. 
 
Zonder vrijwilligers geen onderzoek en zonder onderzoek geen proefschrift. 
Daarom wil ik alle vrijwilligers en hun kinderen bedanken die mee hebben 
gedaan aan de onderzoeken. Ik heb vele mooie maar ook enkele droevige 
momenten met jullie gedeeld die mij altijd zullen bijblijven.  
 
Voordat ik überhaupt aan mijn eerste onderzoek kon beginnen heb ik moeten 
leren echoën. Marlou Vossen en Marleen Beckers, heel erg bedankt voor de tijd 
en moeite die jullie hebben genomen om mij te leren dat er ook daadwerkelijk 
iets te zien is op die zwart/grijs/wit beelden. Verder had ik zonder jullie ook nooit 
zo snel, genoeg zwangere vrouwen voor mijn onderzoek gevonden. Het was 
altijd weer een feest om de echokamer in te lopen en te zien dat er weer zoveel 
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aanmeldingen waren dankzij jullie enthousiaste wervingsacties! Na de spoed-
cursus echoën stond ik meteen voor een nieuwe uitdaging, namelijk het onder 
de knie krijgen van de habituatie techniek. Cathelijne van Heteren, jouw hele 
proefschrift gaat over foetale habituatie dus jij was uiteraard de aangewezen 
persoon om mij deze techniek aan te leren. Hartelijk dank hiervoor. 
 
Nadat alle benodigde technieken waren aangeleerd konden de studies van start 
gaan. Tijdens de gehele onderzoeksperiode heb ik veel hulp gekregen van 
medewerkers van het Maastricht University Medical Centre (MUMC), het Atrium 
MC in Heerlen, het Maaslandziekenhuis in Sittard en de verloskundigen uit 
deze regio’s. Allemaal hartelijk bedankt voor jullie inzet.  
Arnold Kester, beste Arnold, op het moment dat alle data verzameld waren 
kwam daar het moment van de statistiek. Ik heb heel wat uurtjes bij je 
doorgebracht en ook heel veel e-mails gestuurd. Dank je wel voor de fijne 
samenwerking en al dat engelengeduld dat je met mij hebt gehad (als ik het 
dacht te snappen maar even later bleek dat het toch niet het geval was).  
Hasibe, dank je wel voor het uitvoeren van een deel van de vetzuur-
analyses en het altijd luisterende oor! Ook ABL Assen wil ik bedanken voor hun 
bijdrage aan de vetzuuranalyses. Soms liet de computer me weleens in de 
steek maar dan waren daar altijd Loek en Paul om alles weer in orde te maken. 
Verder wil ik ook de (ex-)secretaresses Claudia, Desiree, Ilona, Kerstin, Larisa, 
Monique, Manon en Caroline van Humane Biologie (HB) en Obstetrie & 
Gynaecologie bedanken voor alle hulp.  
Jos Adam, Esther Bakker, José Breedveld-Peters, Manon van Eijsden, 
Willem Jan Gerver, Alex Ghys, Renate de Groot en Carel Thijs, dank jullie wel 
voor alle hulp door de jaren heen met betrekking tot de verschillende 
onderzoeken. Als over een onderzoek uiteindelijk een artikel wordt geschreven 
dan is de inzet en inbreng van alle mede-auteurs heel belangrijk. Daarom gaat 
er ook een groot ‘dank je wel’ naar Antje, Arnold, Gerard, Han, Henk, Jan, 
Janneke (nog bedankt voor alle epidemiologie lessen!), Maaike en Patrick.  
I would like to thank Prof. dr. ir. R.P. Mensink, Prof. dr. ir. P.A. van den 
Brandt, Dr. W.J.M. Gerver, Prof. dr. M. Hadders-Algra and Prof. dr. P. Hepper 
of the assessment committee for their time and effort in the critical evaluation of 
this thesis. 
Als het boekje eenmaal is goedgekeurd door de beoordelingscommissie 
kan het naar de drukker, maar dan moet er natuurlijk eerst nog een kaft om 
heen. Nanni, hartstikke bedankt voor het ontwerpen van de kaft, het is echt 
super mooi geworden! 
 
Zoals al een beetje kan worden opgemaakt uit het begin van dit dankwoord is 
mijn promotietraject iets anders gelopen dan ‘normaal’. De onderzoeken 
beschreven in dit proefschrift maakten deel uit van verschillende projecten 
waardoor ik werkzaam ben geweest op meerdere werkplekken. De laatste jaren 
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van mijn promotie ben ik qua werkplek in een rustiger vaarwater terecht-
gekomen en hiervoor wil ik ook Prof. dr. ir. Ronald Mensink bedanken. Ronald, 
dank je wel voor de mogelijkheid om mijn laatste onderzoek bij HB uit te kunnen 
voeren. Het is heel fijn om in een groep terecht te komen waar veel mensen 
met hetzelfde doel bezig zijn, namelijk uiteindelijk een mooi proefschrift 
afleveren en promoveren. Hierdoor kun je voor vele kleine maar ook grotere 
dingen bij elkaar terecht. Aangezien HB iets te groot is om iedereen op te 
noemen wil ik mij beperken tot de (ex-)middenlob-collega’s. Ariënne, Carla, 
Chris, Elke, Florence, Jogchum, Julia, Julian, Kirsten, Leonie, Marjolijn, Martine, 
Maurice, Noud, Pascal, Ruth, Stan en Stefan, dank jullie wel voor de gezellige 
en leuke tijd. Kirsten, ook al zit je al weer een tijdje op een andere plek, dank je 
wel voor de vele (en niet te vergeten lange) gezellige choco-pauzes!  
Nadat voor mij alle praktische werkzaamheden afgerond waren en ik me 
helemaal kon storten op het schrijven, kwam ik terecht bij de lotgenoten op 
verdieping 1 en uiteindelijk zelfs 0 (het zal een hint zijn geweest). Johan J., 
Julian en Stefan, de een was wat verder dan de ander maar allemaal waren we 
bezig met de laatste loodjes waardoor we veel aan elkaar hadden.  
 
Dan de twee personen die tijdens de verdediging letterlijk en figuurlijk achter me 
staan, mijn paranimfen Kathelijne en Kristel. Om te beginnen bij Kathelijne, we 
hebben samen de basisschool en de middelbare school doorlopen en zijn 
uiteindelijk ook weer op dezelfde universiteit terechtgekomen met als doel om 
uiteindelijk die ‘s’ van de titel af te krijgen. We vertellen weleens gekscherend 
dat we eerder zusjes dan vriendinnen zijn en ik denk dat dat genoeg zegt over 
onze band. Kristel, we hebben samen Gezondheidswetenschappen gestudeerd 
en zijn daarna tegelijkertijd begonnen aan onze promotie waardoor we altijd bij 
elkaar terecht konden (en kunnen) met onze verhalen. We hebben niet alleen 
heel wat afgelachen tijdens onze gezellige wandelpauzes en lunches, maar ook 
veel serieuze dingen besproken.  
 
Kathelijne en Rob, Naomi en Oscar, Karina, Ollie, Raimond en Renate, Sandra 
en John, Kristel en Rob, Barry en Ingrid en Paul en Nadine, dank jullie wel voor 
jullie vriendschap, de zinnige (maar vooral) onzinnige discussies over allerlei 
stellingen die we telkens weer bedachten, de etentjes, de ‘back-to-basic’ 
weekenden, de wandelingen, kortom te veel om op te noemen!  
Verder wil ik natuurlijk mijn (schoon)familie bedanken en dan met name mijn 
ouders. Mama en papa, mede dankzij jullie vertrouwen en onvoorwaardelijke 
steun heb ik het zover kunnen schoppen!  
Lieve Bas, het is een hele fijne gedachte om te weten dat er altijd iemand is 
die meer dan 100 % achter je staat en die iemand ben jij voor mij! Jouw 
bijdrage aan dit proefschrift is dan ook vele malen groter dan iedereen kan 
vermoeden. Dank je wel voor alles! Op naar onze volgende dromen die 
werkelijkheid mogen worden…  
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